Neutrophils sense microbe size and selectively release Neutrophil Extracellular Traps to control large pathogens by Branzk, HN
		
	
1	
						
NEUTROPHILS	SENSE	MICROBE	SIZE	AND	
SELECTIVELY	RELEASE	NEUTROPHIL	EXTRACELLULAR	TRAPS	
TO	CONTROL	LARGE	PATHOGENS			
HANNI	NORA	BRANZK									Molecular	Immunology	The	Francis	Crick	Institute	-	Mill	Hill	Laboratory	The	Ridgeway,	London	NW7	1AA				Supervised	by	Dr	Venizelos	Papayannopoulos							Submitted	to	University	College	London	for	the	degree	of	Doctor	of	Philosophy		April	2016		 	
		
	 	
2	
									 Examination	board:		Prof	Sussan	Nourshargh	Prof	Caetano	Reis	e	Sousa						Thesis	committee:		Prof	Brigitta	Stockinger	Dr	Andreas	Wack	Dr	Pavel	Tolar			 	
		
	
3	
	
	
	
	
	
	
	
	
	
	
	
	
	
I,	 Hanni	Nora	 Branzk	 confirm	 that	 the	work	 presented	 in	 this	 thesis	 is	my	own.	Where	information	has	been	derived	from	other	sources,	I	confirm	that	this	has	been	indicated	in	the	thesis.	
		 	
		
	 	
4	
	
	
ABSTRACT	
	
	
5	
Neutrophils	are	innate	immune	phagocytes	that	are	critical	for	antimicrobial	defence.	 Neutrophils	 are	 thought	 to	 control	 infection	 by	 implementing	 a	single	 antimicrobial	 program.	 It	 is	 unclear	 whether	 they	 are	 able	 to	 adapt	their	 antimicrobial	 strategies	 to	 the	 different	 types	 of	 microbes	 they	encounter.	Neutrophil	extracellular	traps	(NETs)	are	web-like	structures	that	are	 composed	 of	 decondensed	 chromatin,	 decorated	 with	 neutrophil	antimicrobial	 proteins.	NETs	 have	 been	 shown	 to	 trap	 and	 kill	 a	 variety	 of	microbes	 including	 parasites,	 fungi,	 bacteria	 and	 even	 viruses	 but	 their	relevance	for	 immune	defence	 in	vivo	remained	unresolved.	Furthermore,	 it	was	 unknown	 whether	 neutrophils	 regulate	 NET	 release	 to	 selectively	targeted	specific	microbes.	
This	work	examined	 the	 role	of	NETs	 in	 antimicrobial	 defence.	 Specifically,	we	 asked	whether	 NET	 release	 is	 a	 regulated	 process	 that	 targets	 distinct	sets	of	microbes	and	how	regulation	of	NETosis	was	achieved.	Furthermore,	we	 examined	 the	 relevance	 of	 NETs	 against	 different	 microbes	 in	 vivo.	Finally,	 we	 investigated	 which	 receptors	 were	 involved	 in	 triggering	 NET	release	in	response	to	the	fungus	Candida	albicans.	
Using	 dimorphic	 fungi	 and	 bacteria	we	 found	 that	 the	 neutrophils	 regulate	their	 antimicrobial	 strategies	 depending	 on	 the	 size	 of	 the	 microbe	 they	encounter.	 Small	 microbes	 such	 as	 C.	 albicans	 yeast	 are	 phagocytosed,	whereas	 large	microbes	 such	 as	 C.	 albicans	hyphae	 trigger	 NET	 formation.	NETs	were	 critical	 for	 the	 clearance	 of	 large	 hyphae	 but	were	 dispensable	against	small	yeast	 in	mice.	These	data	explain	 the	specific	susceptibility	 to	fungal	 infection	 observed	 in	MPO-deficient	 patients,	whose	 neutrophils	 are	defective	in	NET	formation.	
Importantly,	 we	 found	 that	 phagocytosis	 is	 a	 negative	 regulator	 of	 the	NETosis	 pathway.	 Sequestration	 of	 neutrophil	 elastase	 in	 the	 phagosome	inhibits	 its	 translocation	 to	 the	 nucleus,	 a	 crucial	 requirement	 for	NETosis.	This	strict	regulation	was	crucial	since	excessive	release	of	NET	caused	tissue	damage	and	immune	pathology.	
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Furthermore,	we	identified	a	set	of	C.	albicans	cell	wall	mutants	that	failed	to	trigger	NETosis,	 indicating	 that	N-	 and	O-linked	mannosylation	 of	 cell	wall	proteins	 might	 be	 implicated	 in	 NET	 induction.	 Consistently,	 preliminary	results	 suggest	 the	 involvement	 of	 TLR4	 and	 MR	 in	 the	 initiation	 of	 the	NETosis	pathway	upon	stimulation	with	C.	albicans.	
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This	 study	 addresses	 whether	 neutrophils	 are	 able	 to	 regulate	 their	antimicrobial	 strategies.	 Specifically,	 we	 investigated	 whether	 neutrophil	extracellular	 traps	 (NETs)	 are	 employed	 selectively.	 Since	 neutrophils	 are	crucially	 involved	 in	 antifungal	 immunity,	 we	 employed	 the	 dimorphic	fungus	Candida	albicans	as	a	model	for	the	variability	of	microbes.	Therefore,	the	 following	 chapters	 will	 introduce	 what	 was	 known	 about	 neutrophil	immunity	 and	 the	 release	 of	 NETs	 specifically	 in	 the	 context	 of	 antifungal	immunity.	
The	immune	system	
Immunity	is	an	organism’s	defence	against	infection.	It	requires	the	capacity	to	distinguish	infectious	particles	from	the	host’s	own	tissues.	Some	form	of	immune	 defence	 is	 present	 in	 nearly	 all	 forms	 of	 life,	 including	 plants	 and	unicellular	 organisms.	 Bacteria	 use	 enzymes	 to	 defend	 themselves	 against	bacteriophage	 infection.	 Immune	 systems	 gained	 complexity	 during	evolution.	 Whereas	 innate	 immunity	 is	 found	 in	 all	 plants	 and	 animals,	adaptive	immunity	occurred	first	in	jawed	vertebrates	(Flajnik	and	Kasahara,	2010).	
In	higher	organisms	the	immune	system	has	a	layered	structure.	As	the	first	line	 of	 defence,	 skin	 and	mucosal	 lining	 provide	mechanical,	 biological	 and	chemical	 barriers.	 Thereafter,	 innate	 leukocytes	 (white	 blood	 cells)	 are	immediately	available.	The	innate	immune	system	is	not	specific	against	any	particular	pathogen	but	combats	a	wide	range	of	microbes.	Broad	pathogen	associated	 molecular	 patterns	 (PAMPs)	 are	 recognised	 by	 pre-formed	pattern	 recognition	 receptors	 (PRRs).	 In	 higher	 vertebrates,	 innate	 and	adaptive	 immunity	 work	 together.	 If	 the	 innate	 immune	 system	 is	 not	sufficient	to	resolve	an	infection,	an	adaptive	immune	response	is	triggered.	Adaptive	 immunity	 is	 highly	 specific	 and	 adapts	 to	 infection	 with	 distinct	microbes	through	production	of	unique	receptors.	Adaptive	 immunity	takes	time	 to	develop	and	 is	 continuously	reshaped	 throughout	 the	 lifetime	of	an	organism.	 It	 confers	 immunological	 memory,	 allowing	 for	 a	 rapid	 recall	
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response	upon	re-infection	with	the	same	microbe.	Protective	vaccination	is	based	on	immunological	memory	(Murphy,	2012).	
Immune	 cells	 are	 produced	 mainly	 in	 the	 bone	 marrow	 (BM)	 where	 they	develop	and	mature.	A	common	hematopoietic	stem	cell	gives	rise	to	most	of	the	many	different	hematopoietic	lineages.	
Innate	 immune	 cells	 include	macrophages,	 dendritic	 cells	 (DCs),	mast	 cells,	neutrophils,	eosinophils,	basophils,	and	natural	killer	(NK)	cells.	These	cells	have	direct	antimicrobial	effects	by	release	of	toxic	factors	or	elimination	of	small	 microbes	 via	 phagocytosis.	 Innate	 immune	 cells	 are	 also	 important	activators	 of	 the	 adaptive	 immune	 system	 via	 the	 release	 of	 signalling	molecules	 called	 cytokines.	 The	 complement	 system	 forms	 another	important	 part	 of	 innate	 immunity.	 Different	 complement	 proteins	 coat	microbial	surfaces	and	mark	them	for	elimination	(Murphy,	2012).		
The	adaptive	immune	system	depends	on	B	lymphocytes	and	T	lymphocytes,	which	 represent	 the	 humoral	 and	 the	 cell-mediated	 immune	 response,	respectively.	Both,	B	and	T	cells	carry	highly	specific	receptors	that	recognise	only	a	single	antigen.	These	antigen-specific	receptors	are	produced	through	a	 process	 called	 somatic	 recombination	 in	 the	 early	 stages	 of	 B	 and	 T	 cell	maturation.	T	cells	carry	their	receptors	(TCR)	on	their	surface	and	recognise	antigens	 presented	 by	 the	 major	 histocompatibility	 (MHC)	 complex.	 The	main	classes	of	T	cells	are	killer	T	cells,	T	helper	cells	and	regulatory	T	cells.	Dependent	 on	 their	 phenotype,	 T	 cells	 either	 directly	 kill	 infected	 or	dysfunctional	 cells	 or	 instruct	 other	 immune	 cells	 to	 do	 so.	 When	 B	 cells	recognise	 antigen	 through	 their	 receptor	 (BCR),	 they	 internalise	 it	 and	present	 it	 on	 their	 surface.	 Subsequent	 activation	 of	 these	 B	 cells	 leads	 to	formation	 of	 plasma	 cells,	 which	 then	 secrete	 millions	 of	 copies	 of	 their	specific	receptor	in	the	form	of	antibodies.	Antibodies	circulate	in	the	blood,	where	 they	 mark	 (opsonise)	 pathogens	 that	 carry	 the	 specific	 antigen.	Opsonisation	 leads	 to	 complement	 activation	 or	 uptake	 by	 phagocytes	(Murphy,	2012).	
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Activation	 of	 T	 and	 B	 cells	 leads	 to	 formation	 of	 antigen-specific	 memory	cells.	 In	the	event	of	re-infection	with	the	same	pathogen,	memory	cells	can	mount	 a	 faster	 and	 stronger	 response,	 mediating	 protection.	 Memory	 was	long	 thought	 to	 be	 a	 unique	 feature	 of	 the	 adaptive	 immune	 system.	However,	 the	recent	discovery	of	 trained	 innate	 immunity,	a	 form	of	 innate	memory,	challenges	this	dogma	(van	der	Meer,	2015).	
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1.1 Neutrophils	
Neutrophils	 are	 the	 most	 abundant	 immune	 cells	 in	 the	 human	 body	 and	neutrophil	 deficiencies	 lead	 to	 severe	 infections,	 which	 are	 often	opportunistic.	Neutrophils	are	characterised	by	a	 lobulated	nucleus	and	are	therefore	 characterised	 as	 polymorphonuclear	 cells	 (PMNs).	 They	 carry	different	pre-formed	types	of	granules	that	contain	more	then	700	different	antimicrobial	 granule	 proteins	 (Borregaard,	 2007).	 Neutrophils	 develop	 in	the	 bone	marrow	 (BM)	 and	 are	 terminally	 differentiated	 in	 the	 blood.	 The	neutrophil	 life	 span	 varies	 with	 species	 and	 ranges	 from	 several	 hours	 to	days	 (Pillay,	 2010;	 Tak,	 2013).	 It	 is	markedly	 increased	 upon	 activation	 at	inflammatory	 sites.	 Neutrophils	 are	 recruited	 to	 tissues	 in	 response	 to	microbial	molecules	 and	 cytokines	produced	by	 tissue	 resident	 cells.	These	include	IL-1β,	 IL-6,	TNF-α,	 IL-8	as	well	as	 IL-17.	Neutrophils	arrive	 in	great	numbers	 as	 the	 first	 cells	 at	 the	 site	 of	 infection.	They	 extravasate	 through	the	endothelium	after	endothelial	signals	and	rolling	on	the	endothelial	walls	(Kolaczkowska	and	Kubes,	2013;	Nourshargh	and	Alon,	2014).	In	the	tissues	neutrophils	 are	 fully	 equipped	 for	 a	 range	 of	 different	 antimicrobial	strategies	 including	 degranulation,	 phagocytosis,	 release	 of	 neutrophil	extracellular	 traps,	 autophagy,	 apoptosis	 and	 pyroptosis	 (Kruger,	 2015).	Furthermore,	 neutrophils	 activate	 other	 immune	 cells	 such	 as	 DCs,	macrophages,	 NK	 cells,	 B	 cells	 and	 T	 cells	 (Mantovani,	 2011).	 However,	neutrophils	 are	 also	 implicated	 in	 a	 range	 of	 diseases	 including	 cancer,	metabolic	and	inflammatory	diseases	(Bardoel,	2014).	
1.1.1 Neutrophil	production	and	release	
Granulopoiesis	
Approximately	1-2x1011	neutrophils	 are	produced	daily	 in	humans,	making	granulopoiesis	the	greatest	activity	of	the	BM.	The	hematopoietic	stem	cells	(SCs)	are	 localised	 in	osteoblast	niches	 that	are	characterised	by	 low	blood	flow	 and	 low	 oxygen	 levels.	 More	 mature	 cells	 migrate	 out	 of	 the	 BM	
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sinusoids	 and	 are	 based	 on	 the	 abluminal	 site	 of	 the	 vasculature	 (Winkler,	2010).	
Granulocyte-colony	 stimulating	 factor	 (G-CSF)	 is	 important	 throughout	 all	stages	 of	 neutrophil	 development,	 including	 production,	 proliferation,	survival,	differentiation	and	mobilisation	into	tissues	(Semerad,	2002).	G-CSF	is	 produced	 in	 different	 tissues	 upon	 stimulation	 with	 inflammatory	mediators	 such	 as	 IFN-β,	 TNF-α,	 IL-1	 or	 IL-17.	 Endothelial	 cells	 and	macrophages	are	a	prominent	source	of	G-CSF	(Roberts,	2005).	Despite	 the	importance	 of	 G-CSF	 in	 neutrophil	 development,	 G-CSF-deficient	 mice	 still	support	25%	granulopoiesis	and	can	produce	mature	neutrophils	(Lieschke,	1994).	 Conventional	DCs	 control	 the	production	of	G-CSF.	Depletion	of	DCs	leads	to	accumulation	of	G-CSF	and	loss	of	neutrophils	from	the	bone	marrow	followed	by	secondary	neutrophilia	(Jiao,	2014).	
Granulopoiesis	 starts	 with	 the	 development	 of	 precursors	 in	 the	 stem	 cell	pool.	Thereafter,	terminal	differentiation	is	comprised	of	a	mitotic	pool	and	a	post-mitotic	pool	that	are	separated	by	cell	cycle	exit	(Klausen,	2004).	Post-mitotic	 BM	 neutrophils	 constitute	 95%	 of	 the	 neutrophils	 in	 the	 body	 and	rapidly	enter	circulation.	
The	self-renewable	hematopoietic	stem	cells	(HSC)	are	present	in	the	BM	in	low	numbers	where	they	are	maintained	in	the	BM	niches	by	interaction	with	stromal	cells	such	as	osteoblasts	(Orkin	and	Zon,	2008).	HSC	lose	their	self-renewing	 capacity	 when	 they	 turn	 into	 multipotent	 precursors	 (MPP)	(Görgens,	2013).	Under	the	influence	of	the	transcription	factor	GATA-1	MPP	develop	 into	 erythromyeloid	 progenitors	 (EM)	 that	 give	 rise	 to	 the	 other	granulocyte	 members	 eosinophils	 and	 basophils	 (Figure	 I-1).	 For	 myeloid	lineage	 commitment,	 activation	 of	 the	 transcription	 factor	 PU.1	 is	 required	(Iwasaki,	 2005;	 Nerlov	 and	 Graf,	 1998)	 leading	 to	 development	 of	lymphomyeloid	 progenitors	 (LMP)	 (Arinobu,	 2007;	 McKercher,	 1996).	 The	last	 step	 of	 precursor	 development	 is	 the	 subsequent	 formation	 of	granulocyte/monocyte	 precursors	 (GMP).	 Continued	 PU.1	 activity	 drives	
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monocyte	 commitment.	 GMP	 that	 are	 under	 the	 influence	 of	CCAAT/enhancer	 binding	 protein	 α	 (C/EBPα),	 continue	 towards	 terminal	granulocytopoiesis	 leading	 to	 formation	 of	 mature	 granulocytes.	 C/EBPα	regulates	 the	 expression	 of	 proteins	 that	 are	 necessary	 for	 neutrophil	differentiation,	 such	 as	 the	 G-CSF	 receptor	 (Radomska,	 1998).	 The	 NF-κB	subunit	 p50	 activates	C/EBPα	 alone	or	 in	 complex	with	C/EBPα,	 to	 induce	enhanced	 G-CSF	 production.	 The	 first	 stage	 of	 C/EBPα-dependent	 terminal	differentiation	is	the	formation	of	myeloblasts	(Dahl,	2003;	Radomska,	1998;	Reddy,	 2002),	 which	 are	 comparatively	 small	 and	 do	 not	 contain	 granule	proteins.	Like	C/EBPα,	the	transcription	factor	growth	factor	independent-1	(Gfi-1,	 also	Lef-1)	 is	activated	 in	 the	early	 stages	of	 terminal	differentiation		
		
Figure	 I-1	 |	Neutrophil	 development.	During	precursor	development	hematopoietic	 stem	cells	
(HSC)	give	rise	to	multipotent	precursors	(MPP)	and	lymphomyeloid	precursors	(LMP).	Terminal	
differentiation	 progresses	 from	 myeloblasts	 via	 promyelocytes,	 myelocytes	 through	
metamyelocytes	 and	 band	 cells	 to	 segmented	 neutrophils.	 Granules	 are	 sequentially	 formed:	
azurophilic	 granules	 (black),	 specific	 granules	 (red),	 gelatinase	 granules	 (blue)	 and	 secretory	
granules.	Granulopoiesis	during	homeostasis	is	dependent	on	various	transcription	factors	of	the	
C/EBP	 family,	whereas	emergency	granulopoiesis	 is	mainly	driven	by	C/EBPβ.	 |	Reprinted	 from	
Cell	Host	&	Microbe,	(Bardoel,	2014),	Copyright	2014,	with	permission	from	Elsevier.	
INTRODUCTION	
	
	
23	
and	 decreases	 during	 neutrophil	 development	 (Bjerregaard,	 2003).	 Next,	myeloblasts	 differentiate	 into	 promyelocytes.	 From	 this	 stage	 onward	granules	 are	 produced	 gradually	 and	 promyelocytes	 contain	 primary	 (or	azurophilic)	granules.	Secondary	(or	specific)	granule-containing	myelocytes	develop	next.	This	stage	of	development	is	marked	by	cell	cycle	exit	(Klausen,	2004).	From	the	myelocyte	stage	 to	 the	 following	metamyelocyte	stage,	 the	transcription	factor	C/EBPε	is	expressed	for	a	short	time.	C/EBPε	is	required	for	 the	expression	of	 granule	proteins	 (Bjerregaard,	2003;	Morosetti,	1997;	Yamanaka,	1997)	and	C/EBPε	mutation	leads	to	the	rare	condition	of	specific	granule	 deficiency	 (Gombart,	 2001).	 Metamyelocytes	 further	 differentiate	into	 band	 cells,	 containing	 tertiary	 (or	 gelatinase)	 granules.	 Finally,	segmented	 neutrophils	 that	 contain	 secretory	 vesicles	 leave	 the	 BM	 and	enter	the	blood	stream	(Bainton,	1971)	(Figure	I-1).	They	are	characterised	by	 a	 segmented	 nucleus	 and	 contain	 more	 than	 700	 different	 granule	proteins	(Rørvig,	2013).	
The	transcription	factor	Gfi-1	is	required	for	neutrophil	differentiation	(Hock,	2003;	 Karsunky,	 2002)	 and	 is	 upregulated	 during	 SC	 commitment	 to	 the	granulocyte	 lineage	 (Velu,	 2009).	 Gfi-1	 represses	 SC	 genes,	 which	 drives	differentiation	 and	 restricts	 SC	 proliferation	 (Hock,	 2004;	 Horman,	 2009).	Furthermore,	 Gfi-1	 is	 an	 inhibitor	 of	 monocytopoiesis.	 It	 represses	 the	transcription	factor	early	growth	response-2	(Egr2)	as	well	as	Csf1,	the	gene	coding	 for	 the	 monocyte-promoting	 colony	 stimulating	 factor	 1	 (CSF-1)	(Zarebski,	 2008).	Mutations	 that	 affect	 the	 DNA	 binding	 site	 of	 Gfi-1	 cause	severe	congenital	neutropenia	(Person,	2003).	
PU.1	 activity	 is	 important	 for	 the	 initial	 myelopoiesis	 commitment	 and	increases	during	the	maturation	from	the	myelocyte	stage	on.	PU.1-deficient	mice	are	impaired	in	terminal	differentiation	of	granulocytes	and	have	a	lack	of	committed	SCs	(Bjerregaard,	2003).	
C/EBPα	 expression	 slowly	 decreases	 after	 the	 myeloblast	 stage,	 whereas	C/EBPε	 is	 at	 its	 highest	 at	 the	 myelocyte-metamyelocyte	 stage.	 C/EBPβ,	
INTRODUCTION	
	
	 	
24	
C/EBPγ,	 C/EBPδ	 and	 C/EBPζ	 all	 continuously	 increase	 after	 the	metamyelocyte	 stage	 up	 until	 the	 end	 (Bjerregaard,	 2003)	 (Figure	 I-1).	C/EBPs	 form	 homo-	 and	 heterodimers	 and	 are	 additionally	 regulated	 by	phosphorylation,	 enabling	 a	 highly	 specific	 expression	 of	 granule	 proteins	during	terminal	differentiation	(Chumakov,	2007).	
Neutrophil	release	
Under	normal	conditions	only	mature	neutrophils	are	released	from	the	BM	whereas	 hematopoietic	 stem	 cells	 are	 retained	 in	 BM	 niches.	 Therefore,	neutrophils	 express	 different	 CXCR	motif	 receptors	 that	 regulate	 retention	and	release.	
BM	 stromal	 cells	 such	 as	 osteblasts	 and	 vascular	 endothelial	 cells	 produce	membrane	 bound	 forms	 of	 stem	 cell	 factor	 and	 stromal	 derived	 factor	 1	(SDF1	 or	 CXCL12),	 which	 bind	 c-kit	 (CD117)	 and	 CXCR4	 on	 neutrophils,	respectively.	 CXCR4	 is	 required	 for	 the	 retention	 of	 SCs	 and	 neutrophils	 in	the	BM	and	 its	expression	gradually	decreases	as	neutrophils	mature	 (Ding	and	Morrison,	2013;	Ding,	2012;	Lapidot	and	Kollet,	2002).	Increased	CXCR4	signalling	 in	 WHIM	 syndrome	 (warts,	 hypogammaglobulinemia,	 infections,	myelokathexis)	 causes	 neutrophil	 deficiency	 in	 the	 circulation	 and	accumulation	 of	 mature	 neutrophils	 in	 the	 BM	 (Hernandez,	 2003).	 G-CSF	signalling	 downregulates	 expression	 of	 CXCL12	 by	 BM	 endothelial	 cells,	allowing	for	neutrophil	egress	(Christopher,	2009).	
Conversely,	 during	 neutrophil	 maturation	 expression	 of	 CXCR2	 increases,	allowing	 neutrophils	 to	 respond	 to	 the	 pro-release	 signals	 CXCL1	 (KC),	CXCL2	(MIP-2),	CXCL3,	CXCL5	and	CXCL6	as	well	as	CXCL8	(IL-8)	in	humans	(Hopman	 and	 DiPersio,	 2014;	 Martin,	 2003).	 G-CSF	 upregulates	 the	expression	of	CXCL1	and	CXCL2	on	BM	endothelial	cells,	favouring	neutrophil	release,	whereas	deletion	of	CXCR2	leads	to	retention	of	mature	neutrophils	in	the	BM	(Eash,	2009).	
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Homeostasis	
Neutrophils	 are	 not	 only	 important	 for	 antimicrobial	 defence,	 but	 are	 also	able	 to	 harm	 the	 host.	 Therefore,	 tight	 regulation	 of	 neutrophil	 production	and	 release	 is	 crucial.	 At	 steady	 state	 only	 1-2%	of	mature	neutrophils	 are	found	 in	 circulation	 in	 mice.	 The	 number	 of	 neutrophils	 in	 the	 peripheral	tissues	 influences	 the	 production	 rate	 of	 new	 neutrophils	 in	 a	 negative	feedback	 loop.	 Low	 levels	 of	 peripheral	 neutrophils	 stimulate	 resident	macrophages	and	DCs	to	produce	IL-23,	which	in	turn	activates	production	of	IL-17A	 by	 γδ	 T	 cells	 and	 NK-like	 T	 cells	 (Ley,	 2006).	 IL-17A	 stimulates	production	 of	 G-CSF,	 which	 enhances	 neutrophil	 differentiation	(Schwarzenberger,	2000;	Stark,	2005).	In	contrast,	abundance	of	neutrophils	in	 the	peripheral	 tissues	 leads	 to	neutrophil	 apoptosis	and	clearance	of	 the	apoptotic	 cells	 by	macrophages	 and	DCs.	This	process	 termed	efferocytosis	leads	 to	 a	 reduction	 of	 the	 IL-23	 production	 (Ley,	 2006;	 Stark,	 2005;	 von	Vietinghoff	 and	 Ley,	 2009)	 followed	 by	 low	 levels	 of	 IL-17A	 and	 G-CSF,	causing	 neutrophil	 retention	 in	 the	 BM.	 The	 importance	 of	 IL-17A	 in	 this	process	is	still	debated	since	mice	that	are	deficient	in	IL-17-producing	cells	can	 still	 increase	 granulopoiesis	 independent	 of	 IL-17	 (Bugl,	 2012;	 Bugl,	2013).		
Ageing	(CD62Llo)	neutrophils	upregulate	CXCR4	and	home	to	the	BM,	where	they	 are	 ingested	 by	 macrophages.	 The	 macrophages	 in	 turn	 activate	 the	transcription	factor	LXR	that	mediates	downregulation	of	CXCL12	on	stromal	cells,	 leading	 to	 release	 of	 CD62Lhi	 neutrophils	 from	 the	 BM	 (Casanova-Acebes,	2013).	The	renewal	of	the	neutrophil	pool	peaks	every	24	hours	and	is	dependent	on	the	circadian	rhythm	mediated	by	the	sympathetic	nervous	system	(Scheiermann,	2012).	
Emergency	granulopoiesis	
Neutrophils	 are	 one	 of	 the	 key	 cell	 types	 in	 antimicrobial	 defence	 and	 are	readily	 recruited	 to	 the	 site	 of	 infection.	 Since	 the	 majority	 of	 neutrophils	
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undergo	 cell	 death	 in	 the	 tissue,	 antimicrobial	 activity	 leads	 to	 neutrophil	consumption.	 If	 local	 infections	 are	 not	 cleared	 and	 spread	 systemically,	neutrophil	depletion	increases.	To	replenish	the	neutrophil	pool	and	provide	continuously	 for	 the	 high	 demand	 of	 neutrophils	 during	 infection,	 steady	state	 granulopoiesis	 switches	 to	 emergency	 granulopoiesis	 (Manz	 and	Boettcher,	 2014).	 This	 involves	 the	 de	 novo	 generation	 of	 neutrophils	 by	increased	 proliferation	 of	 myeloid	 progenitors	 as	 well	 as	 the	 release	 of	mature	 and	 immature	neutrophils	 from	 the	BM.	Neutrophil	 depletion	upon	chemotherapy	 or	 irradiation	 also	 triggers	 a	 compensatory	 granulopoiesis	that	is	similar	to	emergency	granulopoiesis	upon	systemic	infection.	
Increased	 serum	 concentrations	 of	 microbial	 products	 and	 inflammatory	mediators	 such	as	 IL-6,	TNFα,	G-CSF,	GM-CSF	and	 IL-3	during	 infection	are	sensed	by	tissue	macrophages	or	non-immune	cells	(Kawakami,	1990;	Selig	and	 Nothdurft,	 1995;	 Tanaka,	 1996).	 Emergency	 granulopoiesis	 and	neutrophil	 release	 is	 dependent	 on	 C/EBPβ	 (Hirai,	 2013;	 Hirai,	 2006)	(Figure	 I-1)	 and	 therefore	 responsive	 to	 G-CSF.	 However,	 the	 absolute	requirement	for	G-CSF	during	emergency	granulopoiesis	is	dependent	on	the	type	of	infection.	Whereas	G-CSF	is	not	required	during	C.	albicans	 infection	(Basu,	 2000),	 it	 is	 crucial	 in	 the	 context	 of	 Listeria	 monocytogenes	(Panopoulos	and	Watowich,	2008).	The	recognition	of	microbial	components	in	this	context	 involves	signalling	through	TLR4	and	TRIF	and	is	dependent	on	 the	 microbiome.	 Strikingly,	 germ-free	 mice	 are	 severely	 neutropenic	(Bugl,	2013).	
The	 differentiation	 of	 neutrophils	 can	 also	 occur	 at	 the	 site	 of	 infection.	Hematopoietic	stem	and	progenitor	cells	(HSPC)	can	migrate	to	tissues	such	as	 skin	 wounds	 where	 they	 differentiate	 into	 mature	 neutrophils.	 This	process	is	dependent	on	TLR2	and	MyD88	(Granick,	2013).	
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Extravasation	
For	neutrophils	 to	 reach	 the	sites	of	 infection,	 they	need	 to	 leave	 the	blood	vessels	 and	 transmigrate	 through	 the	 endothelial	 wall	 into	 the	 tissue.	Transmigration	 is	 not	 only	 a	 migration	 process,	 but	 also	 further	 primes	neutrophils	for	their	subsequent	antimicrobial	activity,	leading	to	an	altered,	activated	 phenotype.	 Neutrophil	 transmigration	 is	 preceded	 by	 a	 tightly	regulated	adhesion	cascade	 that	 is	mediated	by	selectins	and	 integrins.	The	process	 is	 initiated	 by	 microbial	 PAMPs,	 danger	 associated	 molecular	patterns	 (DAMPs)	 from	 damaged	 or	 dead	 cells	 or	 cellular	 stress.	 These	signals	 are	 integrated	 by	 tissue	 resident	macrophages,	mast	 cells	 and	 DCs.	The	 subsequent	 release	 of	 pro-inflammatory	molecules	 initiates	 neutrophil	recruitment	(Ley,	2007).	
The	vessel	endothelium	proximal	to	the	site	of	 infection	is	activated	rapidly	(within	minutes)	by	 inflammatory	molecules	such	as	histamine	and	platelet	activating	 factor	 (PAF).	 This	 type	 I	 activation	 leads	 to	 expression	 of	 pre-formed	 adhesion	 molecules	 such	 as	 P-selectin,	 independent	 of	 protein	synthesis.	 Type	 II	 endothelium	 activation	 is	 slow	 (hours)	 and	 requires	 de	
novo	 transcription	 of	 selectins,	 integrin	 ligands	 and	 chemoattractants.	 It	 is	induced	by	IL-1β	and	TNFα	(Pober	and	Sessa,	2007).	
Neutrophils	arriving	in	the	postcapillary	venules	close	to	the	site	of	infection	engage	in	weak	and	transient	interactions	with	the	endothelial	cells,	leading	to	 reversible	 capture	 by	 the	 endothelium	 (Figure	 I-2).	 Neutrophil	glycoproteins	such	as	the	P-selectin	glycoprotein	ligand-1	(PSGL-1)	bind	to	P-	and	 E-selectins	 on	 the	 endothelium.	 Additionally,	 free	 neutrophils	 can	interact	 with	 already	 attached	 neutrophils	 via	 binding	 of	 a	 leukocyte	 L-selectin	 to	 PSGL-1	 (Walcheck,	 1996).	 These	 interactions	 are	 stabilised	 by	flattening	of	neutrophil	microvilli,	elongation	of	the	rear	ends	and	formation	of	membrane	 slings	 (Chen	 and	 Springer,	 1999;	 Sundd,	 2012).	 This	 process	slows	 the	 neutrophils	 down,	 leading	 to	 rolling	 along	 the	 endothelium,	 and	increases	 the	 interaction	 surface	 for	 integrins	 and	 chemokine	 receptors	
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(Figure	 I-2).	 Rolling	 neutrophils	 bind	 to	 E-selectin	 via	 PSGL-1	 and	 initiate	further	 short-lived	 and	 weak	 bonds	 to	 the	 endothelium:	 Neutrophil	lymphocyte	 function-associated	 antigen	 1	 (LFA-1,	 integrin	αLβ2)	 and	 very	late	 antigen-4	 (VLA-4,	 integrin	 α4β1)	 bind	 to	 endothelial	 intercellular	adhesion	molecule	 1	 (ICAM-1,	 CD54)	 and	 vascular	 cell	 adhesion	 protein	 1	(VCAM-1,	CD106).	These	interactions	further	slow	down	the	rolling,	until	the	neutrophils	 come	 to	 arrest	 (Zarbock,	2011)	 (Figure	 I-2).	Arrest	 is	 initiated	by	inside-out	signalling	by	chemoattractants	via	G-protein-coupled	receptors	(GPCR)	on	neutrophils.	GPCR	signalling	activates	high	affinity	bonds	through	Macrophage-1	 antigen	 (Mac-1,	 integrin	 αMβ2),	 LFA-1	 and	 VLA-4	 and	 the	endothelial	ICAM-1	and	VCAM-1	(Alon	and	Feigelson,	2009;	Dixit	and	Simon,	2012).	 Adherent	 neutrophils	 now	 crawl	 along	 chemotactic	 cues	 by	 serially	activating	integrins	via	chemokine-GPCR	signalling	(Shulman,	2009)	(Figure	
I-2).	 The	 crawling	 is	 regulated	 by	 the	 actomyosin	machinery	 and	 involves	cytoskeletal	 rearrangements	 and	 integrin	 recycling.	 Crawling	 neutrophils	display	a	protrusive	leading	edge	as	well	as	a	contractile	rear	uropod	(Hyun,	2012).	The	serial	activation	of	 integrin	contacts	allows	neutrophils	 to	move	against	or	perpendicular	to	the	blood	flow	direction.	
	
Figure	I-2	|	Neutrophil	extravasation.	Neutrophil	are	captured	by	the	endothelial	 lining,	where	
they	 roll,	 arrest,	 adhere	 and	 crawl	 in	 an	 integrin-	 and	 selectin-	 mediated	 leucocyte	 adhesion	
cascade.	 Finally,	 neutrophils	 migrate	 trough	 the	 epithelial	 layer	 via	 a	 paracellular	 or	 a	
transcellular	route.	On	the	abluminal	side	of	the	vessel,	neutrophils	breach	through	the	pericyte	
sheath	and	the	basement	membrane.	|	Reprinted	by	permission	from	Macmillan	Publishers	Ltd:	
Nature	Reviews	Molecular	Cell	Biology,	(Nourshargh,	2010),	copyright	2010.		
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Finally,	neutrophils	transmigrate	through	the	endothelium	out	of	the	vessel,	by	extension	of	protrusions	through	cell-cell	junctions	or	into	endothelial	cell	bodies	 (Figure	 I-2).	 This	 transendothelial	 migration	 (TEM)	 requires	 a	combination	 of	 exit	 cues,	 chemotactic	 guidance,	 specific	 endothelial	interactions	and	changes	in	neutrophil	morphology	(Nourshargh,	2010).	70-90%	of	TEM	is	paracellular	and	occurs	between	adjacent	cells	by	breaching	cell-cell	 junctions.	Only	a	small	 fraction	of	neutrophils	 leaves	the	vessels	on	the	transcellular	route,	crossing	directly	through	endothelial	cell	bodies	(Ley,	2007;	Woodfin,	2011).	
Signalling	 via	 ICAM-1	 and	 VCAM-1	 induces	 reduction	 in	 the	 endothelial	barrier	properties,	which	include	increased	intracellular	Ca2+	concentrations,	increased	 ROS	 production	 and	 activation	 of	 p38	mitogen-activated	 protein	kinase	(MAPK)	signalling	(Hu,	2000;	Huang,	1993;	Martinelli,	2009).	ICAM-1	activation	 leads	 to	 phosphorylation	 of	 cell	 junction	 molecules	 (Allingham,	2007).	 Junctional	 structures	 in	 the	 endothelium	 are	 mainly	 adherens	junctions	 that	 contain	 VE-cadherin	 and	 tight	 junctions.	 The	 expression	 of	adhesion	molecules	 is	 regulated	 by	 inflammatory	 signals	 and	 TEM	 (Voisin	and	 Nourshargh,	 2013).	 Junctional	 adhesion	 molecules	 can	 recycle	 into	intracellular	 compartments	 (Muller,	 2011).	 Close	 proximity	 of	 adherent	leukocytes	 induces	 the	 transient	 loss	 of	 surface	 VE-cadherin	 by	 reversible	endocytosis	 (Wessel,	 2014).	 Accordingly,	 leukocyte	 transmigration	 is	inhibited	 in	 mice	 with	 defects	 in	 VE-cadherin	 endocytosis	 and	 turnover	(Broermann,	2011;	Vestweber,	2012).	
Transcellular	 TEM	 is	 induced	 by	 ICAM-1	 signalling	 and	 its	 translocation	 to	actin-	 and	 caveola-rich	 domains.	 Formation	 of	 vesiculovacuolar	 organelles	(VVOs)	and	 intracellular	channels	allows	neutrophils	 to	breach	 through	 the	endothelial	cells	via	a	transcellular	pore	(Carman,	2007;	Millan,	2006).	
To	leave	the	vessel	walls	neutrophils	need	to	exit	on	the	abluminal	side	and	cross	 through	 the	 pericyte	 sheath	 and	 the	 venular	 basement	 membrane	(Nourshargh,	 2010).	 Pericytes	 are	 irregularly	 wrapped	 around	 the	
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endothelial	 cells	 and	 embedded	 in	 the	 basement	 membrane.	 They	 express	adhesion	 molecules,	 chemokines	 and	 receptors	 for	 pro-inflammatory	cytokines	 (Pober	 and	 Tellides,	 2012;	 Stark,	 2013;	 Voisin	 and	 Nourshargh,	2013).	Pericytes	provide	a	matrix	for	neutrophils	to	crawl	out	of	the	venular	wall,	 dependent	 on	 interactions	 between	 pericyte	 ICAM-1	 and	 neutrophil	Mac-1	and	LFA-1	 (Proebstl,	2012).	During	TEM,	neutrophils	are	 specifically	primed	 for	 this	 interaction	 with	 pericytes	 (Ayres-Sander,	 2013).	 How	neutrophils	 breach	 the	 basement	membrane	 is	 not	 completely	 understood,	but	 leukocyte-permissive	 regions	 may	 exist	 that	 have	 low	 abundance	 of	matrix	proteins.	These	permissive	regions	are	termed	low	expression	regions	(LERs)	and	are	located	in	the	proximity	of	paracellular	exit	sites	(Voisin	and	Nourshargh,	2013;	Voisin,	2010).	
Neutrophils	in	tissues	
Neutrophils	 follow	 a	 chemokine	 gradient	 to	 extravasate	 from	 the	 blood	vessels.	However,	in	order	move	away	and	to	migrate	further	into	the	tissues	they	need	to	overcome	this	gradient.	Interestingly,	a	hierarchy	of	chemotactic	gradients	exists.	 Intermediate	chemoattractants	such	as	CXCL8	are	released	by	 the	 endothelium.	 End-target	 chemoattractants	 such	 as	 fMLP	 and	complement	 C5a	 in	 the	 immediate	 proximity	 of	 bacteria	 override	intermediate	 chemoattractants.	 Neutrophils	 preferential	 respond	 to	 end-target	chemoattractants	(Foxman,	1997).	End-target	chemoattractants	signal	via	 different	 pathways	 for	 activation	 and	 inhibition	 of	 neutrophil	recruitment.	Low	concentrations	of	fMLP	favour	neutrophil	migration	via	the	p38	MAPK-pathway.	In	contrast,	high	fMLP	concentrations	inhibit	neutrophil	migration	in	an	ERK-dependent	manner	(Liu,	2012).	
In	 the	 tissues,	 neutrophils	 induce	 the	 generation	 of	 chemokines	 and	 pro-inflammatory	 cytokines	 in	 mesenchymal	 and	 myeloid	 cells,	 leading	 to	recruitment	 of	 other	 inflammatory	 cells	 and	more	 neutrophils.	 Neutrophils	can	 also	 directly	 attract	 more	 neutrophils	 to	 the	 tissues	 via	 release	 of	leukotriene	 B4	 (LTB4).	 The	 first	 wave	 of	 neutrophils	 migrate	 towards	 the	
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centre	of	 the	 inflammation	and	high	concentrations	of	LTB4.	This	attracts	a	second	 “swarm”	 of	 neutrophils	 expressing	 the	 leukotriene	 receptor	(Lammermann,	 2015;	 Lammermann,	 2013).	 Such	 chemokine	 signalling	makes	migration	over	long	distances	possible.	
Additionally,	 neutrophils	 can	migrate	 out	 of	 the	 vasculature	 and	 persist	 as	tissue	 resident	 cells.	 Uninfected	 lungs	 have	 a	 marginated	 neutrophil	 pool,	which	consists	of	neutrophils	that	reside	adjacent	to	the	luminal	endothelial	surface.	 During	 infection	 monocytes	 induce	 extravasation	 of	 these	neutrophils	into	the	tissue	(Kreisel,	2010).	
Inflammation	 is	 triggered	both	 in	response	to	 infection	and	to	sterile	 injury	caused	 by	 for	 example	 burns,	 hypoxia,	 or	 chemicals.	 Different	 PAMPs	 and	DAMPs	 can	 activate	 the	 same	 PRRs	 and	 lead	 to	 similar	 pro-inflammatory	responses.	 The	 formyl	 peptide	 receptor	 (FPR)	 responds	 to	 formylated	peptides	released	during	thermal	injury	from	mitochondria	of	damaged	cells	or	 from	 bacteria	 during	 infection	 (McDonald,	 2010).	 During	 infection,	neutrophils	 are	 required	 for	 resolution	 and	 protective	 immunity.	However,	during	sterile	inflammation	neutrophils	aggravate	inflammation	by	releasing	oxidants,	proteases	and	antimicrobial	proteins,	causing	bystander	injury.	It	is	not	 clear	 whether	 the	 neutrophils	 in	 both	 scenarios	 differ	 and	 whether	neutrophils	 can	 distinguish	 between	 infection	 and	 sterile	 inflammation.	Possibly	pro-inflammatory	and	pro-resolving	neutrophils	are	recruited.	
1.1.2 Neutrophil	immune	responses	
In	 the	 tissues	 neutrophils	 encounter	 a	 large	 variety	 of	 different	 microbes.	Neutrophils	posses	a	range	of	antimicrobial	strategies	such	as	degranulation,	phagocytosis	and	NET	release,	but	it	 is	unknown	whether	neutrophils	tailor	their	 antimicrobial	 strategies	 to	 fight	 fungi	 selectively.	 Neutropenia	 and	deficiencies	 in	 neutrophil	 antimicrobial	 strategies,	 lead	 to	 an	 increased	incidence	 of	 invasive	 fungal	 infections,	 indicating	 the	 importance	 of	neutrophils	in	antifungal	immunity	(Brown,	2011).	
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Microbial	sensing	
Neutrophils	 are	 equipped	 with	 an	 array	 of	 pattern	 recognition	 receptors	(PPRs)	that	allow	them	to	sense	microbes	directly.	They	recognise	bacterial,	viral	 and	 fungal	 PAMPs.	 The	 activation	 state	 and	 life	 span	 of	 neutrophils	depends	largely	on	the	signals	received	from	cytokines	and	PAMPs.	The	PRRs	expressed	on	neutrophils	 include	membrane	bound	 receptors	 such	 as	Toll-like	 receptors	 (TLRs)	 and	 C-type	 lectin	 receptors	 (CLRs),	 as	 well	 as	cytoplasmic	 receptors	 such	 as	 absent	 in	melanoma	2	 (AIM2),	 retinoic	 acid-inducible	 gene	 1	 (RIG-I),	 melanoma	 differentiation	 antigen	 5	 (MDA5)	 and	intracellular	 nucleotide-binding	 oligomerisation	 domain	 (NOD)-like	receptors	(NLRs)	(Figure	I-3).	Polymorphisms	in	PRRs	or	adaptor	molecules	leading	 to	 abrogated	 signalling	 pathways	 in	 neutrophils	 and	 other	 innate	immune	cells	often	cause	 increased	susceptibility	to	 fungal	 infections	 in	the	affected	tissues.	
		
Figure	 I-3	|	Neutrophil	pattern	 recognition	 receptors	 (PRRs)	and	 ligands.	The	main	neutrophil	
PRR	 families	 are	 TLRs,	 CLRs	 and	 NLRs.	 While	 TLRs	 and	 CLRs	 recognise	 microbial	 pathogen-
associated	 molecular	 patterns	 (PAMPs),	 NLRs	 signal	 upon	 ligation	 by	 danger-associated	
molecular	patterns	 (PAMPs).	 For	details	 see	 the	main	 text.	 |	Abbreviations:	CLEC,	C-type	 lectin	
domain	 family;	 CLR,	 C-type	 lectin	 receptor;	meso-DAP,	meso-diaminopimelic	 acid;	 FPR,	 formyl	
peptide	 receptor;	 MDL,	 myeloid	 DAP12-associating	 lectin;	 NLR,	 nucleotide-binding	
oligomerisation	domain	(NOD)-like	receptor;	NLRC,	NLR	with	a	CARD	domain;	NLRP,	NLR	with	a	
pyrin	domain;	RLH,	 retinoic	acid-inducible	gene	 (RIG)-like	helicase;	SAP,	spliceosome-associated	
protein;	TLR,	Toll-like	receptor;	TREM,	triggering	receptor	expressed	on	myeloid	cells.	aMouse	but	
not	 human	 neutrophils.	 bHuman	 but	 not	 mouse	 neutrophils.	 |	 Reprinted	 from	 Trends	 in	
Immunology,	(Thomas	and	Schroder,	2013),	Copyright	2013,	with	permission	from	Elsevier.	
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Toll-like	receptors	(TLRs)	
TLRs	are	expressed	on	the	cell	surface	and	in	the	phagosomal	membrane	of	innate	 immune	 cells.	 TLR	 signalling	 leads	 to	 activation	 of	 the	 transcription	factors	NK-κB,	activator	protein	1	(AP-1)	and	the	interferon	regulatory	factor	(IRF)	family	and	triggers	the	release	of	pro-inflammatory	cytokines	and	type	I	interferons	(IFN).	Neutrophils	express	nearly	all	TLRs	except	for	TLR3	and	TLR7	in	humans	(Hayashi,	2003;	Tamassia,	2008).	TLR7	mRNA	is	expressed	in	mouse	neutrophils	(Charmoy,	2007)	that	respond	to	the	TLR7	ligand	R848	after	priming	with	GM-CSF	(Wang,	2008).	TLRs	are	involved	in	the	regulation	of	 nearly	 all	 neutrophil	 responses,	 including	 migration,	 phagocytosis,	degranulation,	ROS	production,	apoptosis,	NETosis	and	cytokine	release.	TLR	signalling	also	strongly	synergises	with	other	stimuli.	Activation	of	TLR4	by	bacterial	 lipopolysaccharide	 (LPS)	 enhances	 ROS	 production	 upon	stimulation	 with	 fMLP	 (Parker,	 2005;	 Prince,	 2011).	 As	 opposed	 to	macrophages,	neutrophil	TLRs	signal	solely	via	the	adapter	protein	myeloid	differentiation	primary	response	gene	88	(MyD88)	and	not	via	TIR-domain-containing	 adapter-inducing	 interferon-β	 (TRIF).	 Consequently,	 neutrophil	TLR	signalling	does	not	 induce	 the	production	of	 type	 I	 IFN.	TRIF	 is	poorly	expressed	in	human	neutrophils	and	it	 is	unclear	whether	it	 is	expressed	in	mouse	 neutrophils	 (Tamassia,	 2007;	 van	 Bruggen,	 2010).	 Interestingly,	MyD88-dependent	 TLR	 signalling	 seems	 to	 be	 dispensable	 in	 some	 cases.	Mice	 deficient	 in	 the	 MyD88-dependent	 interleukin-1	 receptor-associated	kinase	4	(IRAK4)	are	unaffected	in	their	ability	to	kill	C.	albicans,	E.	coli	and	S.	
aureus,	 indicating	 redundant	 PRR	 signalling	 independent	 of	 TLR	 (van	Bruggen,	2010).	
The	contribution	of	TLR	signalling	to	antifungal	immunity	in	neutrophils	and	other	 innate	 immune	 cells	 varies	 depending	 on	 the	 fungal	 species,	morphotypes,	route	of	infection	and	receptor	cooperativity.	TLR2,	TLR4	and	TLR6	 are	 the	main	 TLRs	 involved	 in	 fungal	 recognition	 and	 bind	 zymosan,	phospholipomannan	and	O-linked	mannans	(Netea,	2008;	van	de	Veerdonk,	2008).	Polymorphisms	 in	TLR4	are	associated	with	 increased	susceptibility	
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to	pulmonary	aspergillosis	and	bloodstream	candidiasis	in	humans	(Bochud,	2008;	Carvalho,	2008;	Van	der	Graaf,	2006).	Furthermore,	intracellular	TLRs	are	involved	in	antifungal	immunity.	TLR9	recognises	fungal	DNA	and	chitin	followed	by	the	production	of	anti-inflammatory	cytokines	(Wagener,	2014).	Polymorphisms	 in	 TLR9	 are	 associated	 with	 allergic	 bronchopulmonary	aspergillosis	in	humans	(Carvalho,	2008).	TLR	signalling	also	induces	cellular	antifungal	 immunity	 via	 the	 production	 of	 type	 I	 interferons,	 pro-inflammatory	 TNF-α	 and	 IL-12,	 promoting	 adaptive	 immunity	 (Bourgeois,	2011;	Carvalho,	2012;	Ramirez-Ortiz,	2008).	Furthermore,	TLRs	mediate	the	presentation	 of	 fungal	 antigens	 by	 DCs	 to	 T	 cells	 and	 control	 antigen	processing	and	presentation	(Blander	and	Medzhitov,	2006).	TLRs	are	found	to	cooperate	with	CLRs	and	modulate	CLR	signalling	(Netea,	2006).	TLR2	and	dectin-1	trigger	phagocytosis	and	cytokine	production	in	mice	and	deficiency	of	 the	 CLR	 adaptor	 CARD9	 leads	 to	 increased	 fungal	 infections	 in	 humans	(Drummond	 and	 Brown,	 2011;	 Glocker,	 2009).	 Interestingly,	 the	 role	 for	TLRs	 differs	 in	 humans	 and	 mice.	 In	 mice	 deficiency	 of	 the	 TLR	 adaptor	MyD88	leads	to	increased	susceptibility	towards	C.	albicans,	A.	fumigatus	and	
C.	neoformans,	whereas	in	humans	MyD88-deficiency	causes	susceptibility	to	bacterial	 but	 not	 fungal	 infections	 (Biondo,	 2005;	 Bretz,	 2008;	Marr,	 2003;	von	Bernuth,	2008).	
C-type	lectin	receptors	(CLRs)	
CLRs	are	Ca2+-dependent	carbohydrate-binding	receptors	with	one	or	more	structural	C-type	lectin-like	domain	(CTLD)	(Osorio	and	Reis	e	Sousa,	2011).	They	signal	through	intracellular	immunoreceptor	tyrosine-based	activation	motifs	 (ITAM),	 hemi-ITAMs	 or	 associate	 with	 ITAM-containing	 adaptors.	Some	CLRs	posses	immunoreceptor	tyrosine-based	inhibitory	motifs	(ITIM).	CLR	 activation	 triggers	 phosphorylation	 of	 ITAMs	 and	 activation	 of	 the	spleen	 tyrosine	 kinase	 (Syk).	 Syk	 signalling	 regulates	 neutrophil	phagocytosis	 and	 ROS	 through	 the	 activation	 of	 NF-κB,	MAPK	 and	 nuclear	factor	 of	 activated	 T	 cells	 (NFAT)	 (Mócsai,	 2010).	 The	 canonical	 NF-κB-
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caspase	 recruitment	 domain-containing	 protein	 9	 (CARD9)	 pathway	 is	important	 for	 antifungal	 responses	 (Gross,	 2006)	 and	 deficiencies	 in	 CLRs	cause	increase	susceptibility	to	fungal	infections.	
Dectin-1	
Dectin-1	 (CLEC7A)	 is	primarily	 expressed	by	myeloid	 cells.	 It	 recognises	β-1,3-linked	and	β-1,6-linked	glucans	in	a	variety	of	fungal	species	including	C.	
albicans,	 Aspergillus	 fumigatus	 and	 Pneumocystis	 carinii.	 Dectin-1	 is	 both	 a	phagocytic	and	a	signalling	receptor.	
Activation	 of	 dectin-1	 induces	 production	 of	 pro-	 and	 anti-inflammatory	cytokines	and	chemokines.	Receptor	ligation	leads	mainly	to	activation	of	the	Syk-CARD9	signalling	pathway	 through	protein	kinase	C	 (PKC)	δ	 and	RAF1	kinase	 (Drummond	 and	 Brown,	 2011;	 Drummond,	 2011;	 Glocker,	 2009;	Gross,	 2006;	 Strasser,	 2012).	 Dectin-1-induced	 signalling	 pathways	 act	synergistically	and	cross	regulatory	and	induce	canonical	and	non-canonical	NF-κB	 activation.	 Syk-CARD9	 pathway	 activation	 induces	 cytokine	production,	 ROS	burst	 and	 inflammasome	 activation	 (Hardison	 and	Brown,	2012).	 Dectin-1	 activates	 IL-1β	 production	 via	 the	 NOD-,	 LRR-	 and	 pyrin	domain-containing	3	(NLRP3)	inflammasome	and	caspase	1	(Cheng,	2011)	or	via	 a	 non-canonical	 caspase	 8	 inflammasome	 (Gringhuis,	 2012).	 On	neutrophils,	 dectin-1	 signalling	 is	 CD11b-dependent.	 CD11b	 binds	β-glucan	and	 signals	 via	 Syk	 through	 the	 ITAM-containing	 adaptors	 FcRγ	 and	DNAX	activation	protein	of	12kDa	(DAP12)	(Mócsai,	2006;	van	Bruggen,	2009).	
Deficiencies	 in	 dectin-1	 and	 CARD9	 are	 associated	 with	 increased	 fungal	susceptibility.	 Dectin-1-deficient	 mice	 show	 increased	 mortality	 upon	infection	with	C.	albicans	(Taylor,	2007)	and	A.	fumigatus	(Werner,	2009)	and	have	increased	fungal	burdens	upon	infection	with	P.	carinii	(Saijo,	2007)	and	
Coccidioides	 (Viriyakosol,	 2013)	 species.	 Polymorphisms	 in	 human	dectin-1	trigger	 recurrent	 vulvovaginal	 candidiasis	 including	 colonisation	 of	 the	urinary	tract	(Ferwerda,	2009)	and	 increased	 invasive	aspergillosis	 (Cunha,	
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2010),	 but	 show	 no	 effect	 on	 systemic	 candidiasis	 (Smeekens,	 2013).	However,	 CARD9	 deficiency	 in	 mice	 and	 mutations	 in	 humans	 lead	 to	increased	 susceptibility	 for	 invasive	 candidiasis	 (Drewniak,	 2013;	 Glocker,	2009;	 Gross,	 2006).	 Differences	 in	 β-glucan	 expression	 and	 structure	between	 different	 fungal	 strains	 may	 account	 for	 strain-dependent	susceptibility	to	infection.	
Dectin-1	mediated	activation	of	phagocytosis	by	particulate	β-glucan	occurs	via	the	formation	of	a	phagocytic	synapse	in	macrophages.	Since	neutrophils	do	 not	 respond	 to	 soluble	 β-glucan,	 the	 existence	 of	 a	 similar	 signalling	synapse	in	neutrophils	is	likely	(Goodridge,	2011).	
Mannose	receptor	
The	 mannose	 receptor	 (MR)	 recognises	 a	 broad	 range	 of	 microbes	 of	 all	classes,	 including	 fungi	mainly	 via	N-linked	mannans	 (Lam,	2007).	MR	also	has	affinities	 for	 fungal	α-glucans	and	chitin.	Due	 to	 the	 lack	of	a	 signalling	motif	in	the	cytoplasmic	tail,	the	MR	forms	heterodimers	with	TLRs,	dectin-1	and	the	peroxisome	proliferator	activated	receptor-γ	(PPARγ)	(Gales,	2010).	MR	activation	leads	to	production	of	IL-17	and	phagocytosis	of	unopsonised	yeast.	However	 the	 role	 of	MR	 in	 antifungal	 immunity	 is	mainly	 redundant	with	other	receptors	(Hardison	and	Brown,	2012).	
Dectin-2	
CLEC6A	is	the	most	important	member	of	the	dectin-2	family.	It	is	expressed	on	DCs,	macrophages	and	neutrophils	(Saijo,	2010).	The	receptor	recognises	high	 mannose-containing	 structures	 like	 α-mannose	 and	 mannose-rich	glycoproteins	 on	 fungi	 such	 as	 C.	 albicans,	 P.	 brasiliensis,	 A.	 fumigatus	 and	
Malassezi	 (Ishikawa,	 2013;	 Kerscher,	 2013)	 and	 binds	 C.	 albicans	 hyphae	with	 higher	 affinity	 than	 yeast	 particles.	 Dectin-2	 has	 an	 extracellular	carbohydrate	 recognition	 domain	 but	 lacks	 an	 intracellular	 signalling	domain.	It	pairs	with	other	signalling	receptors	such	as	the	FcRγ	or	dectin-3.	
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The	 activation	 of	 the	 Syk-CARD9	 pathway	 leads	 to	 induction	 of	 pro-inflammatory	cytokines,	ROS	production,	leukotriene	release	and	CD4+	T	cell	Th17	polarisation	(Drummond,	2011;	Hardison	and	Brown,	2012;	Robinson,	2009).	Dectin-2-deficient	mice	 are	more	 susceptible	 to	C.	 albicans	 infection	with	 reduced	 survival	 and	 increased	 fungal	 burden	but	 have	no	phenotype	upon	infection	with	C.	neoformans	(Saijo,	2010).	
Mincle	
Mincle	 is	 another	 member	 of	 the	 dectin-2	 family	 lacking	 an	 intracellular	signalling	domain.	Like	dectin-2	it	associates	with	FcRγ	and	induces	the	Syk-CARD9	 signalling	 pathway	 leading	 to	 NF-κB-mediated	 cytokine	 production	and	modulation	of	 the	adaptive	 immunity.	Mincle	 recognises	damaged	cells	as	 well	 as	 fungi	 such	 as	 C.	 albicans	 and	Malassezia	 species	 (Wells,	 2008;	Yamasaki,	2009).	The	C.	albicans	 ligand	 is	unknown	whereas	recognition	of	
Malassezia	 happens	 via	 glycero-glycolipid	 mannitol-linked	 fatty	 acids	(Ishikawa,	2013).	Even	though	mincle	is	expressed	mainly	on	macrophages	it	also	plays	a	role	in	neutrophil	signalling	(Vijayan,	2012).	
Complement	receptor	3	
The	 complement	 receptor	 3	 (CR3,	 also	Mac-1	 or	αMβ2)	 is	 an	 integrin,	 built	from	 a	 CD11b	 (αM)	 chain	 and	 a	 CD18	 (β2)	 chain.	 CR3	 is	 part	 of	 the	complement	 system	 and	 can	 act	 in	 combination	 or	 without	 other	complement	 factors.	 CR3	 engagement	 induces	 phagocytosis,	 leukocyte	adhesion	 and	 chemotaxis	 (Sandor,	 2013)	 as	 well	 as	 complement-independent	antibody-dependent	phagocytosis	and	killing	of	unopsonised	C.	
albicans	(Gazendam,	2014;	Taborda	and	Casadevall,	2002).	CR3	may	act	as	a	direct	 phagocytic	 receptor	 for	 β-glucan,	 and	 might	 account	 for	 dectin-1-independent	β-glucan	responses	in	humans,	which	are	not	observed	in	mice	(van	Bruggen,	2009).	
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NOD-like	receptors	(NLRs)	and	inflammasomes	
NLRs	 are	 cytoplasmic	 receptors	 that	 recognise	 mainly	 bacterial	peptidoglycan.	NOD1	and	NOD2	activate	MAPK	and	NF-κB	signalling.	NLRP3,	NLRP1	 and	 NLRC4	 are	 part	 of	 inflammasome	 complexes	 and	 induce	inflammation.		
NOD1	 and	 NOD2	 recognise	 different	 substructures	 of	 bacterial	peptidoglycan.	 They	 activate	 NF-κB	 and	MAPK	 signalling	 via	 interaction	 of	the	 CARD	 domain	 with	 the	 kinase	 receptor-interacting	 serine/threonine	protein	kinase	2	(RIP2)	(Fritz,	2006).	NOD1	is	not	found	in	human	peripheral	neutrophils	(Ekman	and	Cardell,	2010),	but	induces	signalling	in	murine	BM	neutrophils	 (Clarke,	 2010).	 Gut	 microbiome-derived	 peptidoglycan	 signals	constitutively	 through	 NOD1	 and	 primes	 BM	 neutrophils	 for	 phagocytosis	and	ROS	production	(Clarke,	2010).	NOD2	is	expressed	in	mouse	and	humans	(Ekman	and	Cardell,	2010).	 Its	activation	leads	to	 loss	of	CD62L	and	CD11b	upregulation,	 chemokine	 production	 and	 neutrophil	migration	 (Ekman	 and	Cardell,	2010).	NLRs	are	involved	in	fungal	sensing	and	NOD2	in	combination	with	MR	 and	 TLR9	 recognise	 chitin	 and	 stimulate	 the	 production	 of	 IL-10	(Wagener,	2014).	
Pyrin-containing	NLR	(NLRP)	are	one	of	several	inflammasome	classes	(Latz,	2013).	NLRP	inflammasome	sensors	include	NLRP3,	NLRP1,	NLRC4,	NLRP12	and	 AIM2.	 They	 consist	 of	 a	 C-terminal	 leucin-rich	 repeat	 (LRR),	 a	 central	oligomerisation	 domain	 and	 a	 N-terminal	 effector	 domain.	 Inflammasomes	are	cytosolic	sensors	of	DAMPs	and	control	the	maturation	of	IL-1β	and	IL-18	through	caspase	1	(Latz,	2013).	 IL-1β	 is	an	 inflammatory	cytokine	 that	acts	locally	 and	 systemically	 and	 requires	 a	 two-step	 activation.	 Signalling	 via	dectin-1	 or	 TLR2/TLR4	 upregulates	 transcripts	 of	 the	 pro-form	 of	 IL-1β	(Bellocchio,	 2004;	 Hise,	 2009;	 Netea,	 2002).	 A	 second	 inflammasome-dependent	proteolytic	 step	by	caspase	1	 is	 required	 to	cleave	 IL-1β	 into	 its	active	 form	 (Wilson,	 1994).	 The	 NLRP3	 inflammasome	 is	 the	 best-studied	inflammasome	and	is	expressed	in	neutrophils,	macrophages,	T	cells,	B	cells,	
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DCs	and	mucosal	epithelium.	It	responds	to	a	variety	of	stimuli	that	 include	microbes	(Allen,	2009;	Craven,	2009;	Dostert,	2009),	host	molecules	such	as	ATP	 (Mariathasan,	 2006),	 uric	 acid	 crystals	 (Martinon,	 2006),	 amyloid-β	fibrils	 (Halle,	 2008)	 and	 crystalline	 compounds	 such	 as	 silica	 crystals,	asbestos	 and	 aluminium	 salts	 (Dostert,	 2008;	 Hornung,	 2008).	 Purified	mouse	 neutrophils	 activate	 Il-1β	 production	 upon	 stimulation	 with	 the	NLRP3	 agonist	 nigericin	 or	 upon	 S.	 aureus	 infection	 (Mankan,	 2012).	Mutations	 in	 NLRP3	 and	 NLRP12	 are	 associated	 with	 IL-1β-dependent	hereditary	 periodic	 fever	 syndrome	 (Jéru,	 2008).	 Defective	 NLRP3	inflammasome	 activation	 leads	 to	 increased	 colonisation	 with	 C.	 albicans	(Gross,	 2009)	 and	 increased	 susceptibility	 to	 mucosal	 candidiasis	 and	disseminated	disease	(Hise,	2009).	The	 inflammasome	activating	C.	albicans	ligands	 are	 not	 entirely	 defined,	 but	 the	 cell	 wall	 preparations	 such	 as	zymosan,	 curdlan	 or	 the	 cell	 wall	 component	 mannan	 and	 the	 secreted	aspartic	proteases	Sap2	and	Sap6	were	all	shown	to	activate	NLRP3	(Kumar,	2009;	 Lamkanfi,	 2009;	 Pietrella,	 2013).	 Interestingly,	 A.	 fumigatus	 and	 C.	
albicans	hyphae	but	not	yeast	activate	NLRP3,	possibly	providing	a	means	of	discrimination	between	colonisation	and	 invasive	 state	of	 the	 fungus	 (Gow,	2012;	Joly,	2009).	
Even	 though	 inflammasomes	 are	 the	 main	 route	 of	 IL-1β	 activation,	 the	cytokine	 can	 also	 be	 processed	 by	 monocytes	 that	 express	 constitutively	active	 caspase	 1	 (Netea,	 2009)	 or	 by	 neutrophil	 PR3	 (Netea,	 2015b).	 Since	neutrophils	are	the	main	effector	cells	in	the	early	response,	IL-1β	processing	by	 PR3	 plays	 an	 important	 role	 in	 the	 early	 stages	 of	 antifungal	 immunity.	Interestingly,	 PR3	 and	 not	 caspase	 1	 is	 crucial	 for	 protection	 against	disseminated	candidiasis	in	mice	(Mencacci,	2000).	Additionally,	C.	albicans-derived	proteases	can	process	pro-IL-1β	(Beausejour,	1998).	
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Anti-microbial	strategies	
Neutrophils	 posses	 a	 range	 of	 antimicrobial	 strategies	 including	 release	 of	antimicrobials	 from	 their	 granules,	 phagocytosis,	 production	 of	 reactive	oxygen	and	NETosis.	
Degranulation	
Neutrophils	 contain	 four	 classes	 of	 granules	 comprised	 of	 azurophilic	granules,	 specific,	 gelatinase	 and	 secretory	 granules	 (Borregaard	 and	Cowland,	1997).	Neutrophils	granules	are	heterogeneous	 in	protein	content	and	 exocytosis	 capacity.	 The	 expression	 profile	 of	 the	 granule	 proteins	changes	during	neutrophil	precursor	maturation.	 Since	granule	proteins	do	not	 contain	 sorting	 signals	 for	 individual	 granule	 compartments,	 their	distribution	 is	 solely	 dependent	 on	 timing	 (Le	 Cabec,	 1996).	 Azurophilic	granules	are	formed	first	during	the	myeloblast	and	promyelocyte	stages	and	contain	a	range	of	proteases	such	as	NE,	CG	and	PR3	as	well	as	antimicrobial	proteins	 such	 as	 defensins,	 lysozyme	 and	 MPO.	 Next,	 during	 the	myelocyte/metamyelocyte	 stage	 specific	 granules	 are	 formed.	They	 contain	proteins	such	as	collagenase,	gelatinase,	 lactoferrin	and	 increasing	amounts	of	 lysozyme.	Gelatinase	granules	are	 formed	during	 the	band	cell	 stage	and	contain	 gelatinase,	 arginase	 and	 increasing	 amounts	 of	 integrins	 including	CD11b	and	CD18	as	well	as	NADPH	oxidase	components	such	as	gp91phox	and	p22phox.	Finally,	secretory	vesicles	are	formed	last	and	contain	a	large	variety	of	 receptors	 including	 cytokine-	 (IFNαR,	 IFNγR,	 TNFR)	 and	 chemokine	receptors	(CXCR1,	CXCR2,	CXCR4)	and	TLRs,	CD14	and	MyD88.	
Furthermore,	the	propensity	of	granules	for	exocytosis	varies.	Granules	that	are	formed	at	late	stages	during	granulopoiesis,	such	as	gelatinase	granules,	are	mobilised	first,	whereas	azurophilic	granules	are	released	last	(Kjeldsen,	1992;	Sengelov,	1995;	Sengelov,	1993).	The	 secretion	propensity	 is	defined	by	the	density	of	vesicle-associated	membrane	protein	2	(VAMP-2)	proteins	in	the	granule	membrane.	VAMP-2	is	a	fusogenic	protein	of	the	v-SNARE	(N-
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methylmaleimide-sensitive	 factor	 attachment	 protein	 (SNAP)–SNAP	receptor)	family.	The	concentration	of	v-SNAREs	is	highest	in	gelatinase	and	secretory	 vesicles	 (Brumell,	 1995)	 the	 mRNA	 profile	 of	 VAMP-2	 increases	during	 myelopoiesis	 when	 neutrophils	 mature	 to	 band	 cells	 (Theilgaard-Monch,	 2005).	 Triggers	 such	 as	 the	 increase	 of	 the	 intracellular	 Ca2+	concentration	activate	granule	exocytosis.	Granule	membranes	are	reservoirs	of	pre-formed	proteins.	Fusion	of	 the	membranes	recruits	proteins	 into	 the	plasma	 membrane,	 including	 β2	 integrins,	 NADPH	 oxidase	 components,	fusogenic	proteins	such	as	SCAMP	(secretory	carrier	membrane	protein)	and	receptors	 such	 urokinase-type	 plasminogen-activating	 receptor	 and	 the	formyl	 peptide	 receptor	 (Borregaard,	 2007;	 Brumell,	 1995;	 Nauseef,	 2007;	Nordenfelt	 and	 Tapper,	 2011).	 Specific	 granules	 fuse	 with	 the	 plasma	membrane,	 whereas	 azurophilic	 granules	 fuse	 preferentially	 with	 the	phagosome.	
The	release	of	granule	contents	such	as	defensins,	bactericidal-permeability-increasing	 protein,	 azurocidin,	 MPO,	 as	 well	 as	 proteases	 such	 as	 NE	 and	cathepsin	 G	 creates	 an	 antimicrobial	 environment	 (Nauseef,	 2007).	Furthermore,	 neutrophil	 granules	 contain	 membrane	 disrupting	antimicrobials	such	as	α-defensin	or	cathelicidin	(Kruger,	2015).	Lactoferrin	and	 lipocalin	 inhibit	 the	microbial	 iron	 uptake.	 Lysozyme	 cleaves	 cell	 wall	peptidoglycans,	whereas	proteases	such	as	NE	degrade	virulence	factors	and	toxins	 (Weinrauch,	 2002).	 Proteinase-3	 (PR3)	 cleaves	 the	 antimicrobial	peptide	LL-37	 into	 its	 active	 form	(de	Haar,	2006).	NE	and	cathepsin	G	are	activated	through	N-terminal	cleavage	by	dipeptidyl	peptidase	1	(DPPI)	and	mutations	 of	 DPPI	 are	 associated	 with	 severe	 neutrophil	 deficiencies	(Korkmaz,	 2010).	 Antimicrobial	 proteins	 are	 also	 associated	 to	 NETs,	facilitating	the	direct	interaction	with	the	microbes	(Bardoel,	2014).	
Degranulation	is	an	important	part	of	neutrophil	antimicrobial	immunity,	as	illustrated	 by	 deficiencies	 in	 specific	 granules,	 which	 causes	 increased	susceptibility	 to	 infection	 (Gombart,	 2001).	 However,	 the	 release	 of	
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antimicrobials	 into	 the	 environment	 also	 has	 the	 potential	 to	 harm	 host	tissues.	Therefore,	the	process	is	tightly	regulated.	
Phagocytosis	
Phagocytosis	 is	one	of	 the	main	neutrophil	 antimicrobial	 strategies.	 It	 is	 an	active	process	that	leads	to	the	uptake	of	small	particles	and	microbes	into	an	intracellular,	membrane-enclosed	phagosome.	It	 is	a	three-step	process	that	is	 initiated	by	binding	of	a	 ligand-bearing	particle,	 followed	by	clustering	of	the	 phagocytic	 receptors.	 Subsequently,	 receptor	 signalling,	 triggers	 actin-dependent	 rearrangement	 of	 the	 cytoskeleton,	 leading	 to	 uptake	 of	 the	particle.		
Phagocytosis	 is	 initiated	 through	 FcR-engagement	 by	 opsonised	 microbes,	complement	 activation	 or	 through	 a	 large	 array	 of	 PRR	 that	 recognise	microbes	directly,	including	TLRs,	NLRs	and	CLRs	such	as	dectin-1	(Bardoel,	2014;	 Kruger,	 2015;	 Nauseef,	 2007).	 In	 a	 “zippering”	mechanism,	 receptor	interaction	 with	 the	 ligands	 repeats	 many	 times,	 wrapping	 the	 membrane	around	 the	particle	 (Griffin,	 1975).	The	FcγR	 is	 the	best-studied	phagocytic	receptor.	 FcγRIIa	 (CD32),	 FcγRIIIb	 (CD16)	 and	 FcγRIV	 are	 constitutively	expressed	 in	 neutrophils,	whereas	 FcγRI	 (CD64)	 expression	 requires	G-CSF	priming	(Nimmerjahn,	2008).	Clustering	of	the	FcγR	is	required	for	signalling,	bringing	 the	 cytosolic	 ITAM	 motifs	 of	 the	 receptor	 in	 close	 proximity	(Holowka,	 2007).	 Upon	 receptor	 engagement	 both	 tyrosines	 of	 the	 ITAM	motifs	are	phosphorylated	by	tyrosine	kinases	of	the	Src	family:	Hck,	Lyn	and	Fgr	 (Hamada,	 1993;	 Wang,	 1994).	 Syk	 kinase	 binds	 to	 the	 double	phosphorylated	ITAMs	via	its	two	Src	homology	2	(SH2)	domains,	leading	to	phosphorylation	 and	 activation	 of	 Syk	 (Johnson,	 1995).	 Subsequently,	adapter	proteins	that	bind	to	the	receptor	complex	 function	as	platform	for	recruitment	 of	 downstream	 signalling	 components.	 FcγR-dependent	phosphorylation	 of	 ITAM	motifs	 leads	 to	 elevation	 of	 intracellular	 calcium	concentrations,	 the	 activation	 of	 the	 NADPH	 oxidase,	 actin-polymerisation	and	granule	secretion	(Nimmerjahn,	2008).	During	the	phagocytic	process	a	
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PI3K-dependent	change	of	the	lipid	composition	in	the	plasma	membrane	is	required	for	invagination	and	phagosome	maturation.	Furthermore,	GTPases	of	 the	 Rho	 family	 are	 crucial	 for	 phagocytosis.	 In	 their	 active,	 guanosine	triphosphate	(GTP)-bound	form	they	are	anchored	to	the	membrane	bilayer	of	 the	plasma	membrane,	whereas	 in	 their	 inactive,	 guanosine	diphosphate	(GDP)-bound	 form	 are	 targeted	 to	 the	 cytoplasm.	 Guanine	 nucleotide	exchange	 factors	 (GEF)	catalyse	 the	GDP	release	and	GTP	replacement.	The	GTPase	Cdc42	is	responsible	for	the	formation	of	filopodia,	whereas	Rac1	and	Rac2	mediate	the	formation	of	lamellipodia	(Hoppe	and	Swanson,	2004).	The	rearrangement	of	the	cytoskeleton	is	dependent	on	actin	polymerisation.	In	a	process	called	treadmilling	actin	monomers	are	associated	at	one	end	of	an	actin	 filament	 and	 dissociated	 from	 the	 rear	 end.	 The	 nucleator	 complex	Arp2/3	 triggers	 branching	 of	 new	 strands	 from	 existing	 actin	 filaments.	Arp2/3	 is	 activated	 by	 nucleation-promoting	 factors	 such	 as	 the	 Wiskott-Aldrich	syndrome	protein	(WASP),	which	is	a	downstream	effector	of	Cdc42	or	the	Scar/WAVE	proteins,	which	are	effectors	of	Rac	(May,	2000).	Actin	is	cleared	 from	 the	 base	 of	 the	 phagocytic	 cup,	 allowing	 the	 sinking	 in	 of	 the	phagocytosed	 particle	 (Larsen,	 2002).	 The	 needed	 membrane	 material	 is	mostly	derived	from	the	plasma	membrane	(Touret,	2005)	or	delivered	from	intracellular	compartments.	
Dectin-1-mediated	 phagocytosis	 is	 similar	 to	 FcγR-dependent	 phagocytosis	even	 though	as	opposed	 to	 the	FcγR,	dectin-1	possesses	only	 a	hemi-ITAM.	Dectin-1	also	signals	via	Syk	and	two	dectin-1	receptors	are	bridged	by	one	Syk	molecule	(Fuller,	2007).	Like	in	FcγR-mediated	phagocytosis	PI3K,	Cdc42	and	Rac1	activation	as	well	as	actin	remodelling	are	required	(Herre,	2004).	
Neutrophil	 phagocytosis	differs	 in	many	aspects	 from	 that	 in	macrophages.	Phagocytosis	in	neutrophils	is	extremely	fast	and	internalisation	of	opsonised	targets	 occurs	 in	 less	 than	 30	 seconds	 (Segal,	 1980),	 whereas	 this	 process	takes	several	minutes	in	macrophages.	Phagosomes	in	macrophages	mature	gradually	 through	 the	 endosomal	 pathway.	 In	 contrast,	 in	 neutrophils	 pre-formed	granules	 fuse	with	the	phagocytic	vacuole	to	 form	a	phagolysosome	
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(Lee,	 2003;	 Segal,	 1980).	 Azurophilic	 and	 specific	 granules	 fuse	 with	 the	plasma	membrane,	just	before	the	phagosome	seals	completely.	Additionally,	azurophilic	 granules	 also	 fuse	with	 the	 formed	phagosome	 later	during	 the	maturation	 process	 and	 are	 targeted	 by	 the	 microtubule	 network	 to	 the	phagosome	 membrane	 (Tapper,	 2002).	 The	 targeting	 and	 fusion	 of	neutrophil	granules	to	phagosome	is	calcium-dependent,	but	differs	between	the	 granule	 types.	 Early	 secretion	 of	 azurophilic	 granules	 is	 calcium-dependent,	 whereas	 fusion	 of	 azurophilic	 granules	 with	 the	 fully	 formed	phagosome	 does	 not	 require	 calcium	 (Nordenfelt,	 2009).	 Macrophage	phagosome	maturation	is	calcium-independent.		
ROS	production	
Phagocytosis	or	the	activation	with	soluble	agents	like	PMA	or	fMLF	triggers	the	 production	 of	 ROS.	 The	 NADPH	 oxidase	 assembles	 first	 at	 the	 plasma	membrane	 and	 later	 at	 the	 phagosome	 (Babior,	 2004;	 Babior,	 2002;	Decoursey	and	Ligeti,	2005).	ROS	production	 in	neutrophils	exceeds	 that	 in	macrophages	 by	 far,	 through	 the	 recruitment	 and	 assembly	 of	 additional	NADPH	 oxidase	 in	 the	 phagosomal	 membrane	 (VanderVen,	 2009).	 The	multicomponent	 complex	 is	 separated	 in	 two	 compartments	 in	 resting	neutrophils.	The	 flavocytochrome	b558	 is	an	 integral	membrane	protein	that	is	mainly	present	in	specific	granules,	but	also	in	the	plasma	membrane	and	secretory	 vesicles.	 It	 is	 a	 heterodimer	 formed	 of	 the	 subunits	 gp91phox	(NOX2)	 and	 p22phox	 (Borregaard	 and	 Tauber,	 1984).	 Upon	 activation,	 the	cytosolic	 components	 p47phox,	 ph67phox,	 p40phox	 associate	with	 the	 complex	bound	to	the	membrane	(Babior,	2004;	Nauseef,	1991;	Wientjes,	1993).	The	GTPases	Rac-1	and	Rac-2	are	also	required	for	complete	activation	(Vignais,	2002).	 Neutrophil	 activation	 phosphorylates	 p47phox,	 leading	 to	 a	conformational	change,	translocation	to	the	membrane	and	association	with	flavocytochrome	b558	(Berthier,	2003;	Heyworth,	1991).	During	phagocytosis	p47phox	 and	 p67phox	 are	 recruited	 to	 the	 phagosome	 where	 they	 remain	transiently.	 p40phox	 associates	 with	 p67phox,	 a	 requirement	 for	 its	
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translocation	 to	 the	 phagosome	 (Allen,	 1999;	 Faure,	 2013;	 van	 Bruggen,	2004).	
The	 activated	 NADPH	 oxidase	 complex	 transfers	 electrons	 from	NADPH	 in	the	 cytosol	 through	membrane-bound	 flavocytochrome	b558	onto	molecular	oxygen	 in	 the	 phagosome,	 reducing	 it	 to	 superoxide	 anion.	 The	 ROS	 burst	consumes	 protons,	 which	 counteracts	 the	 acidification	 of	 the	 neutrophil	phagosome,	maintaining	a	neutral	pH.	(Jankowski,	2002).	A	range	of	different	ROS	 is	 formed	 through	 spontaneous	 dismutation	 of	 the	 superoxide	 and	action	of	MPO.	Furthermore,	oxidants	diffuse	 from	the	phagosome	and	 fuse	with	 other	 granule	molecules.	 ROS	 derivatives	 such	 as	 hydrogen	 peroxide,	hydroxyl	 radicals,	 hypochlorous	 acid,	 singlet	 oxygen	 or	 ozone	 are	 formed	during	 this	process	 (Klebanoff,	 2005).	Different	ROS	have	 specific	 activities	and	 through	 the	 collaboration	 of	 oxidants	 and	 granule	 proteins	 the	phagocytosed	microbes	are	killed.	
ROS	production	 is	 important	 for	microbe	killing	and	mutation	 in	any	of	 the	NADPH	 oxidase	 subunits	 causes	 chronic	 granulomatous	 disease	 (CGD).	Oxidase-defective	 CGD	 neutrophils	 have	 greatly	 impaired	 antimicrobial	function.	Killing	of	S.	aureus	 can	be	 restored	 in	CGD	neutrophils	by	glucose	oxidase	 (GO)-loaded	 liposomes	 or	 PEG-D-amino	 acid	 oxidase,	 which	produces	 H2O2	 (Gerber,	 2001;	 Nakamura,	 2012).	 Interestingly,	 NADPH	oxidase-inhibition	 does	 not	 impair	 killing	 of	 S.	 pneumoniae,	 E.	 coli	 or	 P.	
aeruginosa	(Standish	and	Weiser,	2009),	 indicating	 that	other	antimicrobial	strategies	 are	 in	 place.	 However,	 although	 some	 microbes	 are	 still	 killed,	NADPH	oxidase	deficiency	greatly	impairs	neutrophil	function.	
Neutrophil	extracellular	traps	(NETs)	
NETs	 are	 web-like	 structures	 formed	 of	 extracellular	 chromatin	 and	neutrophil	 antimicrobial	 molecules.	 NETs	 are	 released	 in	 a	 form	 or	programmed	 cell	 death	 termed	 NETosis.	 NETs	 trap	 and	 kill	 a	 variety	 of	
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microbes,	 complementing	 the	 neutrophil	 antimicrobial	 defence	 by	 an	extracellular	strategy.	
The	formation	of	NETs	and	the	 impact	on	neutrophil	 immunity	 is	discussed	in	detail	in	the	following	chapter.	See	NETosis	on	page	51.	
Immune	cell	interaction	
Neutrophils	 interact	 with	 a	 number	 of	 innate	 and	 adaptive	 immune	 cells	including	DCs,	macrophages,	NK	cells,	T	cells	(Scapini	and	Cassatella,	2014).	
During	 infection	with	Leishmania,	DCs	capture	phagocytosing	and	apoptotic	neutrophils.	 This	 Leishmania-driven	 mechanism	 undermines	 the	 efficient	immune	 clearance	 of	 the	 parasite	 (Ribeiro-Gomes,	 2012).	 Neutrophils	themselves	can	acquire	DC	characteristics	and	express	CD11c,	MHCII	and	the	T	cell	 co-stimulatory	molecules	CD80	and	CD86.	This	plasticity	 is	driven	by	GM-CSF	that	is	also	responsible	for	prompting	macrophages	to	acquire	a	DC	phenotype	(Geng,	2013;	Matsushima,	2013).	Neutrophils	can	migrate	 to	 the	lymph	nodes	upon	activation	of	their	CCR7	receptor	by	lymph	node-secreted	CCL19	 and	 CCL21	 (Beauvillain,	 2011).	 In	 the	 lymph	 nodes	 neutrophils	produce	thromboxane	A2,	which	reduces	the	contact	between	DCs	and	T	cells.	Thromboxane	 A2-mediated	 vessel	 constriction	 inhibits	 the	 migration	 of	 T	cells	to	more	central	lymph	nodes	(Yang	and	Unanue,	2013).	Neutrophils	are	the	main	producers	of	MPO.	MPO	can	inhibit	the	proliferation	and	activation	of	DCs,	restricting	CD4+	T	cell	activity	in	the	lymph	nodes	(Odobasic,	2013).	
Furthermore,	 neutrophils	 interact	 in	 various	 ways	 with	 the	 T	 cell	compartment.	Th17	cells	induce	neutrophil	recruitment	by	production	of	IL-17	and	CXCL8.	In	turn,	neutrophils	produce	CCL20	and	CCL2,	mediating	Th17	recruitment	 in	 a	 positive	 feedback	 loop	 (Pelletier,	 2010).	 During	 systemic	inflammation	 a	 subset	 of	 activated	 CD62Ldim	 neutrophils	 suppresses	 T	 cell	proliferation	 in	 a	Mac-1-dependent	manner	 (Pillay,	 2012).	Neutrophils	 that	come	from	the	periphery	can	home	back	into	the	BM	in	a	CXCR4-dependent	
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manner.	 They	 can	 bring	 with	 them	 antigen	 from	 the	 dermis	 to	 the	 BM,	bypassing	 the	 lymph	 nodes.	 Resident	 macrophages	 in	 the	 BM	 take	 the	neutrophils	up	and	present	the	antigen	to	naive	CD8+	T	cells	promoting	their	differentiation	 into	 memory	 T	 cells	 (Duffy,	 2012).	 Finally,	 neutrophilic	myeloid-derived	suppressor	cells	(MDSCs)	interact	with	T	cells	through	ROS,	indoleamine-2,3-dioxygenase	(IDO),	Mac-1,	programmed	death-ligand	1	(PD-L1)	 and	 STAT3	 to	 inhibit	 T	 and	NK	 cell	 proliferation	 (Nagaraj,	 2013;	 Youn	and	Gabrilovich,	2010).		
Furthermore,	 neutrophils	 are	 involved	 in	 NK	 cell	 maturation	 and	neutropenia	causes	diminished	NK	cell	activity	(Jaeger,	2012).	
In	 the	 spleen	marginal	 zone	 neutrophils	 secrete	 the	 B	 cell	 and	 plasma	 cell	survival	 factors	B	 cell	 activating	 factor	 (BAFF)	and	A	proliferation-inducing	ligand	 (APRIL)	 (Huard,	2008;	Scapini,	2005).	 In	 turn,	 a	 subset	of	 splenic	B-cells	 produces	 GM-CSF,	 leading	 to	 differentiation	 of	 splenic	 neutrophils	(Cerutti,	 2013).	 A	 study	 described	 “B-cell	 helper	 neutrophils”	 in	 the	 spleen	that	 activate	 marginal	 zone	 B	 cell	 class	 switching	 and	 T-independent	antibody	 production	 (Puga,	 2012).	 However,	 another	 study	 has	 challenged	the	findings	and	the	existence	of	this	neutrophil	subset	but	offered	no	in	vivo	functional	experiments	(Nagelkerke,	2014).	
Neutrophil	interaction	with	the	microbiome	
The	 influence	 of	 the	 microbiome	 on	 the	 immune	 system	 is	 becoming	increasingly	clear.	Granulopoiesis	and	neutrophil	homeostasis	is	regulated	by	the	 mucosal	 commensal	 flora	 and	 prolonged	 antibiotic	 treatment	 leads	 to	reduced	 neutrophil	 numbers.	 Germ	 free	mice	 are	 neutropenic	 (Deshmukh,	2014;	 Kanther,	 2014;	 Ohkubo,	 1990).	 Microbiota-derived	 PAMPS	 activate	PRRs,	 leading	 to	 G-CSF	 upregulation	 and	 increased	 neutrophil	 production	(Balmer,	 2014;	 Bugl,	 2013).	 Fermentation	 of	 dietary	 fibres	 through	microbiota	 produces	 short	 chain	 fatty	 acids	 (SCFA).	 SCFAs	 signal	 to	neutrophils	 through	 chemoattractant	 receptors	 such	 as	 the	 G	 protein-
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coupled	 receptor	 43	 (GPR43),	 regulating	 the	 resolution	 of	 inflammatory	processes.	 Deficient	 SCFA-GPR43	 interaction	 leads	 to	 exacerbated	inflammation	 in	models	 of	 asthma,	 colitis	 and	 arthritis	 in	mice	 (Maslowski,	2009).	 A	 recent	 study	 showed	 that	 the	 microbial	 PAMPS	 LPS	 and	peptidoglycan	 drive	 neutrophil	 ageing.	 Aged	 neutrophils	 (CD62Llo)	 have	 a	more	activated	phenotype	with	increased	pro-inflammatory	cytokine	release	and	 integrin	 activation.	 Furthermore,	 increased	 NETosis	 in	 CD62Llo	neutrophils	 is	 associated	 with	 tissue	 inflammation.	 Antibiotic	 treatment	reduces	 the	 number	 of	 circulating	 aged	 neutrophils	 and	 improves	pathogenesis	 of	 inflammatory	 organ	 damage.	 Therefore,	 the	microbiome	 is	thought	to	regulate	inflammatory	neutrophil	subsets	(Zhang,	2015).	
1.1.3 Neutrophil	defects	
Mutations	in	neutrophil-associated	genes	and	the	subsequent	impairments	in	neutrophil	 function	 often	 lead	 to	 increased	 susceptibility	 and	 severe	infection,	 emphasising	 the	 particular	 importance	 of	 neutrophils	 in	antimicrobial	defence.	
In	 SCN	 granulopoiesis	 is	 blocked	 at	 the	 promyelocyte-myelocyte	 stage,	leading	 to	deficiency	 in	mature	neutrophils.	SCN	patients	are	susceptible	 to	recurrent	 infections.	 Life-long	 treatment	 with	 G-CSF	 allows	 for	 the	development	 of	 a	 low	 number	 of	 neutrophils	 and	 limited	 restoration	 of	immune	 protection.	 SCN	 is	 caused	 by	 mutations	 in	 different	 genes,	 but	mutations	 in	 the	 gene	 encoding	 for	 NE	 (ELANE)	 are	 most	 frequent.	 An	accumulation	of	misfolded	NE	activates	the	unfolded	protein	response	(UPR)	and	 ER	 stress,	 promoting	 neutrophil	 apoptosis	 (Dale,	 2000;	 Grenda,	 2007;	Kollner,	2006).	Depending	on	the	mutated	gene,	additional	syndromes	such	as	 lymphopenia,	 monocytopenia,	 mental	 retardation,	 seizures,	 uropathy	 or	albinism	can	accompany	SCN	(Kruger,	2015).	
LADs	 are	 caused	 by	 autosomal	 recessive	 mutations	 in	 genes	 coding	 for	selectins	 and	 integrins.	 Due	 to	 these	 defects	 neutrophils	 cannot	 leave	 the	
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circulation	and	patients	have	an	increased	susceptibility	to	infection	(Harris,	2013).	Mutations	in	the	CD18	gene	lead	to	lack	of	β2-chain	integrins	(αLβ2,	
αMβ2,	 αXβ2,	 αDβ2)	 in	 LAD-I.	 LAD-II	 is	 caused	 by	 mutations	 in	 the	 golgi	guanosine	 diphosphate-fucose	 transporter	 (GFTP)	 resulting	 in	 milder	infections	than	LAD-I.	Mutation	of	the	gene	for	the	β-integrin	adaptor	kindlin-3	 leads	 to	 platelet	 defects	 and	 subsequent	 bleedings	 and	 osteopetrosis-like	bone	defects	in	LAD-III.	
LAD-I	neutrophil	recruitment	defects	lead	to	inflammatory	phenotypes	such	as	 periodontal	 bone	 loss	 with	 high	 levels	 of	 IL-17.	 Efferocytosis	 normally	downregulates	 the	 production	 of	 IL-17,	 underscoring	 the	 important	 anti-inflammatory	role	of	neutrophils	in	homeostasis	(Moutsopoulos,	2014).	
CGD	is	caused	by	mutations	in	genes	encoding	for	NADPH	oxidase	subunits.	Mainly	gp91phox	 is	 affected,	 even	 though	mutation	 in	any	 subunit	 can	 cause	CGD	(Segal,	2000;	Stasia	and	Li,	2008).	CGD	pathology	has	an	early	onset	and	is	defined	by	high	morbidity	and	mortality.	Patients	have	a	high	frequency	of	infections.	 The	 increased	 susceptibility	 to	 fungal	 infections,	 such	 as	 A.	
fumigatus,	 has	 been	 attributed	 to	 deficiency	 in	 NET	 release	 in	 CGD.	 Gene	therapy,	 restoring	 NADPH	 oxidase	 function	 and	 NET	 release	 leads	 to	clearance	 of	 infection	 (Bianchi,	 2009;	 Rohm,	 2014).	 Phagosomal	 killing	 is	rescued	 upon	 treatment	 with	 PEGylated	 D-amino	 acid	 oxidase	 (Nakamura,	2012)	 or	 GO-containing	 liposomes,	 restoring	 H2O2	 and	 HOCl	 production,	respectively	 (Gerber,	 2001).	 Unresolved	 infections	 and	 increased	inflammation	 lead	 to	 a	 higher	 incidence	 of	 autoimmune	 disease	 in	 CGD	patients.	
Specific-granule	deficiency	is	a	rare	disease	caused	by	the	lack	of	secondary	and	 tertiary	 granule	 proteins	 due	 to	 deficiency	 in	 cEBPε	 (transcriptional	regulator	 of	 granulopoiesis)	 (Gombart,	 2001).	 Patients	 are	 susceptible	 to	recurrent	bacterial	infections.	
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The	warts,	 hypogammaglobulinemia,	 immunodeficiency,	 and	myelokathexis	(WHIM)	syndrome	is	caused	by	a	mutation	in	CXCR4	leading	to	an	increased	retention	 of	 neutrophils	 in	 the	 BM.	 WHIM	 is	 therefore	 associated	 with	neutropenia	but	also	lymphopenia	and	monocytopenia	(Hernandez,	2003).	
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1.2 NETosis	
The	 discovery	 of	 neutrophil	 extracellular	 traps	 (NETs)	 revolutionised	 the	field	of	 innate	and	particularly	neutrophil	 immunity,	since	programmed	cell	death	as	means	of	 antimicrobial	defence	had	not	been	known	before.	More	importantly,	NETosis	complemented	the	neutrophil	antimicrobial	arsenal	by	an	 extracellular	 defence	 strategy	 and	 challenged	 the	 understanding	 of	neutrophils	 as	 simple	 effector	 cells.	 However,	 it	 was	 unknown	 whether	neutrophil	 antimicrobial	 strategies	were	 employed	 selectively	 and	whether	NET	release	was	regulated.	
1.2.1 NET	release	mechanism	
When	NETs	were	discovered,	NETosis	was	described	as	a	form	of	cell	death,	where	 nuclear	 chromatin	 decondensed	 and	 was	 released	 from	 the	 dying	neutrophil	 in	 web-like	 structures	 that	 captured	 and	 killed	 microbes	(Brinkmann,	2004)	(Figure	I-4).	To	date,	 this	 is	still	 the	most	accepted	and	widely	researched	form	of	NETosis	and	the	results	in	this	thesis	are	based	on	it.	 However,	 recent	 evidence	 suggests	 the	 presence	 of	 alternative	 forms	 of	NETosis	 such	 as	 rapid	 extrusion	of	 chromatin,	 leaving	behind	 live	 anuclear	cytoplasts	that	continue	to	crawl	and	phagocytose	(Pilsczek,	2010)	(Figure	I-
4).	 Furthermore,	 release	 of	 mitochondria-derived	 NETs	 was	 described	recently	(Yousefi,	2009).	
Slow	lytic	cell	death	
The	main	form	of	NETosis	is	caused	by	a	cell	death	programme	that	leads	to	release	 of	web-like	 chromatin	 structures	 into	 the	 extracellular	 space.	Upon	microbe	recognition	ROS	are	produced,	the	nuclear	membranes	disintegrate	and	the	nucleus	starts	to	lose	its	characteristic	lobular	shape.	The	chromatin	decondenses	 into	 the	 cytoplasm.	 In	 this	 process	 neutrophil	 antimicrobial	proteins	 bind	 to	 the	 chromatin,	 forming	 crucial	 NET	 components.	 The	decondensed	 chromatin	 fills	 the	 entire	 cell	 generating	 increasing	 pressure,	
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which	 is	 released	when	 the	plasma	membrane	 ruptures	 and	 the	 chromatin	suddenly	expands	 into	 the	extracellular	space	 (Figure	 I-4).	Microbes	 in	 the	direct	 vicinity	 of	 this	 event	 are	 trapped	 in	 these	webs	 (Brinkmann,	 2004).	Various	NET	components	 are	 thought	 to	mediate	 anti-microbial	 effects	 and	contribute	 to	 killing	 of	 the	microbes.	 See	 also	NETs	 in	 immune	 defence	 on	page	58.	
Chromatin	 decondensation	 is	 driven	 by	 the	 serine	 protease	 neutrophil	elastase	(NE),	which	translocates	to	the	nucleus	where	it	cleaves	the	histones	that	hold	the	DNA	in	a	tightly	packed	state	(Papayannopoulos,	2010)	(Figure	
I-5).	 Normally,	 NE	 is	 localised	 in	 azurophilic	 granules	 together	 with	 other	proteins	 such	 as	 cathepsin	 G	 (CG),	 azurocidin	 (AZU)	 and	 myeloperoxidase	(MPO)	in	a	complex	called	azurosome	(Metzler,	2014).	Upon	ROS	production,	H2O2	 triggers	 the	 dissociation	 of	 NE	 from	 the	 complex	 into	 the	 cytosol.		
		
Figure	I-4	|	NET	release	mechanisms.	Two	main	NET	release	mechanisms	are	known:	Early	rapid	
NET	release	(top	row)	occurs	upon	stimulation	with	S.	aureus.	The	nuclear	membranes	separate,	
vesicles	 filled	 with	 chromatin	merge	with	 the	 intact	 plasma	membrane,	 chromatin	 is	 released	
into	 the	 extracellular	 space.	 Live,	 anuclear	 cytoplasts	 remain	 and	 continue	 to	 phagocytose	
microbes.	 Late	 slow	 NETosis	 (bottom	 row)	 is	 a	 form	 of	 programmed	 cell	 death.	 The	 nuclear	
membranes	 disintegrate,	 the	 nucleus	 loses	 its	 lobular	 shape,	 chromatin	 decondenses	 into	 the	
cytoplasm,	 the	 plasma	 membrane	 ruptures	 and	 decondensed	 chromatin	 is	 released	 into	 the	
extracellular	 space.	 |	 Modified	 after	 (Branzk	 and	 Papayannopoulos,	 2013),	 Seminars	 in	
Immunopathology.	
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Interestingly,	this	process	is	independent	of	membrane	fusion	that	normally	allows	delivery	of	granule	proteins.	H2O2	activates	NE’s	proteolytic	activity	in	an	 MPO-dependent	 manner.	 The	 role	 of	 MPO	 in	 this	 process	 is	 not	 fully	understood.	 However,	 MPO-deficient	 neutrophils	 fail	 to	 translocate	 and	activate	NE.	Most	likely,	the	enzymatic	activity	of	MPO	is	not	required	though,	since	 blocking	 MPO	 activity	 with	 4-aminobenzoic	 acid	 hydrazide	 (ABAH)	does	 not	 influence	 the	 activation	 process.	 NE	 is	 present	 in	 the	 cytoplasm	transiently	 for	 a	 time	 of	 about	 60	minutes	 and	 translocates	 to	 the	 nucleus	thereafter.	In	the	cytoplasm,	activated	NE	binds	to	the	actin	cytoskeleton	and	degrades	 filamentous	 (F)-actin.	 This	 process	 arrests	 the	 cytoskeleton	 and	immobilises	 the	neutrophils	at	 the	point	of	 stimulation,	 allowing	 for	a	 local	deployment	of	the	NETs	onto	the	target.	Thereafter,	NE	dissociates	from	the	actin	 and	 is	 released	 gradually	 into	 the	 nucleus	 (Metzler,	 2014).	 By	 120	minutes	the	majority	of	NE	is	found	in	the	nucleus,	where	it	cleaves	histones	thereby	 initiating	chromatin	relaxation.	Subsequently,	MPO	 follows	 into	 the	nucleus,	further	decondensing	the	chromatin	(Figure	I-5).	The	entire	process	is	 relatively	 slow	 and	 takes	 4	 to	 6	 hours	 in	 vitro	 (Fuchs,	 2007;	Papayannopoulos,	2010).	
		
Figure	I-5	|	Molecular	mechanism	of	NET	release.	In	the	resting	neutrophil,	Neutrophil	elastase	
(NE)	 and	 myeloperoxidase	 (MPO)	 are	 stored	 in	 the	 azurophilic	 granules	 and	 the	 chromatin	 is	
tightly	packed	 in	 the	nucleus.	Upon	activation	of	 the	neutrophil	 through	microbial	 stimulation,	
reactive	oxygen	species	are	produced.	This	induces	translocation	of	NE	into	the	nucleus,	where	it	
cleaves	 histones,	 leading	 to	 chromatin	 decondensation.	 Subsequently,	 MPO	 follows	 into	 the	
nucleus	 and	 contributes	 to	 complete	 chromatin	 decondensation.	 |	 Modified	 after	
(Papayannopoulos,	2010),	The	Journal	of	Cell	Biology.			
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The	receptors	 that	 trigger	NETosis	are	unidentified.	Different	 receptors	are	involved	 in	 the	 recognition	 of	 distinct	microbes,	 but	 to	 date	 it	 is	 unknown	whether	 these	receptors	are	crucial	 for	NET	release.	Most	 importantly,	 it	 is	not	 understood	 at	 which	 point	 activation	 of	 these	 different	 receptors	converges	into	a	common	NETosis	pathway.	
Recognition	of	microbes	through	pattern	recognition	receptors	triggers	ROS	production	in	neutrophils.	Possibly,	initiation	of	a	strong	ROS	burst	provides	a	 strong	 signal	 to	 induce	NETosis.	 It	 has	been	 shown	 that	 extrinsic	 glucose	oxidase	(GO)	or	its	product	H2O2	are	sufficient	to	trigger	NET	release	in	vitro	(Fuchs,	 2007;	 Metzler,	 2014).	 These	 findings	 support	 the	 model	 of	 H2O2-dependent	 NE	 translocation	 (Metzler,	 2014).	 However,	 different	 reports	describe	 ROS-independent	 NET	 release	 and	 it	 is	 emerging	 that	 the	requirement	for	ROS	is	dependent	on	the	microbial	stimulus	(Parker,	2012b).	
The	 addition	 of	 posttranslational	 histone	 modifications	 alters	 chromatin	structure	 and	 density	 and	 is	 therefore	 thought	 to	 be	 important	 for	 NET	release.	 Citrullination	of	 histone	3	 is	 used	 as	 a	 clinical	marker	 for	NETosis,	since	 its	 occurrence	 coincides	 reliably	with	NET	 release	 (Muller	 and	Radic,	2015).	However,	it	is	still	debated	whether	histone	citrullination	is	required	for	 NETosis	 since	 various	 studies	 have	 yielded	 mixed	 results.	Peptidylarginine	 deiminase	 (PAD)	 4	 is	 an	 enzyme	 that	 converts	 the	 amino	acid	 arginine	 into	 citrulline	 by	 replacing	 the	 ketimin	 group	 with	 a	 ketone	group,	 leading	 to	 citrullination	 of	 histone	3	 (Hagiwara,	 2002).	 Inhibition	 of	PAD4	 leads	 to	 decreased	 histone	 citrullination.	 However,	 it	 is	 debated	whether	decreased	citrullination	affects	NET	release.	Whereas	some	groups	claim	 a	 direct	 link	 between	 the	 two	 phenomena	 (Leshner,	 2012;	 Wang,	2009),	 other	 authors	 only	 state	 that	 they	 coincide	 (Neeli,	 2008).	Overexpression	of	PAD4	in	HL-60	neutrophil-like	cell	lines	yielded	increased	NET	 release	 in	 various	 studies	 (Leshner,	 2012;	 Neeli,	 2008;	 Wang,	 2009).	However,	HL-60	cells	are	poor	NET	producers	and	 the	changes	obtained	 in	this	system	are	not	conclusive.	More	importantly,	data	show	that	abrogation	of	histone	citrullination	 in	neutrophils	does	not	 impair	NET	release	 in	vitro	
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(Neeli,	 2008;	Warnatsch,	 2015).	However,	 others	 reported	 that	 neutrophils	from	 PAD4-deficient	mice	 are	 less	 efficient	 in	NET	 release	 and	 subsequent	elimination	of	Shigella	flexneri	in	vivo	(Li,	2010).	
Finally,	 several	 studies	 have	 linked	 calcium	 influx	 in	 neutrophils	 to	 NET	release.	 Calcium	 ionophores	 such	 as	 ionomycin	 are	 sufficient	 to	 trigger	NETosis.	The	mechanism	which	 links	 increased	calcium	 flux	 to	 the	NETosis	pathway	is	not	completely	understood.	A	study	suggests	that	the	activation	of	calcium	 channels	 by	 ionomycin	 stimulate	 protein	 kinase	 C	 (PKC)	 via	phospholipase	C	(PLC),	triggering	NADPH	oxidase	activation	and	production	of	ROS	(Gupta,	2014).	However,	PLC	activation	can	also	recruit	 intracellular	calcium	stores,	which	activate	calcineurin.	The	calcineurin	pathway	recruits	the	nuclear	factor	NF-ATc	to	the	nucleus	where	it	induces	gene	transcription	(Gupta,	 2014).	Therefore,	 both	 extracellular	 and	 intracellular	 calcium	pools	are	 activated	 and	 used	 in	 activating	 NETosis.	 Calcium	 signalling	 after	stimulation	 with	 ionomycin	 induces	 histone	 citrullination	 via	 PAD4.	However,	 PMA	 that	 activates	 PKCα,	 an	 isotype	 of	 classical	 PKC,	 suppresses	this	 ionomycin-induced	 citrullination.	 The	 inhibitory	 function	 of	 PKCα	 on	histone	citrullination	suggests	that	the	presence	of	elevated	calcium	levels	in	the	cell	is	not	an	inducer	of	NETosis	per	se	(Neeli	and	Radic,	2013).	
Live	NET	extrusion	
Apart	 from	 the	 classical	 cell	 death-dependent	 NETosis	 pathway	 other	 NET	release	 mechanisms	 have	 been	 proposed,	 such	 as	 live	 NETing	 neutrophils	that	 continue	 to	 crawl	 and	 phagocytose	 after	 the	 release	 of	 NET	material.	This	novel	 form	of	 live	NET	 release	 in	 response	 to	S.	 aureus	 occurs	 rapidly	within	 5	 to	 60	 minutes	 upon	 stimulation	 and	 is	 independent	 of	 ROS	production	(Pilsczek,	2010).	Interestingly,	no	breach	of	the	cell	membrane	is	seen	and	the	decondensed	chromatin	 is	released	 in	budding	vesicles.	These	vesicles	 are	 released	 into	 the	 extracellular	 space	 where	 they	 rupture	 and	release	 the	 NET	 material.	 The	 remaining	 anuclear	 cytoplasts	 continue	 to	crawl	and	scavenge	 the	environment	 for	phagocytosible	material.	NETosing	
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neutrophils	with	 diffuse	 nuclei	 are	 highly	motile	 and	phagocytose	 bacteria.	Anuclear	 neutrophils	 that	 have	 already	 excreted	 their	 entire	 nucleic	 acid	material	 crawl	 slowly	 and	 continue	 to	 digest	microbes.	 Live	NET	 extrusion	only	involves	a	small	fraction	of	neutrophils.	At	later	stages	other	neutrophils	proceed	 into	 the	 classical	 form	 of	 lytic	 NETosis.	 Live	 NET	 release	 has	 also	been	described	in	vivo	in	a	model	of	S.	aureus	infection	(Yipp,	2012).	Live	NET	extrusion	 is	an	 interesting	concept	since	 it	 seems	to	close	 the	 time	window	between	the	recognition	of	microbes	and	the	late	onset	of	NETosis	at	4	hours.	However,	experimental	verification	by	other	groups	is	needed.	
Mitochondrial	NETs	
Mitochondrial	 DNA	 is	 released	 in	 form	 of	 extracellular	 traps	 in	 a	 fast,	 live	NETosis	 mechanism.	 This	 mechanism	 was	 first	 discovered	 in	 eosinophils	where	it	is	dependent	on	priming	with	IL-5	or	IFN-γ	and	stimulation	with	LPS	or	 complement	 factor	 C5a	 (Yousefi,	 2008).	 Later	 it	 was	 also	 found	 in	neutrophils	after	GM-CSF	priming	and	stimulation	with	LPS	or	C5a	(Yousefi,	2009).	 Mitochondrial	 NETs	 are	 released	 rapidly	 within	 5	 minutes	 upon	stimulation	whereby	 the	actual	 release	happens	as	 fast	 as	 in	1	 second.	The	authors	claim	that	this	form	of	NETosis	is	independent	of	cell	death	since	no	caspase	activation	is	found.	However,	even	though	classical	NETosis	is	a	form	of	cell	death,	 it	 is	clearly	distinct	from	apoptosis	or	necrosis	and	no	caspase	activation	can	be	 found	either.	Therefore,	 further	analysis	of	 the	viability	of	cells	during	mitochondrial	NETosis	 is	 required.	The	mitochondrial	origin	of	the	 DNA	 was	 confirmed	 through	 the	 presence	 of	 specific	 mitochondrial	genes.	Mitochondrial	NETs	were	also	 found	 in	vivo	 in	patients	with	Crohn’s	disease	 or	 bacterial	 gastrointestinal	 infections.	 Crohn’s	 patients	 have	elevated	 levels	 of	 IL-5	 and	 IFN-γ,	 which	 primes	 eosinophils	 accordingly	(Yousefi,	 2008).	 Furthermore,	 mitochondrial	 DNA	 that	 is	 released	 during	trauma	 triggers	 classical	 NETosis	 in	 neutrophils.	 This	 mechanism	 is	independent	 of	 ROS	 and	mediated	 by	 TLR9	 (Itagaki,	 2015).	 This	 finding	 is	interesting	 with	 respect	 to	 mitochondrial	 NETosis,	 since	 it	 raises	 the	
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question	 whether	 NETotic	 mitochondrial	 DNA	 release	 triggers	 classical	nuclear	NETosis,	amplifying	the	overall	response.	
Generally	it	is	not	understood	whether	the	NET	mechanisms	described	above	exist	 next	 to	 each	 other	 and	 are	 triggered	 in	 a	 timely	manner	 in	 different	neutrophil	populations	or	whether	different	ligands	trigger	different	forms	of	NETosis.	
1.2.2 NET	clearance	
NET	release	exposes	a	broad	range	of	antimicrobial	effectors	as	well	as	self-antigens	 linked	 to	 inflammatory	 and	 autoimmune	 diseases.	 Therefore,	 the	timely	clearance	of	NETs	is	crucial	for	host	protection.	Contrary	to	apoptotic	cells,	 NETs	 do	 not	 display	 eat-me	 signals	 (Kaplan	 and	 Radic,	 2012).	 In	contrast,	NETs	are	degraded	extracellularly	by	DNase	I	(Hakkim,	2010).	The	complement	 component	 C1q	 that	 is	 involved	 in	 the	 clearance	 of	 apoptotic	cells,	acts	synergistically	with	DNase	I	to	process	NETs	(Farrera	and	Fadeel,	2013;	 Gaipl,	 2004).	 In	 vitro	 opsonisation	 by	 C1q	mediates	 uptake	 of	 NETs	into	 monocyte-derived	 macrophages	 via	 endocytosis.	 Via	 the	 phagosome	NETs	 are	 shuttled	 to	 the	 lysosome,	where	 they	 are	 degraded.	Macrophage-driven	degradation	of	NETs	does	not	induce	production	of	pro-inflammatory	cytokines	and	represents	a	silent	way	of	disposal	(Farrera	and	Fadeel,	2013).	Furthermore,	NE	that	is	present	on	the	NETs	continues	to	cleave	histones	and	decondense	 chromatin	 (Papayannopoulos,	 2011).	 In	 the	 context	 of	 cystic	fibrosis	 this	 has	 been	 suggested	 to	 improve	 sputum	 solubility	 of	 patients.	NETs	form	a	component	of	the	viscous	sputum	and	are	more	easily	accessible	for	degradation	by	DNase	after	NE-mediated	decondensation.	
Impaired	 clearance	 of	 NETs	 leads	 to	 increased	 incidence	 of	 autoimmune	disease	such	as	systemic	lupus	erythematosus	(SLE)	(Hakkim,	2010;	Leffler,	2012;	Mahajan,	2016).	Over	60%	of	SLE	patients	are	so	called	non-degraders	since	they	lack	the	capacity	to	digest	NETs	by	DNase	I.	This	is	either	caused	by	presence	of	DNase	inhibitors	or	anti-DNA	antibodies	that	protect	the	DNA	
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from	 degradation	 by	 DNase	 (Hakkim,	 2010).	 Other	 studies	 describe	 the	presence	 of	 inhibitory	 anti-DNase	 antibodies	 in	 the	 serum	 of	 SLE	 patients	(Yeh,	2003).	Furthermore,	defects	 in	 complement	 components	 such	as	C1q,	C3	or	C4	are	linked	to	SLE.	SLE	patients	with	complement	deficiencies	have	a	lowered	ability	to	degrade	NETs	(Botto,	1998;	Leffler,	2012).	
1.2.3 	NETs	in	immune	defence	
Neutrophils	 are	 the	 first	 cells	 to	 arrive	 at	 the	 site	 of	 infection,	 where	 they	encounter	a	broad	variety	of	different	microbes.	Many	fungi,	bacteria,	viruses	and	 parasites	 are	 thought	 to	 trigger	 the	 release	 of	 NETs	 (Table	 I-1).	However,	 it	 is	 unknown	what	 the	 activating	 ligands	 are	 and	whether	NETs	are	released	selectively	upon	recognition	of	distinct	microbes.	
Microbial	NET	induction	
Possibly,	different	signalling	pathways,	receptors	and	ligands	are	involved	in	triggering	NETosis,	 acting	 in	 complementary	ways.	Currently	 it	 is	unknown	at	which	point	these	different	triggers	converge	into	a	common	NET	inducing	signal.	However,	some	conserved	NET	induction	strategies	may	exist.	
Recent	 reports	 state	 that	 bacterial	 toxins	 trigger	 NETosis	 by	 inducing	necrosis	 via	pore	 formation	 in	neutrophils.	 The	Mycobacterium	 tuberculosis	protein	 ESAT-6	 triggers	 neutrophil	 necrosis	 by	 inducing	 intracellular	 Ca2+	overload.	Necrotic	neutrophils	subsequently	release	NET	material	measured	as	 free	 MPO	 and	 DNA	 (Francis,	 2014).	 Other	 reports	 also	 indicate	 the	implication	 of	 ruptured	 neutrophil	 membrane	 in	 triggering	 NETosis.	Membrane	 pores	 induced	 by	 the	 Staphylococcus	 aureus	 pore	 forming	 toxin	leukotoxin	 GH	 (lukGH)	 or	 electroporation	 leads	 to	 increased	 NETosis	(Malachowa,	 2013).	 A	 similar	 effect	 is	 induced	 by	 the	 Mannheimia	
haemolytica	 leukotoxin	(LKT)	(Aulik,	2010).	However,	pore	formation	could	simply	 cause	 nuclear	 and	 granular	 material	 to	 leak	 into	 the	 extracellular	space,	making	it	difficult	to	distinguish	between	NET	release	and	necrosis	by		 	
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	 Species/	Agent	 References	
Bacteria	 Burkholderia	pseudomallei	 (Riyapa,	2012)	
	 Echerichia	coli		 (Grinberg,	 2008;	 Lippolis,	 2006;	 McDonald,	 2012;	 Munafo,	
2009)	
	 Eimeria	bovis	 (Behrendt,	2010;	Munoz-Caro,	2015b)	
	 Enterococcus	faecalis	 (Lippolis,	2006)	
	 Haemophilus	influenzae	 (Hong,	2009;	Juneau,	2011)	
	 Helicobacter	pylori	 (Hakkim,	2011)	
	 Klebsiella	pneumoniae	 (Papayannopoulos,	2010;	Sorensen,	2014)	
	 Lactococcus	lactis	 (Buchanan,	2006)	
	 Leptospira	spp	 (Scharrig,	2015)	
	 Listeria	monocytogenes	 (Ermert,	2009;	Munafo,	2009)	
	 Mannheimia	haemolytica	 (Aulik,	2010)	
	 Mycobacterium	
tuberculosis	
(Francis,	2014;	Ramos-Kichik,	2009)	
	 Neisseria	ghonorrhoeae	 (Gunderson	and	Seifert,	2015;	Juneau,	2015b)	
	 Porphyromonas	gingivalis	 (Jayaprakash,	2015)	
	 Pseudomonas	aeruginosa	 (Kamoshida,	2015;	Yoo,	2014)	
	 Pseudomonas	fluorescens	 (Chi	and	Sun,	2016)	
	 Shigella	flexneri	 (Brinkmann,	2004;	Li,	2010)	
	 Staphylococcus	aureus	 (Berends,	 2010;	 Fuchs,	 2007;	 Malachowa,	 2013;	 Pilsczek,	
2010;	Yipp,	2012)	
	 Streptococcus	pyogenes	 (Buchanan,	2006;	Lauth,	2009;	Sumby,	2005)	
	 Streptococcus	suis	 (Zhao,	2015)	
	 Yersinia	enterolitica	 (Casutt-Meyer,	2010)	
	 Yersinia	pseudotuberculosis	 (Gillenius	and	Urban,	2015)	
	 Lipopolysaccharide	(LPS)	 (Yousefi,	2008)	
Fungi	 Aspergillus	fumigatus	 (Bruns,	2010;	Loures,	2015;	McCormick,	2010;	Rohm,	2014)	
	 Aspergillus	nidulans	 (Bianchi,	2009;	Bianchi,	2011)	
	 Candida	albicans	 (Byrd,	 2013;	 Byrd,	 2015;	 Ermert,	 2009;	 Metzler,	 2011;	
Papayannopoulos,	2010;	Urban,	2009;	Urban,	2006)	
	 Candida	glabrata	 (Springer,	2010)	
	 Cryptococcus	gattii	 (Springer,	2010)	
	 Cryptococcus	neoformans	 (Urban,	2009)	
	 Paracoccidioides	
brasiliensis	
(Mejia,	2015)	
	 Paracoccidioides	spp	 (Bachiega,	2016;	Della	Coletta,	2015)	
Table	I-1	|	NET-inducing	microbes.	
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Parasites	 Cryptosporidium	parvum		 (Munoz-Caro,	2015a)	
	 Eimeria	bovis	 (Behrendt,	2010)	
	 Leishmania	amazonensis	(amastigotes)	 (Guimaraes-Costa,	2009)	
	 Leishmania	amazonensis,	L.	major,	L.	
chagasi	(promastigotes)	
(Guimaraes-Costa,	2009;	Wardini,	2010)	
	 Leishmania	donovani	 (Gabriel,	2010)	
	 Leishmania	mexicana	 (Hurrell,	2015)	
	 Plasmodium	falciparum	 (Baker,	2008)	
	 Strongyloides	stercoralis	 (Bonne-Annee,	2014)	
	 Toxoplasma	gondii	 (Abi	Abdallah,	2012)	
Viruses	 HIV-1	 (Saitoh,	2012)	
	 Influenza	 (Hemmers,	2011;	Narasaraju,	2011)	
	 Rabbit	poxvirus	(MYXV)	 (Jenne,	2013)	
	 Respiratory	syncytial	Virus	(RSV)	 (Funchal,	2015)	
Table	I-1	|	NET-inducing	microbes	(continued).		
solely	 measuring	 the	 release	 of	 NET	 material.	 Furthermore,	 a	 mechanistic	explanation	of	how	pore	formation	and	necrosis	would	induce	NETosis	is	still	missing.	Further	research	into	this	phenomenon	is	required.	
Though	ROS	products	can	induce	NETosis	directly	(Akong-Moore,	2012),	it	is	unknown	 whether	 a	 strong	 microbial	 ROS	 induction	 is	 sufficient	 for	 NET	release	 in	 the	absence	of	 additional	 signals.	The	conidia	 form	of	 the	 fungus	
Paracoccidioides	brasiliensis	induce	NETosis	independent	of	ROS	production,	whereas	 the	 yeast	 form	 depends	 on	 NADPH	 activity	 for	 NET	 release.	Interestingly,	 a	mutant	P.	 brasiliensis	 strain	with	 reduced	 expression	of	 the	alternative	 oxidase	 (AOX),	 important	 for	 reduction	 of	 ROS,	 induced	 higher	levels	 of	 NETs	 (Mejia,	 2015).	 Yersinia	 pseudotuberculosis	 triggers	 ROS	production	and	NET	release	in	neutrophils	via	the	adhesive	protein	invasin.	
E.	coli	expressing	the	Y.	pseudotuberculosis	 invasin	gain	the	ability	to	induce	NETs	and	show	increased	ROS	production	(Gillenius	and	Urban,	2015).	
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NET	antimicrobial	mechanisms	
NETs	are	an	antimicrobial	strategy	with	the	aim	to	limit	infection.	Originally	NETs	were	thought	to	entrap	microbes	to	physically	contain	dissemination.	A	more	 targeted	 delivery	 of	 antimicrobials	 through	NETs	 could	 contribute	 to	the	antimicrobial	activity	of	NETs	(Brinkmann,	2004).	Whether	NETs	kill	the	entrapped	microbes	is	debated	and	differs	between	microbes.	Microbes	have	developed	several	NET	evasion	strategies.	See	Microbial	NET	evasion	on	page	64.	
Already	in	the	 initial	description	NETs	were	suggested	to	prevent	microbial	dissemination	 by	 ensnaring	 and	 physically	 trapping	microbes	 (Brinkmann,	2004).	Experimental	bacterial	sepsis	with	E.	coli	induces	NETosis,	increasing	bacterial	 trapping	 and	 reducing	 dissemination	 in	 vivo	 (McDonald,	 2012).	NETs	 from	 myeloid	 related	 protein	 (MRP)	 14-deficient	 neutrophils	 fail	 to	control	 Klebsiella	 pneumoniae	 in	 vitro.	 In	 MRP14	 knockout	 mice	 K.	
pneumoniae	 disseminates	more	 readily,	which	 support	 the	 role	 of	 NETs	 as	effectors	against	bacterial	dissemination	(Achouiti,	2012).	
Another	 interesting	 concept	 is	 the	 immobilisation	 of	 microbes	 to	 facilitate	attack	by	other	immune	cells.	The	helminth	Strongyloides	stercoralis	induces	NETs.	 Even	 though	 NETs	 are	 ineffective	 in	 killing	 S.	 stercoralis	 larvae,	 the	entrapment	 by	 NETs	 is	 required	 for	 killing	 by	 macrophages	 and	 other	incoming	neutrophils	(Bonne-Annee,	2014).	
Contact	of	NETs	with	bacteria	 can	 lead	 to	growth	 inhibition	of	 the	bacteria	and	potentially	 lower	 the	 infectivity	upon	reinfection	with	 these	bacteria	 in	
vivo.	 Pseudomonas	 fluorescens	 triggers	 NET	 release	 in	 fish	 neutrophils.	Trapped	P.	 fluorescens	 are	 inhibited	 in	 replication.	Re-infection	of	 fish	with	these	 trapped	 bacteria	 results	 in	 lowered	 dissemination	 and	 colonization	indicating	an	anti-bacterial	effect	(Chi	and	Sun,	2016).	A	similar	effect	is	seen	on	 the	 parasite	 Eimeria	 bovis,	 which	 induces	 NETs	 and	 is	 trapped	 and	immobilized	 by	 these.	 Infection	 of	 bovine	 umbilical	 vein	 endothelial	 cell	
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(BUVEC)	cultures	 in	vitro	was	 lowered	with	 trapped	E.	bovis	 sporozoites	as	compared	 to	 controls	 (Behrendt,	 2010).	 These	 studies	 indicate	 NET-associated	 damage	 to	 trapped	microbes	 that	 result	 in	 decreased	 infectivity	beyond	prevention	 of	 physical	 dissemination.	However,	 it	 is	 unknown	how	NETs	bind	 to	microbes	 and	 research	 is	 required	 into	which	 components	 of	the	microbes	are	altered	by	this	contact,	causing	the	decreased	infectivity.	
The	ultimate	aim	of	each	antimicrobial	strategy	is	elimination	of	the	invading	pathogen.	However,	the	killing	capacity	of	NETs	is	variable	and	seems	to	be	dependent	 on	 the	 entrapped	 pathogen.	 Mannheimia	 haemolytica	 and	
Leptospira	 species	 trigger	 NET	 release	 and	 are	 trapped	 and	 subsequently	killed	 in	 those	 (Aulik,	 2010;	 Scharrig,	 2015).	 E.	 coli	 is	 killed	 by	 shrimp	haemocyte	 ETs	 (Ng,	 2013).	 Interestingly,	 NETs	 induced	 by	 Neisseria	
ghonorrhoeae	are	inefficient	in	killing	these	gonococci	but	do	kill	the	common	vaginal	 bacterium	 Lactobacillus	 crispatus	 (Gunderson	 and	 Seifert,	 2015).	Microbes	have	developed	escape	strategies	such	as	polysaccharide	capsules	that	prevent	killing	via	NETs.	Streptococcus	suis	capsule	negative	mutants	are	killed	 in	 NETs	 (Zhao,	 2015).	 Furthermore,	 NETs	 are	 ineffective	 in	 killing	some	 parasites	 such	 as	 Strongyloides	 stercoralis,	 Leishmania	 mexicana,	
Eimeria	bovis	(Behrendt,	2010;	Bonne-Annee,	2014;	Hurrell,	2015).	However,	promastigotes	 of	 Leishmania	 amozonensis,	 L.	 major,	 L.	 chagasi	 and	amastigotes	of	L.	 amazonensis	 are	 efficiently	killed	by	NETosis	 (Guimaraes-Costa,	2009).		
The	mechanisms	by	which	NETs	kill	microbes	are	not	 fully	understood	but	different	mechanism	are	proposed.	Possibly	a	combination	of	different	killing	mechanism	may	be	involved.	NETs	contain	wide	range	of	antimicrobials	that	are	 known	 to	 kill.	 The	 ion	 chelator	 calprotectin	 is	 found	 on	 NETs	 and	scavenges	zinc	and	manganese	 from	the	environment,	depriving	 fungi	 from	essential	 growth	 conditions.	 While	 some	 studies	 report	 calprotectin-dependent	killing	of	NET-trapped	fungi	such	as	Aspergillus	nidulans	(Bianchi,	2011)	 other	 studies	 propose	 growth-inhibition	 without	 final	 killing	 (Clark,	2015).	 In	 vivo	 studies	 in	C.	 albicans	 infection	models	 only	 provide	 indirect	
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evidence	 for	 calprotectin-dependent	 killing	 by	 NETs.	 Calprotectin-deficient	mice	 succumb	 to	 pulmonary	 candidiasis	 and	 spreading	 of	 subcutaneous	 C.	
albicans	infection	is	increased	as	compared	to	control	animals	(Urban,	2009;	Urban,	2006).	However,	it	is	not	clear	whether	this	is	directly	dependent	on	NET-mediated	killing.	
Furthermore,	the	antimicrobial	peptide	LL-37	has	been	shown	to	play	a	role	in	 NET-mediated	 killing.	 Neutralisation	 of	 LL-37	 by	 group	 A	 Streptococcus	(GAS)	 serotype	 M1T1	 via	 the	 surface	 protein	 M1	 leads	 to	 impaired	neutrophil-	 and	 NET-mediated	 killing	 (LaRock,	 2015;	 Lauth,	 2009).	 M1-deficient	GAS	mutants	are	efficiently	killed	by	NETs.	
Interestingly,	 NETs	 can	 also	 associate	 with	 microbial	 components	 that	enhance	the	anti-microbial	activity	of	the	extracellular	traps.	Staphylococcus	
epidermidis	 produces	 the	 phenol-soluble	 modulin	 δ-toxin	 (PSMγ)	 that	associates	 with	 the	 NET	 component	 cathelicidin.	 δ-toxin-containing	 NETs	show	increased	killing	of	GAS	(Cogen,	2010).	
The	importance	of	ROS	for	NET-mediated	killing	is	debated.	However,	a	study	shows	 killing	 of	 Staphylococcus	 aureus	 dependent	 on	 HOCl.	 The	 authors	describe	a	mechanism	by	which	MPO	bound	to	NETs	may	metabolise	H2O2	to	HOCl.	 In	 this	 in	 vitro	 study,	 addition	of	 exogenous	H2O2	was	 required	 for	S.	
aureus	killing.	(Parker,	2012a).	In	vivo	the	infiltration	of	activated	neutrophils	may	provide	a	source	of	H2O2.	However,	ROS	mediated	microbial	killing	may	not	necessarily	be	NET-mediated.	Evidence	suggests	that	ROS	is	required	for	fungal	 killing.	 Direct	 neutrophil-fungal	 contact	 triggers	 a	 ROS	 burst	 and	degranulation,	 independent	 of	 NET	 formation	 (Diamond	 and	 Clark,	 1982;	Jahn,	1996;	Levitz	and	Diamond,	1985;	Schaffner,	1986).	
There	 are	 certain	 technical	 caveats	 with	 NET	 killing	 assays	 used	 in	 some	studies.	The	major	problem	may	be	clumping	of	microbes	that	are	trapped	in	(pre-formed)	 NETs	 followed	 by	 plating	 of	 these	 “colony	 forming	 units”	 on	agar	plates.	The	resulting	colony	counts	may	underestimate	the	numbers	of	
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actually	 alive	microbes.	 Treatment	 of	 the	 trapped	microbes	with	 DNase	 to	dissolve	the	NETs	before	plating	could	solve	this	 issue.	 Interestingly,	where	DNase	digestion	was	used	the	observed	killing	is	comparatively	low	(Bruns,	2010;	Menegazzi,	2012;	Parker,	2012a).	
Microbial	NET	evasion	
Triggering	 NETosis	 combined	 with	 the	 inefficiency	 of	 the	 NETs	 to	 kill	 the	entrapped	microbes	 is	 an	 immune	evasion	 strategy,	 harming	 the	host.	NET	release	 that	 does	 not	 lead	 to	 efficient	 microbe	 elimination,	 depletes	 the	neutrophil	 pool,	 further	 weakening	 the	 immune	 response	 (Gunderson	 and	Seifert,	2015).	Furthermore,	continued	NET	triggering	which	is	not	haltered	by	microbial	 clearance	 increases	 the	 risk	 for	host	damage	due	 to	 the	 tissue	toxicity	of	NETs.	
Microbes	 have	 developed	 several	 NET	 evasion	 strategies,	 which	 will	 be	discussed	below.	
Polysaccharide	capsules	are	a	common	virulence	strategy	in	bacteria,	which	allow	 the	 microbe	 to	 prevent	 immune	 strategies	 such	 as	 uptake	 by	phagocytes.	 However,	 more	 recent	 reports	 indicate	 that	 capsules	 can	 also	prevent	killing	by	NETosis	or	NET	induction	in	the	first	place.	The	bacterium	
Streptococcus	 suis	 contains	 a	 polysaccharide	 capsule	 that	 prevents	 both	phagocytosis	 and	 NET	 killing	 (Zhao,	 2015).	 The	 Streptococcus	 pneumoniae	polysaccharide	 capsule	 reduces	 trapping	 in	 and	 killing	 by	 NETs	 with	increased	 susceptibility	 in	 capsule	 deficient	 mutants	 (Wartha,	 2007).	
Burkholderia	 pseudomallei	 induces	 NETs	 dependent	 on	 the	 capsular	polysaccharide	 I	 (CPS-I).	 CPS-I-deficient	 B.	 pseudomallei	 mutants	 show	 a	decreased	capacity	to	induce	NETosis	(Riyapa,	2012).	
Haemophilus	 influenzae	 forms	 biofilms	 and	 bacterial-induced	 NETs	 are	 a	component	 of	 these	 biofilms.	 H.	 influenzae	 is	 resistant	 to	 NET	 killing	dependent	 on	 the	 expression	 of	 catalase	 (hktE)	 and	 peroxiredoxin-
INTRODUCTION	
	
	
65	
glutaredoxin	 (pdgX).	 Strains	 lacking	 these	 enzymes	 show	 increased	susceptibility	to	peroxide	as	well	as	decreased	survival	within	NETs	(Juneau,	2015a).	
Streptococcus	 pyogenes	 (group	 A	 Streptococcus,	 GAS)	 M1	 serotype	 induces	more	NETs,	but	is	more	resistant	to	NET	killing	as	compared	to	serotypes	not	expressing	the	M1	protein.	M1	sequesters	the	active	forms	of	cathelicidin	LL-37	(human)	and	mCRAMP	(mouse)	leading	to	impaired	NET	killing	(LaRock,	2015;	Lauth,	2009).	
Nontypeable	Haemophilus	influenzae	(NTHI)	is	characterised	by	formation	of	biofilm	 composed	 of	 a	 polymeric	 lattice	 that	 contains	 lipooligosaccharides	(LOS).	Interestingly,	NETs	have	been	identified	as	host-derived	component	in	these	biofilms.	NTHI	survive	within	NETs	and	resist	phagocytosis	dependent	on	 the	 expression	 of	 LOS.	 Mutants	 with	 altered	 LOS	 composition	 and	structure	 are	 susceptible	 to	 NET-mediated	 killing	 (Hong,	 2009;	 Juneau,	2011).	 However,	 it	 is	 unclear,	 what	 the	 contribution	 of	 these	 biofilm	components	 to	 NET	 evasion	 is	 compared	 to	 expression	 of	 ROS	 reducing	enzymes	as	described	by	the	same	group.	(See	above	(Juneau,	2015a).)	
The	 most	 common	 NET	 evasion	 strategy	 is	 the	 degradation	 of	 NETs	 by	microbe-derived	nucleases.	Neisseria	gonhorroea	induces	the	release	of	NETs	and	 similarly	 their	 degradation	 over	 time,	 dependent	 on	 the	 putatively	secreted	 thermonuclease	 (Nuc)	 that	 is	 normally	 required	 for	 biofilm	remodelling.	 Since	 NETs	 have	 antimicrobial	 activity	 against	N.	 gonhorroea,	Nuc	 expression	 enhances	 bacterial	 survival	 (Juneau,	 2015b).	 Streptococcus	
pyogenes	 (group	 A	 Streptococcus,	 GAS)	 M1	 serotype	 expresses	 the	extracellular	 DNase	 Sda1.	 GAS	 eliminate	 NETs	 by	 Sda1	 digestion	 and	 are	more	 resistant	 to	 neutrophil	 killing	 than	 an	 Sda1	 KO	 mutant,	 which	 also	induce	smaller	 lesions	and	 lower	bacterial	 titres	 in	vivo	 than	wild	 type	GAS	(Buchanan,	2006).	GAS	deficient	for	three	extracellular	DNases	(NAK)	induce	smaller	 lesions	 and	 no	 viable	 bacteria	 in	 a	mouse	 infection	model	 (Sumby,	2005).	Streptococcus	suis	induces	and	degrades	NETs	in	vitro	via	the	secreted	
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nuclease	A	 (SsnA).	 A	 SsnA	mutant	 is	 attenuated	 in	NET	degradation	 and	 is	less	 protected	 against	 NET	 antimicrobial	 activity	 in	 vitro	 (de	 Buhr,	 2014).	Another	 S.	 suis	 nuclease	 Endonuclease	 A	 (EndAsuis)	 degrades	 NETs	dependent	 on	Mg+.	However,	 contrary	 to	 SsnA	EndAsuis	 deficiency	 did	 not	lead	 to	 higher	 susceptibility	 to	NET	killing	 (de	Buhr,	 2015).	Staphylococcus	
aureus	 nuclease	 (nuc)	 degrades	 NETs.	 Nuc	 deficient	 strains	 are	 more	susceptible	 to	 extracellular	 killing.	 Therefore	 infection	 with	 Nuc-sufficient	wild	 type	 S.	 aureus	 leads	 to	 delayed	 clearance	 in	 the	 lung	 and	 increased	mortality	 in	 mice	 as	 compared	 to	 infection	 with	 a	 Nuc	 deficient	 mutant	(Berends,	2010).	Similarly,	a	Streptococcus	pneumonia	endonuclease	(endA)-deficient	 strain	 is	 less	 virulent	 and	 mice	 show	 increased	 survival	 (Beiter,	2006).	
Microbes	are	also	able	 to	directly	alter	neutrophil	 responses	 including	NET	release	 by	 inducing	 signalling	 cascades	 via	 either	 direct	 cell	 interaction	 or	provision	of	signalling	mediators.	The	S.	aureus	enzymes	nuclease	(nuc)	and	adenosine	 synthase	 (adsA)	 convert	 NETs	 to	 deoxyadenosine	 (dAdo),	 a	deoxyribonucleoside	base	of	DNA.	dAdo	causes	accumulation	of	intracellular	dATP,	which	subsequently	quenches	DNA	synthesis	and	 triggers	 caspase-3-dependent	 immune	 cell	 death,	 excluding	 macrophages	 from	 S.	 aureus	abscesses	 (Thammavongsa,	2013).	Therefore,	S.	aureus	does	not	only	cause	NET	 degradation,	 but	 also	 utilizes	 the	 degradation	 products	 for	 further	immune	 suppression.	 Group	 B	 Streptococcus	 expresses	 a	 sialylated	polysaccharide	in	its	capsule,	which	engages	Siglec-9	on	neutrophils.	Siglec-9	signalling	 dampens	 neutrophil	 reactivity	 characterised	 by	 a	 reduced	 ROS	burst	and	decreased	NET	release	(Carlin,	2009).	
Interestingly,	NET	evasion	 is	 a	primarily	bacterial	phenomenon.	This	might	mainly	 be	 explained	 by	 the	 fact	 that	 most	 pathogenic	 bacteria	 express	nucleases,	whereas	fungi	are	nuclease	free.	
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NET	interaction	with	the	gut	microbiota	
The	 influence	 of	 the	 microbiome	 on	 the	 immune	 system	 has	 become	increasingly	clear	in	the	last	few	years.	Therefore,	it	is	not	surprising	that	gut	bacteria	 also	 influence	 neutrophil	 immunity,	 including	 NETosis.	 The	 gut	contains	 a	 plethora	 of	 bacteria	 representing	 potential	 NET	 triggers.	Unregulated	NETosis	would	 lead	 to	 severe	 bowel	 inflammation,	 due	 to	 the	tissue	toxicity	of	NETs.	
Interestingly,	bacterial	cultures	isolated	from	Citrobacter	rodentium-infected	mice	enriched	for	probiotic	Lactobacillus	species	did	not	induce	NET	release	
in	vitro	in	contrast	to	cultures	enriched	for	aerobic	and	facultative	anaerobic	bacteria	 or	 E.	 coli.	 Furthermore,	 Lactobacillus	 rhamnosus	 suppresses	 NET	release	upon	stimulation	with	S.	aureus	and	PMA	in	vitro.	S.	aureus-	mediated	cytotoxicity	was	reduced	in	the	presence	of	L.	rhamnosus,	which	the	authors	attribute	 to	 reduced	 S.	 aureus-induced	 NETosis	 (Vong,	 2014;	 Vong,	 2015).	Microbiota	and	microbiome-derived	components	(LPS,	peptidoglycan)	drive	neutrophil	 ageing	 in	 vivo.	 Aged	 neutrophils	 show	 an	 activated	 phenotype,	which	 includes	 increased	 NET	 formation.	 Antibiotic	 treatment	 decreases	neutrophil	 ageing	 and	 reduces	 NET	 release	 followed	 by	 decreased	 tissue	damage	 in	mice	 (Zhang,	 2015).	 Therefore,	 increased	 NET	 induction	 due	 to	dysbiosis	could	contribute	to	inflammatory	bowel	conditions.	
NETs	and	adaptive	immunity	
Various	 interactions	 of	 neutrophils	 with	 the	 adaptive	 immune	 system	 are	known.	 However,	 research	 is	 needed	 into	 the	 implication	 of	 NETs	 in	 these	interactions.	A	recent	report	describes	a	B	cell-helper	subset	of	neutrophils	(NBH)	in	the	marginal	zone	(MZ)	of	the	spleen,	characterised	by	an	activated	phenotype,	 that	 drives	 class	 switching,	 somatic	 hypermutation	 and	immunoglobulin	 production	 in	 B	 cells.	 NBH	 constitutively	 release	 NETs	 in	close	 proximity	 to	MZ	 B	 cells.	 The	 authors	 of	 the	 study	 suggest	 that	 NETs	released	by	NBH	enhance	T-independent	immunoglobulin	B	cell	responses	by	
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trapping	 antigen	 and	more	 directly	 by	 delivering	 immunostimulatory	 DNA	(Puga,	 2012).	 These	 findings	 indicate	 a	 protective	 function	 of	 NETs	 by	initializing	 the	 adoptive	 immune	 system,	 by	 priming	 of	 B	 cells	 through	constitutively	released	NETs.	
NET	deficiencies	
There	 are	 several	 lines	 of	 evidence	 that	 suggest	 that	NETosis	 is	 crucial	 for	antimicrobial	 defence	 (Bianchi,	 2009;	 Bianchi,	 2011).	 However,	 the	 overall	contribution	of	NETs	in	immunity	is	not	clearly	defined.		
ROS	play	a	crucial	role	in	triggering	NETosis	for	most	stimuli	(Fuchs,	2007).	However,	 since	 ROS	 are	 also	 implicated	 in	 other	 neutrophil	 immune	functions	 it	 is	 difficult	 to	 dissect	 the	 role	 of	NETs	 in	ROS	deficient	 patients	completely.	Patients	with	ROS	deficiencies	suffer	from	severe	infections	with	pathogenic	 and	 commensal	microbes.	 Interestingly	 however,	 these	patients	are	 specifically	 prone	 to	 fungal	 diseases	 (Bianchi,	 2009;	 Parker	 and	Winterbourn,	 2012;	 Segal,	 2000;	 Stasia	 and	 Li,	 2008).	 The	 NADPH	 oxidase	drives	 metabolism	 of	 oxygen	 to	 superoxide,	 which	 is	 then	 further	metabolised	 into	 hydrogen	 peroxide	 (H2O2)	 and	 hypochlorite.	 NADPH	oxidase	 deficiency	 leads	 to	 chronic	 granulomatous	 disease	 (CGD).	 CGD	patients	 suffer	 from	 severe	 and	 recurrent	 opportunistic	 infections	 with	mostly	 fungi	 such	 as	 Aspergillus	 fumigatus	 (Antachopoulos,	 2010).	 CGD	neutrophils	are	unable	to	form	NETs	upon	stimulation	with	PMA	or	bacteria	and	addition	of	H2O2	restores	NET	formation	(Fuchs,	2007).	In	humans,	gene	therapy	 rescued	NADPH	 oxidase	 activity	 and	 restored	 antifungal	 immunity	against	A.	fumigatus.	Patients	neutrophils	treated	with	gene	therapy	killed	A.	
fumigatus	hyphae	mostly	by	NETosis	(Bianchi,	2009;	Bianchi,	2011)	In	mice,	deficiency	 of	 the	NADPH	 oxidase	 subunit	 p47phox	 abrogates	NET	 release.	A.	
fumigatus	 infections	are	not	resolved	in	these	mice	(Rohm,	2014).	Similarly,	CGD	mice	deficient	in	the	gp91	subunit	of	the	NADPH	oxidase	are	deficient	in	NET	release	upon	infection	with	C.	albicans	(Ermert,	2009).	
INTRODUCTION	
	
	
69	
Myeloperoxidase	 is	 another	 important	 enzyme	 in	 the	 ROS	 cascade	metabolising	 H2O2	 into	 hypochlorite.	 Patients	 with	 MPO	 mutations	 show	varied,	 complex	 clinical	 manifestation	 since	 many	 of	 these	 mutations	 only	cause	partial	 loss	of	 enzyme	activity	 (Kameoka,	2004;	Kutter,	1998;	Kutter,	2000;	 Metzler,	 2011).	 However,	 complete	 MPO	 deficiency	 leads	 to	 chronic	fungal	 susceptibility.	 Interestingly,	 residual	 MPO	 activity	 of	 only	 3%	 is	sufficient	 for	 NETosis.	 However,	 completely	 MPO-deficient	 neutrophils	 are	unable	 to	 release	 NETs	 (Metzler,	 2011;	 Parker,	 2012b).	 The	 only	 sporadic	episodes	 of	 fungal	 infection	 in	 MPO-deficient	 patients	 are	 explained	 by	slightly	 impaired	 but	 overall	 sufficient	 capacity	 of	 their	 neutrophils	 to	phagocytose,	 which	 allows	 them	 to	 eliminate	 most	 infections	 in	 the	 early	stages.	
Patients	 with	 Papillon-Lefèvre	 syndrome	 (PLS)	 have	 a	 genetic	mutation	 in	cysteine	protease	cathepsin	C	(CTSC)	that	is	required	for	processing	of	serine	proteases,	leading	to	deficiency	in	cathepsin	G,	proteinase	3	(PR3)	and	NE.	A	recent	 study	 shows	 that	 PLS	 neutrophils	 do	 not	 release	 NETs	 in	 vitro.	Interestingly,	 the	 studied	 patient	 did	 not	 show	 any	 signs	 of	immunodeficiency	 apart	 from	 periodontal	 complications.	 Furthermore,	patient	neutrophils	were	sufficient	in	bacterial	killing	when	challenged	with	
S.	aureus	or	Klebsiella	pneumoniae	(Sorensen,	2014).	
The	requirement	 for	PAD4	and	histone	citrullination	 in	NETosis	 is	debated.	However,	several	studies	indicate	that	PAD4	deficiency	abrogates	NETosis.	In	
vitro,	 neutrophils	 from	 PAD4-deficient	mice	 are	 impaired	 in	 NET-mediated	killing	 of	 Shigella	 flexneri	 and	 group	 A	 streptococcus	 (GAS).	 NET	 deficiency	impacts	mice	 in	 a	model	 of	 GAS-induced	 necrotizing	 fasciitis	where	 PAD4-deficient	mice	 develop	 bigger	 lesions	 compared	 to	WT	 controls	 (Li,	 2010).	Contrarily,	 PAD4-dependent	 NETosis	 is	 dispensable	 in	 an	 influenza	 A	infection	model,	where	 PAD4-deficient	mice	 show	 similar	 virus	 titres,	 viral	replication	and	survival	rates	compared	to	control	animals	(Hemmers,	2011).	These	 findings	 indicate	 that	 even	 though	 PAD4	 deficiency	 seems	 to	 impair	NET	 release,	 the	 importance	 of	 this	 impairment	 is	 dependent	 on	 the	
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microbial	stimulus.	Furthermore,	no	human	PAD4	deficiencies	are	known.	In	a	 study	of	polymicrobial	 sepsis,	where	PAD4-mediated	NET	release	did	not	affect	 bacteremia	 in	 mice,	 the	 authors	 concluded	 that	 PAD4	 inhibition	 in	inflammatory	 diseases	 would	 not	 likely	 increase	 host	 vulnerability	 to	infection	in	humans	(Martinod,	2015).	
1.2.4 NETs	in	disease	
NETs	 are	 not	 only	 antimicrobial,	 but	 excessive	 NETosis	 and	 impaired	 NET	clearance	 are	 involved	 in	 a	 number	 of	 autoimmune	 and	 inflammatory	diseases.	Free	double-stranded	DNA	acts	as	DAMP	and	induces	activation	of	immune	responses.	Extracellular	histones	are	cytotoxic	and	can	cause	tissue	inflammation.		
Autoimmunity	
NETs	are	a	major	source	of	extracellular	chromatin,	neutrophil	proteins	and	antimicrobial	molecules	and	have	 therefore	been	 implicated	 in	 the	onset	of	autoimmune	diseases.	
SLE	 patients	 display	 high	 titres	 of	 anti-neutrophil	 cytoplasmic	 antibodies	(ANCA)	and	anti-nuclear	antibodies	(ANA)	(Tsokos,	2011),	linking	NETosis	to	this	 disease.	 The	NET-associated	 antimicrobial	 peptide	 LL-37	 enhances	 the	ability	 of	 DNA	 to	 activate	 plasmacytoid	 dendritic	 cells	 (pDCs)	 via	 TLR9	(Garcia-Romo,	 2011;	 Lande,	 2011).	 Interestingly,	 a	 subset	 of	 so-called	 low-density	 granulocytes	 undergoes	 spontaneous	 NETosis	 (Denny,	 2010;	Villanueva,	2011),	which	induces	pDCs	to	secrete	IFNα.	IFNα	promotes	auto-reactivity	 (Garcia-Romo,	2011;	Villanueva,	2011)	and	primes	neutrophils	 to	respond	 to	 immune	 complexes	 with	 NET	 release.	 This	 process	 further	activates	 pDCs	 (Garcia-Romo,	 2011;	 Lande,	 2011)	 and	 represents	 a	 vicious	cycle	of	inflammation.	Accordingly,	impaired	NET	clearance	in	SLE	patients	is	associated	with	increased	autoantibody	titres.	DNase	inhibitors	and	anti-NET	antibodies	 that	protect	 from	DNase	activity	 (Hakkim,	2010)	as	well	as	anti-
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DNase	 antibodies	 (Yeh,	 2003)	 have	 been	 identified	 as	 causes	 for	 impaired	NET	degradation.	
Rheumatoid	 arthritis	 (RA)	 is	 a	 systemic	 disease	 that	 causes	 chronic	inflammation.	 High	 levels	 of	 citrullinated	 proteins	 and	 anti-citrullinated	peptide	 antibodies	 (ACPA)	 are	 disease	 indicators	 (Chang,	 2005)	 and	 NETs	are	present	in	the	synovial	fluids,	rheumatoid	nodules	and	in	the	skin	of	RA	patients.	Patient	synovial	 fluids	and	ACPA-containing	serum	induce	NETs	in	healthy	 neutrophils	 (Khandpur,	 2013).	 NETs	 contain	 auto	 antigens,	 which	feed	 into	a	 cycle	of	 continued	NET	release.	Furthermore,	metalloprotease-8	(MMP-8)	 is	 associated	 with	 RA	 NETs	 (Khandpur,	 2013)	 and	 is	 critical	 for	tissue	destruction	in	arthritis	(Malemud,	2006).	
Inflammation	
Gout	 is	 the	most	 common	 form	of	 arthritis.	 It	 is	 caused	 by	 precipitation	 of	uric	 acid	 in	 sodium	 containing	 fluids,	 yielding	 monosodium	 urate	 (MSU)	crystals.	 MSU	 crystals	 activate	 the	 NALP3	 inflammasome	 and	 induce	 IL-1β	release.	 The	 subsequent	 production	 of	 IL-8	 leads	 to	 recruitment	 of	neutrophils.	 Interestingly,	 MSU	 crystals	 induce	 NET	 release,	 which	 cause	persisting	inflammation	(Mitroulis,	2011).		
The	lack	of	sputum	clearance	leads	to	chronic	airway	inflammation	in	CF.	It	has	been	shown	that	high	levels	of	decondensed	extracellular	DNA	contribute	to	 sputum	 viscosity.	 Accordingly,	 DNase	 treatment	 improves	 sputum	solubilisation	 in	 CF	 patients	 (Cantin,	 1998;	 Vogelmeier	 and	 Döring,	 1996).	NETs	 are	 an	 important	 source	 of	 this	 extracellular	 DNA.	 Other	 NET	components	 such	 as	 MPO	 and	 NE	 have	 also	 been	 found	 (Marcos,	 2010;	Papayannopoulos,	2011;	Ratjen,	2008).	However,	NE	that	remains	bound	to	chromatin	 and	 continues	 to	 degrade	 histones,	 further	 decondensing	 the	chromatin	 and	 allowing	 for	 a	 better	 accessibility	 to	 therapeutic	 DNases	(Papayannopoulos,	 2011).	 NE	 inhibitors	 block	 the	 effectiveness	 of	 DNase	therapy.	
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NETs	 interact	 with	 endothelial	 cells,	 platelets,	 coagulation	 factors	 and	 red	blood	 cells	 (von	 Bruhl,	 2012),	 providing	 scaffolds	 in	 the	 circulation	 that	promote	 thrombus	 formation	 (Gould,	 2015).	 Accordingly,	 neutrophil	depletion	 or	 intravenous	 DNase	 injection	 prevents	 thrombus	 formation	(Brill,	 2012;	 von	 Bruhl,	 2012).	 IL-8	 and	 ROS	 produced	 by	 activated	endothelial	cells	leads	to	recruitment	of	additional	neutrophils	and	release	of	NETs	 (Gupta,	 2010).	 Furthermore,	 endothelial	 cells	 release	 fibrin	 and	 von	Willebrand	factor	(vWF),	which	promote	blood	coagulation	and	formation	of	thrombus	 scaffolds.	 vWF	has	a	high	affinity	 for	histones	and	binds	 to	NETs	(Gonias,	 1985;	 Ward,	 1997).	 Additionally,	 histones	 have	 been	 shown	 to	inhibit	anti-coagulants	in	the	plasma	(Ammollo,	2011).	Finally,	NETs	interact	with	 platelets	 (Gould,	 2014;	 Renesto	 and	 Chignard,	 1993;	 Si-Tahar,	 1997)	and	 SLE	 patients	 with	 anti-platelet	 antibodies	 have	 an	 increased	 risk	 for	thrombosis	(Al-Homood,	2012).	
Atherosclerosis	 is	 a	 disease	 that	 is	 characterised	 by	 the	 deposition	 of	 fatty	plaques	 in	 the	arteries.	Cathelicidin-related	antimicrobial	peptide	 (CRAMP),	the	 murine	 homologue	 of	 LL-37)	 recruits	 inflammatory	 monocytes	 to	 the	arteries.	NETs	are	implicated	in	the	formation	of	atherosclerosis.	Complexes	of	 CRAMP	 and	 DNA	 stimulate	 pDCs	 in	 the	 fatty	 plaques	 to	 generate	autoantibodies,	 which	 aggravates	 the	 course	 of	 atherosclerosis	 (Doring,	2012a;	 Doring,	 2012b).	 Double-stranded	 DNA,	 nucleosomes	 and	MPO-DNA	complexes	 are	 increased	 in	 the	 plasma	 of	 patients	 with	 severe	 coronary	atherosclerosis	 (Borissoff,	 2013).	 Recent	 data	 from	 our	 group	 shows	 that	cholesterol	 crystals	 trigger	 NETosis.	 The	 NETs	 are	 able	 to	 prime	macrophages	for	the	release	of	IL-1β.	This	activates	Th17	cells,	which	further	amplify	 immune	 cell	 recruitment	 to	 the	 plaques	 (Nahrendorf	 and	 Swirski,	2015;	Warnatsch,	2015).	
NETs	are	released	spontaneously	and	PMA-dependent	NETosis	 is	 increased	under	conditions	of	high	glucose	in	vitro	(Menegazzo,	2015).	Interestingly,	a	study	shows	spontaneous	NETosis	in	diabetes,	whereas	LPS-induced	NETosis	is	 impaired	 at	 high	 glucose	 concentrations.	 The	 authors	 conclude	 that	 a	
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chronic	 pro-inflammatory	 state	 induces	 constitutive	NET	 release,	 causing	 a	weak	response	upon	stimulation	(Joshi,	2013).	NET	formation	is	impaired	in	diabetic	patients	during	 infection	with	Burkholderia	pseudomallei,	 causing	a	high	 susceptibility	 to	 this	 bacterium	 (Riyapa,	 2012).	 However,	 diabetic	patients	 show	 increased	 levels	 of	NET	 components	 such	 as	NE	 and	DNA	 in	the	 plasma	 in	 absence	 of	 infection	 (Menegazzo,	 2015).	 Furthermore,	 the	excess	NETosis	has	been	shown	to	impair	wound	healing	in	diabetic	patients	(Wong,	 2015).	 NETosis	 is	 also	 linked	 to	 type	 I	 diabetes,	 as	 high	 amounts	 of	NET	enzymes	 correlate	with	autoantibodies	against	 the	 insulin-releasing	β-cells	(Leslie	and	Bradford,	2014;	Wang,	2014).	
Cancer	
Neutrophils	play	a	major	role	in	cancer	as	they	are	part	of	the	inflammatory	infiltrate	 in	 tumours.	However,	 their	 specific	 function	 is	debated	since	both	pro-	 and	anti-tumour	effects	have	been	described	 (Brandau,	2013;	Gregory	and	 Houghton,	 2011).	 NETs	were	 found	 in	 Lewis	 lung	 carcinoma	 (Ho-Tin-Noe,	 2009)	 and	 Ewing	 sarcoma	 (Berger-Achituv,	 2013).	 Furthermore,	 a	tumorigenic	 role	 of	 NE	 was	 attributed	 in	 lung	 adenocarcinoma,	 where	tumours	grow	slower	 in	NE-deficient	mice	 (Houghton,	2010).	Finally,	NETs	promote	cancer	metastasis.	During	systemic	infection	NETs	are	deposited	on	the	blood	vessels	and	trap	circulating	cancer	cells.	These	cells	proliferate	and	form	 cancerous	 nodules.	 Therefore,	 NETs	 promote	 tumour	 progression	(Cools-Lartigue,	2013;	Cools-Lartigue,	2014).	
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1.3 Anti-fungal	immunity	
Fungi	 are	 heterotroph	 eukaryotes	 that	 are	 ubiquitous	 in	 the	 environment.	Yeast	 and	 filamentous	 growth	 forms	 exist.	 Fungi	 sense	 their	 surroundings	and	 respond	 to	 environmental	 cues	 that	 promote	 their	 survival	 through	specific	reprogramming	(Brown,	2007;	Hube,	2009).	Interaction	with	plants,	animals	and	humans	can	be	symbiotic,	commensal,	latent	or	pathogenic.	The	high	 incidence	 of	 fungi	 in	 the	 environment	 causes	 continuous	 exposure.	Humans	inhale	hundreds	of	spores	and	small	yeast	daily.	
Fungi	cause	a	wide	spectrum	of	diseases,	which	range	from	cutaneous	lesions	and	 acute	 self-limiting	 pulmonary	 disease	 in	 immunocompetent	 people	 to	inflammatory	diseases	 and	 life-threatening	 infections.	 Even	non-lethal,	 skin	and	mucosal	 infections	 are	 difficult	 to	 treat	 and	 often	 recurrent.	 Over	 one	million	life	threatening	infections	are	caused	by	fungi	each	year	reaching	up	to	95%	mortality.	Fungal	 infections	are	often	difficult	 to	diagnose	and	drug	resistance	 and	 the	 lack	 of	 new	 antifungal	 drugs	 and	 vaccines	 poses	 a	 big	health	 problem	 (Brown,	 2012a).	 Most	 fungi	 are	 opportunistic	 and	 the	incidence	 of	 systemic	 infections	 has	 increased	 due	 to	 the	 use	 of	immunosuppressive	 drugs,	 the	 raise	 of	 acquired	 immunodeficiencies	 (e.g.	HIV)	 as	 well	 as	 the	 increase	 in	 clinical	 interventions	 in	 intensive	 care	(Pappas,	2010).	
Immunity	to	fungal	infections	is	extremely	dependent	on	the	site	of	infection	and	 the	 fungal	 species.	 Fungi	 have	 co-evolved	with	 the	 host	 over	 time	 and	host	immune	mechanisms	antagonise	with	fungal	strategies.	Host	defence	is	complex	 and	 requires	 both	 the	 innate	 and	 adaptive	 immune	 system.	 The	initial	 recognition	 by	 epithelial	 cells	 and	 macrophages	 induces	 pro-inflammatory	 responses	 and	 initiates	 immune	 cell	 activation.	 A	 barrier	breach	induces	antigen	presentation	and	adaptive	immune	cell	recruitment.	
	
INTRODUCTION	
	
	
75	
1.3.1 Candida	albicans	
C.	albicans	 is	a	diploid	fungus	that	 is	a	commensal	 in	around	30-70%	of	the	human	population.	 It	colonises	 the	 intestinal	and	vaginal	mucosa	as	well	as	the	skin.	In	healthy	individuals	it	rarely	causes	disease	symptoms	(Perlroth,	2007).	 However,	 C.	 albicans	 is	 an	 opportunistic	 pathogen	 that	 can	 cause	severe	 infections	 when	 host	 immunity	 is	 disturbed.	 Invasive	 candidiasis	occurs	 in	 patients	with	 neutropenia,	 pancreatitis	 or	 renal	 insufficiency	 and	after	 treatment	 with	 glucocorticosteroids	 or	 systemic	 antibiotics.	 Further	risk	factors	are	indwelling	devices	such	as	catheters,	parenteral	nutrition	or	major	 surgery.	 Systemic	 candidiasis	 is	 difficult	 to	 treat	 with	 current	antifungal	 drugs.	 Improved	 diagnostics	 and	 new	 drug	 targets	 are	 required	(Brown,	2012b;	Gudlaugsson,	2003).	C.	albicans	is	not	naturally	a	commensal	in	 mice,	 which	 makes	 it	 an	 ideal	 model	 to	 study	 the	 involvement	 of	 both	innate	and	adaptive	immunity	in	antifungal	defence.	
C.	albicans	 is	a	dimorphic	fungus	that	grows	as	unicellular	budding	yeast	or	filamentous	 hyphae	 (Figure	 I-6a-c).	 Furthermore,	 it	 also	 forms	pseudohyphae,	 which	 are	 chains	 of	 elongated	 yeast	 cells	 that	 are	 not	separating	 from	the	mother	cell	after	budding.	Therefore,	C.	albicans	 is	also	called	 polymorphic.	 Whereas	 other	 fungal	 species	 have	 environmental	reservoirs,	 C.	 albicans	 yeast	 and	 hyphae	 grow	 uniquely	 inside	 mammalian	host	tissues	(Romani,	2003).		
C.	albicans	 is	covered	by	a	cell	wall	 that	contains	mainly	carbohydrates	and	cell	 wall	 proteins	 that	 are	 foreign	 to	 the	 host.	 This	 allows	 for	 a	 good	discrimination	between	self	and	non-self	by	the	immune	system.	Most	of	the	fungal	 PAMPs	 are	 cell	 wall-related	 (Netea,	 2015a;	 Romani,	 2011).	 The	 C.	
albicans	cell	wall	 is	 composed	of	 two	 layers:	The	outer	 layer	 is	made	up	of	glycoproteins.	About	80%	of	the	covalently	linked	sugars	are	O-	and	N-linked	mannans.	 The	 outer	 layer	 is	 attached	 to	 the	 inner	 layer	 by	glycosylphosphatidylinositol	 (GPI)	 residues	 that	 are	 linked	 to	 β-glucans	(Cutler,	2001;	Ernst	and	Prill,	2001).	The	inner	layer	contains	the	structural	
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polysaccharides	 chitin	 and	β-glucan	 that	provide	 strength	and	 shape	 to	 the	cells	 (Figure	 I-6d).	 The	 dry	 weight	 of	 a	 yeast	 particle	 contains	 about	 2%	chitin,	 40%	 β-1,3-glucan	 and	 20%	 β-1,6-glucan	 (Netea,	 2008).	 The	composition	 of	 the	 cell	wall	 can	 change	 for	 example	 in	 situations	where	β-glucan	 synthesis	 is	 disturbed.	 Hyphae	 contain	 3	 to	 5	 times	more	 chitin	 as	compared	to	yeast	cells	(Munro,	1998).	The	β-glucan	content	is	similar,	but	is	shielded	 in	 hyphae	by	 the	mannan	 layer.	 It	 is	mainly	 exposed	 in	 yeast	 bud	scars	(Gantner,	2005;	Marakalala,	2013).	
The	change	of	morphology	from	yeast	to	hyphae	is	associated	with	changes	in	the	cell	wall	composition	and	architecture.	Many	genes	that	encode	hypha-specific	 proteins	 are	 upregulated	 during	 morphoswitching.	 The	morphogenesis	 of	 C.	 albicans	 can	 be	 induced	 by	 different	 mechanisms,	triggered	by	different	environmental	factors.	Most	commonly	hyphal	growth	is	 induced	via	 the	 cyclic	AMP-protein	kinase	A	 complex	 (PKA)	 (cAMP-PKA)	signalling	 pathway.	 Many	 environmental	 cues	 regulate	 this	 pathway	 and			
		
Figure	I-6	|	C.	albicans	morphology	and	cell	wall	composition.	(a	-	c)	C.	albicans	morphologies:	
budding	yeast	particles	(a),	germinating	C.	albicans	hyphae	(b)	and	fully	developed	hyphae	(c).	(d)	
C.	albicans	cell	wall	composition.	The	cell	wall	consists	of	two	distinct	layers	that	are	connected	
via	 glycosylphosphatidylinositol	 (GPI)	 residues	 that	 are	 linked	 to	β-1,6-glucan.	 The	 outer	 layer	
contains	glycoproteins	 that	are	mannosylated	via	O-	and	N-linkages.	The	 inner	 layer	consists	of	
the	structural	polysaccharides	chitin	and	mannan.|	(a-c)	Reprinted	from	Trends	 in	Microbiology	
(Sudbery,	 2004),	 Copyright	 2004,	 with	 permission	 from	 Elsevier.	 Modified.	 (d)	 Reprinted	 by	
permission	from	Macmillan	Publishers	Ltd:	Nature	Reviews	Microbiology	(Gow,	2012),	copyright	
2012.	
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most	 are	 integrated	 by	 adenyl	 cyclase	 Cyr1	 (also	 Cdc35).	 Cyr1	 can	 be	activated	 directly	 by	 CO2	 or	 serum	muramyl	 dipeptide	 (MDP),	 the	minimal	peptidoglycan	structure	that	is	present	on	gram-positive	bacteria	(Hall,	2010;	Xu,	2008).	Glucose	and	amino	acids	signal	via	Cyr1	indirectly	through	small	GTPases	 (Maidan,	 2005).	Other	 factors	 activate	 the	 cAMP-PKA	pathway	 via	unidentified	modes:	Temperatures	below	35°C	stop	hyphal	germination	via	activation	 of	 the	 heat	 shock	 protein	 Hsp90	 (Shapiro,	 2009).	 Furthermore,	accumulation	of	 the	quorum	sensing	molecule	 farnesol	 in	situations	of	high	fungal	 density	 downregulates	 cAMP-PKA	 signalling	 (Deveau,	 2010).	Activation	 of	 Cyr1	 leads	 to	 increased	 levels	 of	 cAMP,	 which	 induce	 the	dissociation	of	the	PKA	regulatory	subunit	(Bcy1)	from	the	catalytic	subunits	(Tpk1	 and	 Tpk2),	 leading	 to	 activation	 of	 PKA.	 PKA	 phosphorylates	 and	activates	 the	 transcription	 factor	 Efg1,	 which	 induces	 hypha-specific	 genes	(Bockmuhl	 and	Ernst,	 2001;	 Sohn,	 2003).	 These	 include	 adhesins,	 invasins,	immune	modulators	 and	 the	 cyclin	 Hgc1.	 Hgc1	 interacts	 with	 cell	 division	cycle	 28	 (Cdc28),	 which	 mediates	 the	 activation	 of	 the	 septins	 Cdc11	 and	Sep7,	 driving	 polarised	 growth	 and	 cell	 separation	 (Bishop,	 2010).	 Hgc-	deficiency	leads	to	a	yeast-locked	state	(Zheng,	2004).	
Immunity	 to	 C.	 albicans	 differs	 dependent	 on	 the	 colonisation	 or	 invasion	state.	 Colonising	 yeast	 particles	 are	 mainly	 commensal	 whereas	 hyphal	germination	 triggers	 invasion	 and	 activation	 of	 an	 antifungal	 immune	cascade.	
1.3.2 Innate	anti-fungal	immunity	
The	 skin	 and	mucosal	 surfaces	 are	 the	 first	 line	 of	 contact	 with	microbes,	including	 fungi.	Epithelial	 and	endothelial	 cells	 form	a	physical	barrier	 that	protects	 the	 underlying	 tissues.	 Many	 fungi	 are	 commensal	 in	 healthy	individuals	 and	are	kept	 in	 check	by	 the	 innate	 immune	 system.	When	 this	immune	 balance	 is	 disturbed	 or	 the	 epithelial	 barrier	 is	 broken	 colonising	commensals	can	become	invasive.	Innate	immune	cells	posses	a	set	of	broad	specificity	 pattern	 recognition	 receptors	 (PRR)	 that	 recognise	 pathogen	
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associated	molecular	 patterns	 (PAMPs).	 Fungal	 PAMPs	 are	mainly	 cell	wall	derived	 and	 include	β-glucan,	 chitin	 and	mannans.	 Different	 fungal	 species	express	 different	 PAMPs	 on	 their	 surface	 that	 vary	 dependent	 on	 the	morphotype,	growth	stage	and	fungal	environment	(Bourgeois,	2010;	van	de	Veerdonk,	2008).	Innate	immune	cells	involved	in	antifungal	defence	include	monocytes,	 macrophages,	 neutrophils,	 NK	 cells	 and	 some	 innate-like	 cells	such	 as	 innate	 lymphoid	 cells	 (ILCs).	 Engagement	 of	 PRRs	 triggers	downstream	activation	of	signalling	cascades	leading	to	phagocytosis,	release	of	 antimicrobial	 effectors,	 cytokine	production	 and	 subsequent	 recruitment	of	 other	 effector	 cell	 types	 as	 well	 as	 activation	 of	 adaptive	 immunity.	 A	functioning	 innate	 immune	 response	 is	 able	 to	 inhibit	 fungal	 growth	 or	directly	trigger	fungal	killing.	
Innate	effector	cells	
A	 complex	 interplay	 of	 innate	 immune	 cells	 is	 required	 for	 sufficient	antifungal	 defence.	 Each	 effector	 cell	 type	 plays	 specific	 roles	 in	 the	recognition	of	fungi	and	the	deployment	of	antifungal	strategies	(Figure	I-7).		
Epithelial	 and	endothelial	 cells	 contribute	 to	 immune	defence	by	 forming	a	physical	barrier	between	microbes	and	the	host	tissue.	ECs	provide	the	first	point	 of	 contact	with	 the	host	 immune	 system.	They	 express	TLRs	 and	 can	upregulate	CLRs	as	seen	during	pulmonary	aspergillosis	(Guo	and	Wu,	2009;	Sun,	2012;	Weindl,	2010).	ECs	produce	pro-inflammatory	cytokines	and	IL-8	upon	TLR	activation	or	stimulation	with	antimicrobials	(Guo	and	Wu,	2009;	Wagener,	2013).	Morphological	 changes	of	C.	albicans	 from	yeast	 to	hyphal	form	induces	penetration	of	ECs	and	leads	to	tissue	invasion.	Two	main	ways	of	 invasion	 are	 known:	C.	 albicans	 triggers	TLR	 signalling	 and	 activation	 of	NF-κB	and	 JUN	(AP-1)	 independent	of	 the	 fungal	morphology.	This	 leads	 to	induced	 endocytosis	 by	 the	 ECs	 and	 transgression	 through	 the	 epithelial	barrier	 (Weindl,	 2007).	 However,	 C.	 albicans	 can	 also	 invade	 by	 active	penetration.	Morphoswitching	to	hyphae	activates	MAPK1	and	FOS	signalling	in	ECs	(Moyes,	2011;	Moyes,	2010).	It	is	not	known	which	C.	albicans	cell	wall	
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components	or	ECs	receptors	are	required	for	this	interaction.	The	initiated	signalling	 causes	 the	 release	 of	 pro-inflammatory	 cytokines	 from	 ECs	 and	initiation	of	a	downstream	host	response.	 IL-22	released	by	Th17	T	cells	or	ILCs	triggers	production	of	β-defensins	in	ECs,	which	controls	the	commensal	state	of	C.	albicans	(Eyerich,	2011;	Tomalka,	2015).	
Neutrophils	 are	 the	 first	 cells	 that	 are	 recruited	 to	 the	 site	 of	 infection	 by	chemokines	 such	 as	 CXCL8	 (IL-8)	 secreted	 by	 ECs	 and	 tissue	 resident	macrophages	(Netea,	2008).	Neutrophils	are	the	only	host	cells	that	can	fully	prevent	the	morphoswitch	of	C.	albicans	and	neutropenia	is	an	important	risk	factor	for	invasive	fungal	infections	(Brown,	2011;	Uzun,	2001).	Neutrophils	exert	a	variety	of	antifungal	defence	strategies.	ROS	production,	phagocytosis	and	 release	 of	 NETs	 are	 dependent	 on	 NADPH	 oxidase	 and	 MPO.	 Non-oxidative	killing	strategies	include	the	release	of	antimicrobial	factors	such	as	lysozyme,	 lactoferrin,	 elastase,	 β-defensins,	 gelatinase,	 cathepsin	 G,	calprotectin,	 azurocidin	 and	 cathelicidin.	 Cathelicidin	 is	 processed	 by	 PR3	into	 the	 antimicrobial	 peptide	 LL-37,	 which	 causes	 disruption	 of	 fungal	membranes,	 inhibition	 of	 biofilm	 formation,	 fungal	 adhesion,	 chemotaxis,	ROS	production	and	inhibition	of	neutrophil	apoptosis	(Alalwani,	2010;	Tsai,	2011).	Mice	deficient	in	calprotectin	are	more	susceptible	to	fungal	infection	(Urban,	2009).	See	also	Neutrophil	immune	responses	on	page	31.	
Monocytes	are	blood-borne	and	migrate	into	the	tissues	upon	inflammatory	signals	 where	 they	 differentiate	 into	 macrophages.	 Mice	 deficient	 in	 the	chemokine	 receptor	CXCR1	 (IL8RA)	 fail	 to	 recruit	monocytes	 to	 the	 tissues	and	suffer	from	renal	failure	upon	infection	with	C.	albicans	(Lionakis,	2013).	Decreased	 CXCR1	 function	 in	 humans	 leads	 to	 increases	 susceptibility	 to	disseminated	candidiasis	(Lionakis,	2013).	Similarly,	 failure	to	recruit	blood	monocytes	by	CCL2	binding	to	CCR2	leads	to	increased	incidents	of	invasive	candidiasis	 (Ngo,	 2014).	 In	 the	 tissues	 macrophages	 acquire	 distinct	phenotypes.	 Classical	 activation	 by	 inflammatory	 cytokines	 such	 as	 IFN-γ	triggers	 M1	 macrophages	 that	 acquire	 an	 antimicrobial	 phenotype	 and	release	 pro-inflammatory	 IL-12.	 Alternatively	 activated	 M2	 macrophages	
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receive	 anti-inflammatory	 signals	 like	 TGF-β	 and	mediate	 tissue	 repair	 via	secretion	of	IL-10	(Mosser	and	Edwards,	2008).	Macrophage	phenotypes	are	relevant	in	antifungal	defence	since	it	has	been	shown	that	M2	macrophages	confer	 susceptibility	 in	 pulmonary	 Cryptococcus	 neoformans	 infection.	However,	 immunisation	 with	 a	 vaccine	 strain	 induces	 M1	 macrophages,	promoting	 rapid	 resolution	 of	 infection	 with	 wild-type	 C.	 neoformans	(Hardison,	2012).	Plasticity	between	M1	and	M2	macrophages	 is	 important	against	 infections	with	Paracoccidioides	 (Feriotti,	 2013).	 Interestingly,	 in	C.	
albicans	 infection	 depletion	 of	 tissue	 resident	 M2	 macrophages	 leads	 to	increased	 susceptibility	 (Lionakis,	 2013;	 Qian,	 1994).	 Importantly,	monocytes	 and	macrophages	 confer	 trained	 immunity,	 a	 short-term	 innate	immune	memory.	Monocytes	 stimulated	with	β-glucan	 acquire	 a	protective	phenotype	upon	re-stimulation.	This	innate	memory	is	caused	by	epigenetic	reprogramming	and	metabolic	changes	 (Cheng,	2014;	Quintin,	2012;	Saeed,	2014).	
NK	cells	are	normally	known	for	their	role	in	antiviral	and	antitumor	defence.	But	NK	cells	also	have	antifungal	properties	as	evidenced	in	infections	with	C.	
albicans,	A.	fumigatus,	C.	neoformans	and	Pneumocystis	species	(Islam,	2013;	Kelly,	2013;	Longhi,	2012;	Schmidt,	2013b).	NK	cells	kill	 yeast	particles	via	perforins,	 secrete	 inflammatory	 cytokines	 and	 kill	 infected	 host	 cells.	However,	the	role	of	NK	cells	in	antifungal	immunity	is	complex	and	NK	cells	also	 influence	 other	 antifungal	 immune	 cells	 (Schmidt,	 2013b).	 Therefore	depletion	of	NK	cells	has	been	shown	to	have	varying	effects	ranging	from	no	effect	to	increased	susceptibility	to	disseminated	candidiasis	(Romani,	1993;	Whitney,	 2014).	 Depletion	 of	 NK	 cells	 in	 lymphocyte	 deficient	 SCID	 mice	increases	 invasive	candidiasis	but	does	not	affect	WT	mice	 (Quintin,	2014).	Additionally,	 some	 fungal	 species,	 such	 as	Rhizopus	 oryzae	 have	 evolved	 to	actively	suppress	NK	cell	function	(Schmidt,	2013a).	
Dendritic	 cells	 are	 classically	 involved	 in	 antiviral	 immunity.	 Even	 though	they	 are	 less	 efficient	 in	 phagocytosing	 and	 killing	 fungi,	 they	 have	 been	implicated	 in	antifungal	 immunity	(Netea,	2004).	They	are	activated	via	 the	
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Syk/IRF5	pathway	and	respond	by	producing	IFN-β	(del	Fresno,	2013).	Most	importantly	however,	DCs	process	and	present	antigen	to	induce	an	adaptive	T	cell	response.	It	is	not	fully	understood	which	DC	subsets	are	required	for	antifungal	 immunity	 even	 though	 evidence	 suggests	 that	mice	 deficient	 for	plasmacytoid	DCs	(pDCs)	are	susceptible	to	invasive	aspergillosis	(Ramirez-Ortiz,	 2011).	 A	 recent	 study	 suggests	 that	 in	 a	 model	 of	 cutaneous	candidiasis,	nocireceptive	pathways	in	the	skin	drive	production	of	IL-23	by	CD301b+	 dermal	 DCs.	 IL-23	 signalling	 stimulates	 IL-17	 production	 in	 γδ	 T	cells,	leading	to	protective	immunity	(Kashem,	2015b).	
The	involvement	of	other	innate	immune	cells	in	antifungal	immunity	is	less	investigated	and	in	most	parts	indicated	by	indirect	evidence.	
As	 indicated	 above,	 γδ	 T	 cells	 are	 suspected	 to	 play	 a	 role	 in	 antifungal	immunity	due	to	their	capacity	to	produce	large	amounts	of	IL-17	(Gladiator,	2013).	γδ	T	cells	express	an	invariant	T	cell	receptor	(TCR)	containing	a	γ	and	a	 δ	 chain	 that	 doesn’t	 require	 recombination	 and	 therefore	 classifies	 these	cells	as	innate-like.	γδ	T	cells	are	mainly	found	in	the	gut	mucosa.	
Innate	 lymphoid	 cells	 (ILCs)	 are	 found	 in	 mucosal	 tissues.	 By	 their	 use	 of	lineage-defining	 transcription	 factors	 and	 the	 production	 of	 hallmark	cytokines	 ILCs	 are	 divided	 in	 3	 groups	 that	mirror	 the	 compartments	 of	 T	helper	 cells.	 ILC1s	 produce	 IFN-γ,	 ILC2s	 produce	 IL-4	 and	 IL-13,	 whereas	ILC3s	 release	 IL-17	 (Spits,	 2013).	 ILCs	 are	 a	 relatively	 new	 field	 and	 their	involvement	 in	antifungal	defence	 is	partially	 contradicting	and	 likely	 to	be	dependent	on	the	fungal	species	and	site	of	infection.	ILC3s	are	thought	to	be	important	 in	mucosal	 candidiasis	 since	Rag-1-deficient	mice	depleted	of	 IL-17	 secreting	 ILCs	 fail	 to	 control	mucosal	 candidiasis	 (Gladiator,	 2013).	 It	 is	unclear	how	ILCs	contribute	to	immunity	during	invasive	fungal	infections.	
Innate	NK	(iNK)	T	cells	have	an	invariant	TCR	that	recognises	lipid	antigen	in	the	 context	 of	 an	MHC	CD1d	 complex.	 CD1d-deficient	mice	 that	 lack	 iNK	T	cells	have	an	increased	susceptibility	to	A.	fumigatus	(Cohen,	2011).	
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In	mice	C.	albicans	in	the	blood	stream	bind	and	activate	platelets,	which	have	antimicrobial	effects	through	induction	of	CCL5	(RANTES)	and	platelet	factor	4.	 Platelet-rich	 plasma	 inhibits	 the	 growth	 of	 C.	 albicans	 (Drago,	 2013;	Robert,	2000).	
	
	
		
Figure	 I-7	 |	 Antifungal	 effector	 cells.	 Epithelial	 cells	 (ECs)	 provide	 a	 physical	 barrier	 between	
fungal	 particles	 and	 host	 tissues.	 They	 express	 pattern	 recognition	 receptors	 and	 produce	
inflammatory	cytokines	 that	 lead	 to	 the	 recruitment	of	phagocytic	 cells.	Upon	stimulation	by	T	
cell-derived	IL-22	ECs	produce	antifungal	β-defensins.	Fungi	such	as	Candida	albicans	can	breach	
the	tissue	barrier	by	induced	endocytosis	or	active	penetration	upon	hyphal	germination.	Once	in	
the	 tissue	 fungi	 are	 countered	 by	 tissue-resident	macrophages	 that	 phagocytose	 the	 particles	
and	 release	 inflammatory	mediators	 that	 recruit	 neutrophils.	 Neutrophils	 are	 the	most	 potent	
antifungal	cells	and	release	reactive	oxygen	species	(ROS),	antimicrobials	such	as	calprotectin	and	
neutrophil	extracellular	traps	(NETs).	Dendritic	cells	(DCs)	migrate	to	the	lymph	nodes	where	they	
modulate	 T	 helper	 cell	 responses.	 Th17	 cells	 have	 an	 important	 antifungal	 function	 since	 the	
release	 of	 IL-17	 recruits	more	 neutrophils,	whereas	 IL-22	 stimulates	 ECs	 to	 produce	 defensins.	
Invasive	 fungi	 such	 as	C.	 albicans	 activate	 platelets	 in	 the	 blood	 stream,	which	 in	 turn	 release	
antifungal	mediators	 such	 as	 CCL5	 and	 platelet	 factor	 4	 (PF4).	 Natural	 killer	 (NK)	 cells	 release	
antifungal	perforins.	|	Reprinted	by	permission	 from	Macmillan	Publishers	Ltd:	Nature	Reviews	
Immunology	(Netea,	2015a),	copyright	2015.		
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1.3.3 Adaptive	anti-fungal	immunity	–	T	cell	responses	
In	most	cases	 the	epithelial	and	phagocyte	responses	are	enough	to	control	the	 fungi	 at	 barrier	 sites	 and	 prevent	 dissemination.	 However,	 when	 the	infection	 is	 not	 controlled	 immediately,	 adaptive	 immunity	 provides	 the	second	line	of	defence.		
Innate	 immune	sensing	activates	CD4+	T	helper	cells.	DCs	are	specialised	 in	receiving	 fungal	 signals	 and	 activate	 different	 pathways	 that	 shape	 T	 cell	responses	 accordingly	 (Bonifazi,	 2009).	 The	 innate	 and	 adaptive	 antifungal	responses	depend	on	the	balance	of	different	DC	subsets	(Claudia,	2002).	In	cases	 of	 severe	 fungal	 disease	 or	 relapsing	 diseases	 inflammatory	 DCs	develop.	 Inflammatory	DCs	 initiate	Th17	and	Th2	cell	responses	via	MyD88	signalling.	In	cases	of	asymptomatic	or	mild	disease,	tolerogenic	DCs	initiate	Th1	and	Treg	cell	differentiation	via	signalling	 through	TRIF.	 In	some	cases	fungi	 exploit	 balance	 between	 different	 T	 cell	 effector	 types	 and	 establish	commensalism	and	infection	(Romani,	2002).	
Th1	helper	 cell	 responses	 correlate	with	 protective	 immunity	 and	 effective	fungal	 vaccination	 (Spellberg,	 2008;	 Zhang,	 2009).	 Th1	 cells	 produce	 IFN-γ	and	 induce	 the	 production	 of	 opsonising	 antibodies,	which	 lead	 to	 optimal	activation	 of	 phagocytes	 at	 the	 site	 of	 infection.	 Failure	 to	 raise	 these	activating	 signals	 leads	 to	 persistence	 of	 fungal	 infection	 (Romani,	 2004).	Furthermore,	 a	 direct	 inhibition	 of	 Th1	 cell	 proliferation	 by	 crytptococcal	polysaccharides	 leads	 to	 a	 defective	 adaptive	 immunity	 and	 persistent	
crytptococcus	infections	(Yauch,	2006).	
IL-4	 and	 IL-13	 production	 by	 DCs	 favours	 the	 production	 of	 Th2	 helper	 T	cells,	 dampens	 the	 Th1	 response	 and	 promotes	 alternatively	 activated	macrophages.	Th2	responses	promotes	fungal	infection,	disease	relapse	and	fungal	 allergy	 (Muller,	 2007).	 Limiting	 IL-4	 signalling	 restores	 antifungal	immunity	in	mice	(Szymczak	and	Deepe,	2009).	
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Th17	 cells	 reside	 mainly	 in	 mucosal	 tissues.	 They	 have	 functions	 in	 the	defence	against	extracellular	pathogens	and	are	involved	in	autoimmune	and	allergic	disorders.	However,	Th17	cells	are	also	the	main	T	effector	cell	type	involved	in	antifungal	immunity.	They	are	activated	by	macrophages	and	DCs	through	 signalling	 via	 the	 mannose	 receptor,	 Syk,	 CARD9	 and	 MyD88	(LeibundGut-Landmann,	2007;	Robinson,	2009)	and	inhibited	through	type	I	IFNs.	 Th17	 cells	 are	 found	 in	 the	 fungal-specific	 T	memory	 cell	 repertoire	(Acosta-Rodriguez,	2007).	In	C.	albicans	 infections	Th17	cells	support	a	Th1	response	 and	 suppress	 Th2	 cells	 (Conti,	 2009).	 Defective	 IL-17	 signalling	leads	 to	 an	 increased	Th2	 response	 and	 fungal-associated	 allergy.	The	host	defence	 to	 fungal	 infections	 vary	 dependent	 on	 the	 site	 of	 infection	 and	whether	disease	is	compartmentalised	or	disseminated	(Dongari-Bagtzoglou	and	Fidel,	2005).	Th17	cells	are	 important	 for	mucosal	antifungal	 immunity	and	 are	 the	 main	 producers	 of	 IL-17	 in	 the	 mucosa.	 During	 oropharyngal	candidiasis	(OPC)	a	strong	induction	of	Th17	genes	in	the	oral	mucosa	takes	place	 including	CXCL2,	 CXCL5	 and	G-CSF	 that	mobilise	 the	neutrophil	 pool,	antimicrobials	 such	 as	 β-defensin-3,	 S100	 proteins	 and	 CLRs	 like	 mincle,	dectin-2	 and	 dectin-1	 (Aujla,	 2007).	 Saliva	 has	 candidacidal	 activity	 that	 is	lost	in	Th17-deficient	mice	(Conti,	2009).	OPC	is	increased	in	CXCR2-deficient	mice	due	to	the	 lack	of	neutrophil	recruitment	and	mice	suffer	 from	weight	loss,	increased	fungal	burden	and	an	in	turn	increased	IL-17	gene	signature.	Depletion	of	neutrophils	in	wild-type	mice	has	a	comparable	effect	indicating	the	 importance	 of	 IL-17	 signalling	 through	 recruitment	 of	 antifungal	neutrophils	 (Huppler,	2014).	Similar	 to	mice	Th17	defects	 in	humans	cause	increased	susceptibility	to	mucosal	but	not	systemic	candidiasis	(Hernandez-Santos	 and	Gaffen,	 2012;	Liu,	 2011;	Puel,	 2011).	Psoriasis	patients	 that	 are	treated	 with	 anti-IL-17	 antibodies	 show	 increased	 susceptibility	 to	 fungal	infections	(Langley,	2014).	Apart	from	Th17	T	cell	some	innate	sources	of	IL-17	are	known.	NK	T	cells,	γδ	T	cells,	CD4-CD8-TCRβ+	cells	and	natural	Th17	cells	 that	do	not	require	activation	via	a	TCR,	produce	 IL-17	(Cua	and	Tato,	2010;	Spits,	2013).	Neutrophils,	mast	cells,	macrophages	and	paneth	cells	are	also	 considered	 to	 be	 sources	 of	 IL-17	 (Hueber,	 2010;	 Lin,	 2011;	 Werner,	
INTRODUCTION	
	
	
85	
2011).	 In	 dermal	 candidiasis	 γδ	T	 cells	 are	 the	main	 producers	 of	 IL-17.	C.	
albicans	 downregulates	 Th17	 responses	 and	 failure	 to	 do	 so	 results	 in	chronic	inflammation	(Cheng,	2010).	
The	immune	system	must	eliminate	fungi	and	at	the	same	time	avoid	tissue	damage.	In	chronic	fungal	disease	and	non-resolving	inflammation	regulatory	T	cells	produce	high	 levels	of	 IL-10	to	supress	production	of	 IFN-γ	 (Romani	and	Puccetti,	2006).	During	fungal	infection,	Treg	cells	may	shift	the	immune	response	from	protection	to	immunosuppression	(Ferreira,	2010).	
Immunity	to	yeast	and	hyphae	
An	 important	 virulence	 factor	 of	 C.	 albicans	 is	 its	 capacity	 to	 switch	morphology	 from	 small	 yeast	 particles	 to	 large	hyphal	 filaments.	 Immunity	towards	these	two	fungal	morphoforms	differs	in	many	aspects	(Gow,	2012).	
C.	 albicans	 yeast	 but	 not	 hyphae	 induce	 a	 tolerogenic	 DC	 phenotype	characterised	 by	 the	 production	 of	 IL-12	 via	 signalling	 through	 TLR4	(d'Ostiani,	2000).	Recognition	of	hyphae	differs	due	to	an	altered	exposure	of	
β-glucan	 on	 the	 surface.	 β-glucan	 is	 exposed	 in	 the	 yeast	 bud	 scars	 but	 is	shielded	in	hyphae	by	a	layer	of	mannoproteins.	However,	some	reports	also	state	a	slight	exposure	of	β-glucan	on	hyphae	due	to	incomplete	coverage	by	mannan	fibrils	that	are	stretched	during	hyphal	outgrowth	(Gantner,	2005).	Apart	 from	different	cytokine	 induction,	hyphae	also	differ	 in	 the	activation	of	 inflammasomes,	which	is	not	triggered	by	the	yeast	particles.	Differential	inflammasome	activation	is	an	important	discrimination	mechanism	between	colonisation	 and	 invasion	 (Cheng,	 2011;	 Gow,	 2012).	 The	 chemistry	 of	 cell	wall	 polysaccharides	 differs	 between	 yeast	 and	 hyphae	 and	 could	 be	 an	additional	 means	 of	 discrimination	 between	 the	 colonising	 and	 invasive	morphoforms	 forms	 (Lowman,	 2014).	 Interestingly,	 Candida	 glabrata	 does	not	form	hyphae	and	is	yet	virulent	(Brunke	and	Hube,	2013).	
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1.4 Introduction	summary	
Neutrophils	 are	 important	 innate	 immune	 cells	 and	 their	 release	 and	recruitment	is	tightly	regulated.	In	the	tissues	they	encounter	a	large	variety	of	 microbes.	 Neutrophils	 possess	 different	 immune	 strategies	 such	 as	degranulation	 of	 antimicrobial	 agents,	 ROS	 production,	 phagocytosis	 and	NET	release.	However,	 it	 is	not	understood	whether	neutrophils	are	able	to	regulate	 their	 antimicrobial	 strategies	 and	 use	 them	 selectively	 to	 target	distinct	microbes.	Neutrophils	are	thought	to	be	of	particular	importance	for	antifungal	 defence	 since	 neutrophil	 deficiencies	 often	 lead	 to	 fungal	infections.	However,	it	is	unknown	whether	neutrophils	can	control	fungi	and	whether	selected	antimicrobial	strategies	are	employed.	Furthermore,	 fungi	induce	NET	release	but	it	is	not	understood	which	receptors	lead	to	initiation	of	 the	 NETosis	 pathway.	 The	 following	 study	 will	 address	 these	 open	questions.	
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2.5 NETosis	is	a	selective	strategy	against	large	microbes	
The	results	discussed	in	this	chapter	were	published	in	Nature	Immunology	(Branzk,	 2014).	 Some	 of	 the	 fluorescent	microscopy	 stainings	 shown	were	produced	 in	 collaboration	 with	 Dr	 Qian	 Wang	 and	 Ms	 Aleksandra	Lubojemska.	 The	 S.	 pneumoniae	 infection	 was	 done	 by	 Dr	 Gregory	 T	 Ellis.	Contributions	 are	 acknowledged	 in	 the	 figure	 legends.	 Some	 analysis	 was	performed	in	collaboration	with	Dr	Venizelos	Papayannopoulos.		
2.5.1 Background	and	aims	
Neutrophils	 encounter	 a	 variety	 of	 microbes	 at	 the	 sites	 of	 infection.	However,	 neutrophils	 have	 long	 been	 considered	 to	 undertake	 a	 single	antimicrobial	program	with	 limited	means	of	adaptation	and	 it	 is	unknown	whether	 they	 can	 respond	 to	 different	 microbes	 selectively.	 However,	 the	discovery	 of	 NETs	 (Fuchs,	 2007)	 indicated	 that	 neutrophils	 utilize	 several	antimicrobial	strategies.	NETs	have	been	shown	to	be	involved	in	antifungal	defence	 through	 mechanisms	 that	 are	 poorly	 understood	 (Bianchi,	 2009;	Bianchi,	 2011;	 Metzler,	 2011).	 Emerging	 evidence	 shows	 that	 NETs	 are	involved	in	a	variety	of	immune	pathologies	(Knight,	2012;	Villanueva,	2011).	This	 raises	 the	 question	 whether	 a	 regulatory	 mechanism	 exists	 that	prevents	excessive	NET	release.	
Despite	 recent	 work	 showing	 that	 macrophages	 are	 able	 to	 discriminate	between	 soluble	 microbial	 ligands	 and	 particulate	 microbes	 (Goodridge,	2011),	it	is	unknown	whether	immune	cells	discriminate	between	microbial	particles	of	differing	size.	NETosis	is	an	extracellular	defence	strategy	but	it	is	unknown	whether	it	is	specifically	targeted	at	larger	pathogens.	
Therefore,	we	 investigated	 the	 importance	of	NETs	 in	 immune	defence	and	asked	why	NETs	where	 potently	 released	 in	 response	 to	 fungal	 pathogens.	Secondly,	we	explored	whether	neutrophils	are	able	to	discriminate	between	
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microbes	 of	 differing	 size	 and	 adapt	 their	 antimicrobial	 strategies	accordingly.	Specifically,	the	following	questions	were	addressed:	
Can	neutrophils	 sense	 the	 size	of	microbes	and	 selectively	 initiate	 intra-	or	extracellular	defence	mechanisms?	
Is	NETosis	down-regulated	in	order	to	avoid	unnecessary	exposure	of	NETs	to	 the	 host	 environment	 in	 situations	where	 other	 antimicrobial	 strategies	are	sufficient	to	counter	microbes?	
If	yes,	what	is	the	molecular	mechanism	of	this	regulated	release?	
2.5.2 NETosis	depends	on	microbe	size	
Only	hyphae	induce	NETs	but	not	yeast	
Like	many	fungi,	C.	albicans	is	a	dimorphic	fungus	and	can	be	present	as	small	budding	yeast	particles	or	 large	 filamentous	hyphae.	 It	 is	a	good	 inducer	of	NETosis	 in	 vitro	 in	 the	 presence	 of	 blood	 plasma	 (Ermert,	 2009;	 Urban,	2006).	Plasma	is	one	of	the	factors	that	drives	switching	of	the	morphology	in	
C.	 albicans,	 resulting	 in	 the	 formation	 of	 large	 filamentous	 hyphae	 (Nantel,	2002).	Importantly,	it	has	not	previously	been	resolved	whether	NET	release	can	be	triggered	by	both	morphoforms	of	C.	albicans.	
To	 dissect	 the	 influence	 of	 plasma	 on	 NETosis,	 we	 stimulated	 human	peripheral	neutrophils	with	wild	type	(WT)	C.	albicans	in	the	presence	of	3%	blood	 plasma.	 C.	 albicans	 triggered	 NET	 release	 only	 in	 the	 presence	 of	plasma.	 Interestingly,	 NETosis	 coincided	 with	 the	 formation	 of	 C.	 albicans	hyphae	(Figure	1a).	
Next	we	tested	whether	plasma	drives	NETosis	by	promoting	transformation	from	yeast	to	hyphae.	A	yeast-locked	C.	albicans	strain	carries	a	mutation	in		
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Figure	 1	 |	Only	 hyphae	 induce	NETs	 but	 not	 yeast.	 (a)	 Release	 of	 NETs	 by	 human	 peripheral	
neutrophils	left	unstimulated	(Unst)	or	stimulated	with	wild-type	(WT)	C.	albicans	in	the	presence	
(right)	or	 absence	 (left)	of	3%	plasma.	Extracellular	DNA	was	 stained	with	SYTOX	4	hours	after	
stimulation	(top	panels).	Brightfield	microscopy	of	the	neutrophils	and	C.	albicans	 (bottom).	 (b)	
Release	 of	 NETs	 by	 human	 peripheral	 neutrophils	 stimulated	 with	 C.	 albicans	 WT	 hyphae	 or	
hgc1Δ	 yeast	 (hgc1Δ),	 in	 the	 absence	 of	 plasma	 (top).	 Quantification	 of	 NET	 release	 (bottom),	
presented	 as	 SYTOX+	 events	 relative	 to	 total	 neutrophils.	 Below,	 graphic	 representation	 of	
SYTOX+	 area	 ranging	 from	 condensed	 necrotic	 nuclei	 (left)	 to	 decondensed	 NETotic	 chromatin	
(right).	 (c)	Release	of	NETs	by	human	peripheral	neutrophils	 stimulated	with	C.	albicans	hgc1Δ	
yeast,	 in	 the	 presence	 of	 3%	plasma	 (left).	Quantification	 of	NET	 release	 by	 human	 peripheral	
neutrophils	 left	 unstimulated	 or	 stimulated	 with	 C.	 albicans	 pre-formed	 wild-type	 hyphae	 or	
hgc1Δ	 yeast	 in	 the	 presence	of	 3%	plasma.	 (d)	 Immunoblot	 analysis	 of	 degradation	 (arrow)	 of	
histone	H3	 (17	kDa)	 in	neutrophils	 left	unstimulated	or	 stimulated	with	C.	albicans	 pre-formed	
wild-type	hyphae	or	hgc1Δ	yeast,	for	the	indicated	times	in	the	absence	of	plasma.	|	Multiplicity	
of	 infection	 (MOI)	=	10.	 Scale	bars	=	50	µm.	 Statistics	by	one-way	ANOVA	 followed	by	Tukey’s	
multiple	 comparison	 post-test.	 ****	 p	 ≤	 0.0001.	 Data	 are	 representative	 of	 at	 least	 three	
independent	experiments.		
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the	hgc1	gene	that	 is	required	for	hyphal	 formation	(Zheng,	2004).	We	pre-cultured	the	WT	and	the	hgcΔ1	yeast-locked	C.	albicans	strains	in	conditions	that	 favour	 hyphal	 growth.	 Under	 these	 conditions	 only	 WT	 C.	 albicans	formed	 hyphae,	 whereas	 the	 hgc1Δ	 mutant	 remained	 small	 yeast	 particles	(Figure	1b).	We	then	stimulated	neutrophils	with	both	strains	in	the	absence	of	 plasma.	 Interestingly,	 without	 plasma	 only	 the	 WT	 hyphae	 but	 not	 the	small	yeast	form	triggered	the	release	of	NETs	(Figure	1b).	Furthermore,	in	the	 presence	 of	 plasma	 the	 small	 yeast	 form	 was	 unable	 to	 trigger	 NET	release,	 contrary	 to	 the	WT	 form	 of	 the	 fungus	 (Figure	 1c).	 The	 hgc1Δ	 C.	
albicans	 mutant	 remained	 in	 the	 small	 budding	 yeast	 form	 and	 did	 not	convert	 to	 hyphae	 even	 in	 the	 presence	 of	 plasma.	 All	 following	 in	 vitro	experiments	 were	 carried	 out	 in	 the	 presence	 of	 3%	 plasma	 to	 provide	optimal	culture	conditions	for	the	neutrophils.	
Histone	 degradation	 is	 a	 hallmark	 of	 NETosis	 (Papayannopoulos,	 2010).	Therefore,	 we	 investigated	 whether	 or	 not	 histones	 were	 degraded	 upon	stimulation	 with	 pre-formed	 C.	 albicans	 WT	 hyphae	 and	 hgc1Δ	 yeast	particles.	We	probed	the	degradation	of	histone	3	over	the	course	of	5	hours	by	 Western	 blotting.	 Unstimulated	 neutrophils	 showed	 no	 histone	degradation,	 indicated	 by	 the	 stable	 presence	 of	 a	 17	 kDa	 band,	corresponding	to	the	full-length	histone	3	protein.	However,	stimulation	with	
C.	albicans	wild	type	hyphae	induced	histone	3	degradation	already	as	early	as	1	hour	after	stimulation.	This	is	 indicated	by	the	appearance	of	a	protein	fraction	smaller	than	17	kDa.	The	degradation	was	fully	developed	by	2	hours	and	remained	stable	until	5	hours	post	stimulation.	 In	contrast,	 stimulation	with	 the	 small	 yeast	 locked	 hgc1Δ	 particles	 induced	 minimal	 histone	 3	degradation	 at	 2	 hours	 and	 remained	 negligible	 up	 until	 4	 hours	 post	stimulation	(Figure	1d).		
These	 results	 indicate	 that	 NET	 release	 is	 independent	 of	 the	 presence	 of	plasma.	However,	plasma	indirectly	enables	NETosis	by	driving	the	switch	in	fungal	morphology	 from	 yeast	 to	 hyphae.	 Therefore,	 these	 results	 uncover	
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the	mechanism	by	which	plasma	potentiates	NETosis.	 Importantly,	NETosis	is	induced	by	the	large	C.	albicans	hyphae	form	but	not	by	the	small	yeast.	
NET-inducing	capacity	of	C.	albicans	is	size-dependent	
We	 investigated	 whether	 the	 discrimination	 between	 the	 two	 C.	 albicans	growth	 forms	 was	 based	 on	 differences	 in	 the	 expression	 of	 surface	molecules	or	differences	in	the	size	of	the	particles.	
Therefore,	 we	 devised	 an	 experimental	 approach,	 which	 prevented	phagocytic	uptake	of	the	C.	albicans	particles	while	at	the	same	time	allowing	for	direct	contact	and	sensing	of	the	microbe	by	the	neutrophils.	We	modified	a	commercially	available	transwell	so	that	it	could	be	placed	directly	over	the	neutrophils	 that	were	seeded	at	 the	bottom	of	 the	well.	For	 stimulation	we	added	WT	C.	albicans	hyphae	or	small	hgc1Δ	yeast	particles	to	the	upper	part	of	the	transwell	(Figure	2a).	
We	 confirmed	 the	 direct	 contact	 of	 the	 neutrophils	 with	 the	 C.	 albicans	particles	 by	 staining	 the	 bottom	 of	 the	 transwell	 filter	 with	 DAPI.	 This	revealed	 that	 a	 large	number	of	neutrophils	 attached	 to	 the	bottom	side	of	the	filter	(Figure	2b).	
Stimulation	with	WT	C.	albicans	hyphae	in	this	modified	transwell	triggered	the	release	of	NETs	to	a	similar	extend	as	compared	to	a	classical	stimulation	set	up	as	described	before.	Surprisingly,	 the	small	hgc1Δ	mutant	C.	albicans	yeast	 particles	 that	 were	 prohibited	 from	 phagocytic	 uptake	 gained	 the	capacity	to	induce	release	of	NETs	comparable	to	the	WT	hyphae	(Figure	2c	and	d).	Importantly,	small	hgc1Δ	C.	albicans	yeast	particles	were	not	able	to	trigger	 the	 release	 of	 NETs	 in	 a	 classical	 suspended	 transwell	 that	 did	 not	allow	for	direct	contact	with	the	neutrophils	(Figure	2e).	
These	 results	 show	 that	 only	 particles	 that	 cannot	 be	 phagocytosed	 by	neutrophils	trigger	release	of	NETs.	This	applies	to	particles	of	 large	size	or			
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Figure	2	|	Preventing	uptake	of	yeast	induces	NETosis.	(a)	A	modified	transwell	(Mod	TW)	allows	
contact	between	C.	albicans	particles	(top)	and	neutrophils	(bottom)	but	prevents	phagocytosis.	
(b)	Human	peripheral	neutrophils	attached	to	the	bottom	of	the	modified	transwell	membrane	1	
hour	 post	 stimulation.	 Nuclei	 were	 stained	 with	 DAPI	 (blue).	 (c)	 Release	 of	 NETs	 by	 human	
peripheral	 neutrophils	 left	 unstimulated	 (Unst)	 or	 stimulated	 with	 C.	 albicans	 wild-type	 (WT)	
hyphae	or	hgc1Δ	yeast,	directly	 (No	TW,	top)	or	with	separation	by	a	modified	Transwell	 (Mod	
TW,	 bottom).	 Extracellular	 DNA	 was	 stained	 with	 SYTOX	 4	 hours	 after	 stimulation.	 (d)	
Quantification	of	NET	 release	by	human	peripheral	 neutrophils	 left	 unstimulated	or	 stimulated	
with	 C.	 albicans	 pre-formed	WT	 hyphae	 directly	 or	 hgc1Δ	 yeast	 with	 separation	 by	 modified	
Transwell	(yeast	(hgc1Δ)	+	mod	TW),	presented	as	SYTOX+	events	relative	to	total	neutrophils.	(e)	
Quantification	of	NET	 release	by	human	peripheral	 neutrophils	 left	 unstimulated	or	 stimulated	
with	C.	albicans	pre-formed	WT	hyphae	directly	or	hgc1Δ	yeast	with	separation	by	a	suspended	
Transwell	 that	 did	 not	 allow	 direct	 contact	 but	 exchange	 of	 soluble	 factors	 (yeast	 (hgc1Δ)	 +	
suspended	TW).	|	Multiplicity	of	infection	(MOI)	=	10.	Scale	bars	=	50	µm.	Statistics	by	one-way	
ANOVA	 followed	 by	 Tukey’s	multiple	 comparison	 post-test.	 NS	 (not	 significant)	 p>0.05,	 **	 p	 ≤	
0.01,	****	p	≤	0.0001.	Data	are	representative	of	at	least	three	independent	experiments.		
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when	uptake	is	hindered	by	a	physical	barrier	such	as	a	modified	transwell.	Small	 phagocytosible	 particles	 do	 not	 induce	 NETosis.	 Furthermore,	 direct	contact	 is	 required	 and	 no	 soluble	 mediators	 activate	 NET	 release	 in	 this	context.	 To	 further	 corroborate	 the	 size-dependent	 concept,	 we	 tested	whether	 fragmentation	 of	 the	 large	 hyphal	 filaments	 into	 small	phagocytosible	fragments	would	abrogate	formation	of	NET	release.		
We	fragmented	C.	albicans	hyphae	by	high-pressure	homogenisation	(Figure	
3a).	 We	 confirmed	 by	 confocal	 microscopy	 staining	 that	 the	 fragmented	hyphae	 were	 phagocytosed	 by	 the	 neutrophils.	 In	 contrast,	 large	 hyphal	filaments	were	not	taken	up	and	were	located	extracellularly	(Figure	3b).	
We	used	heat-inactivated	WT	C.	albicans	hyphae	for	fragmentation	to	exclude	that	 killing	 of	 the	 particles	 altered	 the	 NET-inducing	 response.	 C.	 albicans	killing	by	heat-inactivation	did	not	abrogate	NET	release	(Figure	3c	and	d).	Heat-inactivation	even	increased	the	rate	of	NET	release,	most	 likely	due	to	exposure	 of	 further	 activating	 cell	 wall	 components	 (Figure	 3d).	Surprisingly,	 small	 fragments	of	 the	 same	WT	hyphae	 lost	 their	 capacity	 to	induce	NETs	(Figure	3e	and	f).		
Taken	together,	 these	results	suggest	 that	NET	release	depends	on	microbe	size.	 Only	 large	 fungal	 particles	 that	 cannot	 be	 taken	 up	 by	 phagocytosis	trigger	 NETosis,	 whereas	 small	 particles	 of	 the	 same	 fungal	 microbe	 are	phagocytosed	 and	do	not	 elicit	 a	NETosis	 response.	Both	morphoforms	are	equally	 able	 to	 trigger	 NET	 release	 when	 phagocytosis	 is	 prevented,	suggesting	that	the	response	is	not	regulated	by	the	differential	expression	of	fungal	surface	molecules.	
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Figure	3	|	Fragmented	hyphae	are	phagocytosed	and	fail	to	induce	NETosis.	(a)	WT	C.	albicans	
hyphae	 were	 heat-inactivated	 and	 fragmented	 by	 pressure.	 The	 hyphal	 fragments	 were	 small	
enough	to	be	phagocytosed.	(b)	Confocal	microscopy	of	human	peripheral	neutrophils	stimulated	
with	intact,	heat-inactivated	C.	albicans	hyphae	(left)	or	fragmented,	heat-inactivated	C.	albicans	
hyphae	(right).	Fixed	1	hour	post	stimulation.	Stained	for	MPO	(green),	C.	albicans	(red)	and	DAPI	
(blue).	0.8	μm	z-stacks.	Scale	bars	=	5	µm.	(c)	Release	of	NETs	by	human	peripheral	neutrophils	
stimulated	with	 intact	 heat-inactivated	WT	C.	 albicans	 hyphae.	 Extracellular	 DNA	 stained	with	
SYTOX	4	hours	after	stimulation	 (top).	Brightfield	 images	of	neutrophils	and	heat-inactivated	C.	
albicans	 (bottom).	 Scale	 bars	 =	 50	 µm.	 (d)	 Quantification	 of	 NET	 release	 by	 human	 peripheral	
neutrophils	 left	 unstimulated	 (Unst)	 or	 stimulated	 with	 heat-inactivated	 or	 untreated	 WT	 C.	
albicans	hyphae,	presented	as	SYTOX+	events	relative	to	total	neutrophils.	(e)	Release	of	NETs	by	
human	peripheral	neutrophils	 left	unstimulated	or	 stimulated	with	 intact	or	 fragmented	WT	C.	
albicans	 hyphae.	 Scale	 bars	 =	 50	 µm.	 (f)	 Quantification	 of	 NET	 release	 by	 human	 peripheral	
neutrophils	 left	unstimulated	or	stimulated	with	 intact	or	fragmented	WT	C.	albicans	hyphae.	|	
Multiplicity	 of	 infection	 (MOI)	 =	 10	 (or	 fragments	 equivalent	 of	 MOI	 =	 10	 of	 intact	 hyphae).	
Statistics	by	one-way	ANOVA	followed	by	Tukey’s	multiple	comparison	post-test.	***	p	≤	0.001	
and	****	p	≤	0.001.	Data	are	representative	of	at	least	three	independent	experiments.		
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A.	fumigatus	hyphae	and	aggregates	induce	NETs	
Next,	we	investigated	whether	the	size-dependent	regulation	of	NET	release	was	a	general	mechanism	that	applied	to	other	microbes	beyond	C.	albicans.	
Aspergillus	 fumigatus	 is	 a	dimorphic	 fungus	 that	 can	 switch	 its	morphology	between	small	conidia	and	large	hyphae.	The	conidia	have	a	comparable	size	to	C.	albicans	yeast	particles	(3-5	µm).		
We	 tested	 NET	 induction	 by	 Aspergillus	 fumigatus	 in	 the	 presence	 and	absence	of	plasma	in	the	cell	culture	medium.	A.	fumigatus	triggered	NETosis	in	 the	 presence	 but	 not	 in	 the	 absence	 of	 3%	 plasma.	 Interestingly,	 in	contrast	to	C.	albicans,	plasma	did	not	induce	A.	fumigatus	hyphal	growth	but	triggered	conidia	 to	accumulate	 to	 large	aggregates.	These	 large	aggregates	stimulated	 the	 release	 of	 NETs	 (Figure	 4).	 We	 pre-formed	 A.	 fumigatus	hyphae	in	RPMI	medium	to	confirm	the	importance	of	fungal	size	rather	than	the	 presence	 of	 plasma.	 Importantly,	 stimulation	 of	 neutrophils	 with	 the	large	filaments	induced	NET	release	in	the	absence	of	plasma	(Figure	4).	
These	data	confirm	that	size-dependent	NET	release	applies	to	other	fungal	species	and	 is	not	 restricted	 to	C.	albicans.	Furthermore,	 this	process	 is	not	dependent	 on	 plasma	 or	 on	 the	 presence	 of	 fungal	 hyphae.	 It	 is	 instead	dependent	 on	 the	 presence	 of	 microbial	 particles	 that	 are	 too	 large	 to	 be	phagocytosed.	
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Figure	 4	 |	 A.	 fumigatus	 filaments	 and	 aggregates	 induce	 NETs.	 Release	 of	 NETs	 by	 human	
peripheral	neutrophils	stimulated	with	A.	fumigatus	in	the	absence	(top)	or	presence	(middle)	of	
3%	plasma	or	A.	fumigatus	pre-formed	hyphae	(in	RPMI)	 in	the	absence	of	plasma	(bottom).	A.	
fumigatus	 aggregates	 in	 the	 presence	 of	 plasma	 (middle).	 Extracellular	 DNA	 was	 stained	 with	
SYTOX	 4	 hours	 after	 stimulation	 (left).	 Brightfield	microscopy	 of	 neutrophils	 and	A.	 fumigatus	
(right).	Scale	bars	=	50	µm.	Data	are	representative	of	at	least	three	independent	experiments.		
Single	bacteria	do	not	induce	NETosis	
Next,	we	tested	whether	size-dependent	NET	release	was	restricted	to	fungi.	Bacteria	are	small	microbes	that	can	easily	be	phagocytosed	by	neutrophils.	According	 to	 the	 above	 findings	 the	 small	 size	 would	 make	 bacteria	unsuitable	NET-inducers.	
We	stimulated	neutrophils	with	Escherichia	coli	and	Klebsiella	pneumoniae.	In	line	with	our	previous	 findings,	 the	 small	 single	bacteria	did	not	 elicit	NET	release	 (Figure	 5a	 and	 b).	 Next	 we	 presented	 bacteria	 via	 the	 modified	transwell	 described	 above,	 allowing	 for	 direct	 contact	 but	 preventing	phagocytic	 uptake.	 Interestingly,	 bacteria	 that	 were	 presented	 in	 the	
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transwell	 induced	 NET	 release	 (Figure	 5a	 and	b),	 indicating	 that	 bacteria	have	the	potential	to	activate	NETosis	when	prevented	from	phagocytosis.	
A	more	physiological	 approach	 to	 investigate	 this	 concept	 is	 the	use	 of	 the	Bacillus	 Calmette–Guérin	 (BCG)	 strain	 of	Mycobacterium	 bovis.	 BCG	 forms	irregular,	 large	 aggregates	 (Bernut,	 2014;	 Ratliff,	 1994).	 We	 investigated	whether	 bacterial	 aggregation	 played	 a	 role	 in	 NET	 release.	 In	 our	experiment	a	red	fluorescent	strain	of	BCG	(BCG-dsRed)	formed	large	as	well	as	smaller	aggregates.	 Interestingly,	 the	size	of	 the	BCG	aggregates	strongly	correlated	with	 their	 capacity	 to	 induce	NET	 release.	Only	 large	 aggregates	induced	 NETosis	 whereas	 smaller	 aggregates	 and	 single	 bacteria	 failed	 to	trigger	 NET	 release.	 The	 smaller	 particles	 were	 taken	 up	 by	 phagocytosis	(Figure	5c	-	e).	
These	 data	 show	 that	 bacteria	 have	 the	 potential	 to	 induce	 NET	 release.	However,	their	small	size	down-regulates	this	process.	Preventing	uptake	of	small	 bacteria	 by	 modified	 transwells	 or	 formation	 of	 large	 aggregates	triggers	release	of	NETs	similar	to	large	microbes.	
Taken	 together,	 these	 in	 vitro	 experiments	 show	 for	 the	 first	 time	 that	neutrophil	 antimicrobial	 responses	 are	 regulated.	 This	 regulation	 is	neutrophil	 intrinsic.	 Neutrophils	 recognise	 the	 size	 of	 a	 microbe	 through	whether	or	not	 it	 can	be	 taken	up.	NETosis	 is	an	extracellular	 strategy	 that	specifically	targets	large	forms	that	cannot	be	eliminated	intracellularly.	Most	fungi	 are	 di-morphic	 and	 germinate	 to	 larger	 hyphal	 forms	 for	 full	pathogenicity.	 Bacteria	 are	 small	 and	 are	 phagocytosed	 rapidly.	 Our	 data	show	 that	 bacteria	 do	 not	 trigger	 NET	 release,	 unless	 their	 uptake	 is	prohibited.	 Formation	 of	 large	 aggregates	 in	 e.g.	 biofilms	 is	 a	 virulence	mechanism	 of	 bacteria	 to	 avoid	 phagocytosis.	 Multiple	 bacterial	 virulence	factors	lead	to	abrogated	phagocytosis,	explaining	literature	describing	NET	release	upon	bacterial	stimulation	(Johnson	and	Criss,	2013;	Juneau,	2015b).	
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Figure	 5	 |	 Single	 bacteria	 do	 not	 induce	 NETosis.	 (a)	 Release	 of	 NETs	 by	 human	 peripheral	
neutrophils	left	unstimulated	(Unst)	or	stimulated	with	Escherichia	coli	(strain	DH5α)	or	Klebsiella	
pneumoniae	 (strain	 Kp52.145),	 directly	 (No	 TW,	 top	 and	 middle)	 or	 separated	 by	 a	 modified	
transwell	 to	 allow	 direct	 contact	 with	 the	 bacteria	 but	 prevent	 phagocytosis	 (+TW,	 bottom).	
Extracellular	DNA	was	stained	with	SYTOX	4	hours	after	stimulation	(top	and	bottom).	Brightfield	
images	of	 the	neutrophils	 and	bacteria	 (middle).	 Scale	bars	=	50	µm.	 (b)	Quantification	of	NET	
release	by	human	peripheral	human	peripheral	neutrophils	 in	 response	 to	BCG	as	described	 in	
(a),	presented	as	SYTOX+	events	relative	to	total	neutrophils.	ND,	not	detectable.	 (c)	Release	of	
NETs	by	human	peripheral	neutrophils	 stimulated	with	BCG-DsRed	 (red),	MOI=10.	 Extracellular	
DNA	was	stained	with	SYTOX	(green)	4	hours	after	stimulation.	Necrotic	neutrophils	responding	
to	 single	 BCG	 bacteria	 and	 small	 aggregates	 of	 BCG	 (i)	 and	 neutrophils	 undergoing	 NETosis	 in	
response	 to	 large	 aggregates	 of	 BCG	 (ii).	 Scale	 bars	 =	 50	 µm.	 (d)	 Quantification	 of	 necrotic	
neutrophils	 (i)	 and	 NET	 release	 (ii)	 by	 human	 peripheral	 neutrophils	 in	 response	 to	 BCG	 as	
described	in	(c)	presented	as	SYTOX+	events	relative	to	total	neutrophils.	(e)	Still	images	obtained	
from	 time-lapse	 video	 microscopy	 of	 human	 peripheral	 neutrophils	 stimulated	 with	 single	
bacteria	 (*)	 and	 large	 aggregates	 (arrowheads)	 of	 BCG-dsRed	 (red)	 in	 the	 presence	 of	 SYTOX	
(green).	Scale	bars	=	150	µm.	|	Statistics	by	one-way	ANOVA	followed	by	Sidak’s	(b)	or	Tukey’s	(d)	
multiple	comparison	post-test.	NS	(not	significant)	p	>	0.5,	***	p	≤	0.001,	****	p	≤	0.0001.	Data	
are	representative	of	two	independent	experiments.	
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2.5.3 NETs	have	direct	antifungal	activity	in	vitro	
Release	 of	 NETs	 was	 selectively	 triggered	 by	 large	 microbes	 such	 as	 C.	
albicans	hyphae.	However,	 the	 antimicrobial	 effect	 of	NETs	 on	 hyphae	was	unknown.	Therefore,	we	tested	whether	NETosis	was	required	to	control	C.	
albicans	hyphae	in	vitro.	
First,	 we	 employed	 a	 growth	 inhibition	 assay	 that	 was	 based	 on	 the	enzymatic	 activity	 of	 the	 live	 fungus.	 Live	 C.	 albicans	 metabolised	 the	substrate	 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide	 (XTT)	 and	 produced	 a	 measurable	 yellow	 colour	 reaction	(Figure	6a).	
When	C.	albicans	was	incubated	in	the	presence	of	neutrophils,	viability	was	decreased	 compared	 to	 untreated	 C.	 albicans.	 At	 a	 multiplicity	 of	 infection	(MOI)	of	1,	C.	albicans	growth	was	not	completely	controlled	by	4	hours	and	the	 fungus	 continued	 to	 grow	 over	 night.	 At	 a	 decreased	 MOI	 of	 0.1,	 C.	
albicans	 growth	 was	 completely	 inhibited	 and	 outgrowth	 was	 abrogated	(Figure	 6b),	 indicating	 that	 neutrophils	 are	 able	 to	 control	 C.	 albicans	viability.	
The	 enzymatic	 assay	 allowed	us	 to	 investigate	 killing	 of	C.	albicans	 since	 it	required	 a	 live	 fungus	 to	 metabolise	 the	 substrate.	 However,	 the	disadvantage	of	this	assay	is	that	it	only	represents	the	effect	of	neutrophils	on	 the	 entire	 C.	 albicans	 population.	 In	 order	 to	 dissect	 the	 effect	 of	neutrophils	 on	 individual	 hyphal	 filaments,	 we	 employed	 time-lapse	microscopy.	
C.	 albicans	 WT	 hyphae	 showed	 a	 continued	 linear	 growth	 over	 10	 hours,	reaching	up	to	30	times	their	original	length	under	in	vitro	culture	conditions.	Addition	of	neutrophils	 to	 the	cultures	 led	 to	 inhibited	hyphal	growth.	This	inhibition	was	directly	dependent	on	the	number	of	neutrophils	present.	Full	growth	inhibition	was	achieved	at	an	MOI	of	0.04	where	on	average	25	times	more	neutrophils	than	hyphal	filaments	were	present	(Figure	6c).	To	test	the	
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importance	of	NET	release	 in	C.	albicans	killing,	we	dissolved	NETs	directly	after	release	by	the	presence	of	DNase	I	in	the	culture	medium.	As	before,	C.	
albicans	hyphae	alone	grew	several	 times	their	original	 length,	whereas	the	presence	 of	 neutrophils	 inhibited	 hyphal	 growth	 (Figure	 6d	 and	 e).	Importantly,	hyphal	growth	 inhibition	was	dependent	on	NETosis	as	 it	was	partially	recovered	in	the	presence	of	DNase	I	(Figure	6d	and	e).	
Since	ROS-deficient	mice	 succumb	 to	 infection	with	C.	 albicans	due	 to	 their	lack	of	NETosis,	we	tested	whether	ROS	is	required	for	direct	hyphal	growth	inhibition.	 Therefore,	 we	 isolated	 bone	 marrow	 neutrophils	 from	 NADPH	oxidase-deficient	mice	and	investigated	their	anti-fungal	properties.	
Interestingly,	C.	albicans	hyphae	that	were	co-cultured	with	NADPH	oxidase-deficient	neutrophils	showed	hyphal	growth	comparable	to	untreated	control	hyphae.	 NADPH	 oxidase-deficient	 neutrophils	 did	 not	 exert	 any	 anti-fungal	effect	on	C.	albicans	(Figure	6f).	
Taken	 together,	 these	 data	 suggest	 that	 neutrophils	 directly	 kill	C.	 albicans	hyphae	 and	 that	 NETs	 are	 required	 for	 hyphal	 growth	 inhibition.	Furthermore,	 the	 data	 underscore	 the	 importance	 for	 ROS	 during	 NET-mediated	C.	albicans	fungal	control.	
	
Figure	6	|	NETs	have	direct	antifungal	activity	in	vitro.	(a)	Graphic	representation	of	XTT-based	
viability	 assay.	 C.	 albicans	 was	 left	 untreated	 (top)	 or	 co-incubated	 with	 human	 peripheral	
neutrophils	 (bottom),	 XTT	 substrate	 was	 added	 after	 indicated	 time-points.	 Live	 C.	 albicans	
metabolised	 substrate	 to	 yellow	 chromogenic	 substance,	 no	 reaction	 was	 seen	 in	 killed	 C.	
albicans.	 Absorbance	measured	 at	 450	 nm.	 (b)	 Fraction	 of	 viable	C.	 albicans	WT	hyphae	 after	
incubation	with	human	peripheral	neutrophils	for	 indicated	times,	as	compared	to	untreated	C.	
albicans	 hyphae	 alone	 (dotted	 line).	MOI	 =	 1	 (black	 bars)	 and	 0.1	 (white	 bars).	 (c)	 Brightfield	
microscopy	 of	 C.	 albicans	WT	 hyphal	 outgrowth	 after	 10	 hours,	 left	 untreated	 (left	 panel)	 or	
incubated	 with	 increasing	 amounts	 of	 human	 peripheral	 neutrophils.	 Scale	 bar	 =	 50	 µm.	 (d)	
Brightfield	microscopy	 of	C.	 albicans	WT	hyphal	 outgrowth	 after	 10	 hours,	 left	 untreated	 (left	
panel)	or	 incubated	with	human	peripheral	neutrophils,	 in	 the	presence	or	absence	of	50	U/ml	
DNase	I.	Scale	bar	=	50	µm.	
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Figure	6	(continued)	|	(e)	Quantitation	of	C.	albicans	WT	hyphal	outgrowth	as	in	(d).	Fold	change	
as	compared	to	hyphal	length	at	0	h.	(f)	Quantitation	of	C.	albicans	WT	hyphal	outgrowth	over	10	
hours	 left	 untreated	 or	 incubated	 with	 WT	 or	 NADPH	 oxidase	 KO	 mouse	 bone	 marrow	
neutrophils.	|	Statistics	(a)	by	one-way	ANOVA	followed	by	Sidak’s	multiple	comparison	post-test.	
Error	bars	=	SD,	 standard	deviation.	 (d	and	e)	 compared	 to	no	neutrophils	by	 two-way	ANOVA	
followed	by	Dunnett’s	multiple	comparison	post-test.	If	nothing	indicated	=	not	significant	(NS)	p	
>	0.05.	Otherwise:	*	p	≤	0.05,	**	p	≤	0.01,	***	p	≤	0.001,	****	p	≤	0.0001.	Data	are	representative	
of	at	least	three	independent	experiments.		
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2.5.4 NETs	control	hyphae	in	vivo	
Our	 results	 showed	 that	 NETs	 were	 selectively	 released	 upon	 stimulation	with	 large	 microbes	 and	 controlled	 C.	 albicans	 hyphae	 in	 vitro.	 Next,	 we	tested	whether	NETs	were	released	in	a	size-dependent	manner	 in	vivo	and	which	role	selective	NETosis	played	during	effective	antifungal	defence.	
In	 a	 pulmonary	 infection	model,	 C57BL/6	WT	mice	were	 inoculated	 intra-tracheally	with	C.	albicans	pre-formed	WT	hyphae	and	the	hgc1Δ	yeast	locked	strain.	In	line	with	the	in	vitro	findings,	we	observed	NET	release	in	the	lungs	of	 mice	 infected	 with	 C.	 albicans	 WT	 hyphae.	 In	 contrast,	 animals	 infected	with	 C.	 albicans	 hgc1Δ	 yeast	 particles	 did	 not	 release	 NETs	 in	 the	 lungs.	NETosis	 was	 indicated	 by	 the	 presence	 of	 citrullinated	 histone	 3	 (citH3)	(Figure	7a).	
Similarly,	 infection	 with	 the	 lung	 pathogenic	 bacterium	 Streptococcus	
pneumoniae	did	not	trigger	NET	release	in	the	lung	(Figure	7b)	(Ellis,	2015),	which	confirmed	the	 in	vitro	 findings	showing	that	bacteria	are	too	small	to	trigger	NETosis.	
These	findings	suggest	that	NET	release	in	vivo	is	dependent	on	microbe	size.	
After	 we	 established	 that	 NETosis	 was	 selectively	 induced	 by	 large	extracellular	microbes	in	vitro	and	in	vivo,	we	tested	whether	size-dependent	NETosis	was	crucial	for	sufficient	antifungal	defence	in	vivo.	
Since	MPO	is	required	for	the	onset	of	NETosis	and	its	absence	leads	to	NET	deficiency	in	mice	and	humans	(Metzler,	2011),	we	tested	the	importance	of	NETosis	 for	 size-specific	 antimicrobial	 defence	 by	 pulmonary	 infection	 of	MPO-deficient	mice.	
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Figure	7	|	Hyphae	but	not	yeast	induce	NETs	in	vivo.	(a)	NET	release	(white	arrows)	in	the	lungs	
of	wild-type	 (C57BL/6)	mice	 24	 hours	 after	 intratracheal	 infection	with	 1	 ×	 105	 colony-forming	
units	 (CFU)	 of	 C.	 albicans	 pre-formed	 WT	 hyphae	 or	 hgc1∆	 yeast,	 assessed	 by	
immunofluorescence	microscopy.	Bottom	 row,	 enlargement	of	 area	outlined	 in	 top	 left	 image.	
(b)	 NET	 release	 in	 the	 lungs	 of	 wild-type	 (C57BL/6)	 mice	 after	 intranasal	 infection	 with	 2x107	
Streptococcus	pneumoniae	D39	or	intratracheal	infection	with	1	×	105	colony-forming	units	(CFU)	
of	C.	 albicans	 pre-formed	WT	hyphae,	 assessed	by	 immunofluorescence	microscopy.	 |	 Stained	
for	citrullinated	histone	H3	 (citH3;	 red),	MPO	(green)	and	DNA	 (DAPI,	blue).	Scale	bars,	20	μm.	
Images	are	representative	of	two	independent	experiments.	(b)	Infection	courtesy	of	Dr	Gregory	
T	Ellis.		
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We	 infected	 C57BL/6	WT	 and	MPO-deficient	 (ΔMPO)	mice	 intra-tracheally	with	WT	 C.	 albicans	 and	 the	 hgc1Δ	 yeast-locked	 strain.	We	monitored	 the	weight	and	general	health	of	the	mice	over	the	course	of	6	days.	Initially,	all	mice	lost	weight	due	to	the	stress	of	the	infection.	WT	mice	recovered	quickly	and	regained	weight	48	hours	after	infection	with	either	strains	of	C.	albicans	(Figure	8a).	ΔMPO	mice	recovered	quickly	from	the	infection	with	the	yeast-locked	 hgc1Δ	 strain	 of	 C.	 albicans.	 In	 contrast,	 NET-deficient	 ΔMPO	 mice	succumbed	 rapidly	 to	 infection	with	 the	 hyphal-containing	WT	 strain	 of	C.	
albicans.	 These	 mice	 lost	 up	 to	 30%	 of	 body	 weight	 6	 days	 post	 infection	(Figure	 8a).	 Furthermore,	WT	mice	 cleared	 infection	 completely	 by	 day	 6	post	infection,	as	indicated	by	the	absence	of	C.	albicans	colony	forming	units	(CFU)	 in	 the	 lung	and	 spleen	of	 these	mice.	 In	 contrast,	 high	numbers	of	C.	
albicans	 CFU	 were	 present	 in	 the	 lungs	 of	 the	 NET-deficient	 ΔMPO	 mice.	Furthermore,	the	infection	in	these	mice	spread	systemically,	as	indicated	by	the	presence	of	C.	albicans	CFU	in	the	spleen	on	day	6	post	infection	(Figure	
8b).	
To	verify	 that	 the	selective	susceptibility	of	mice	 towards	 large	WT	hyphae	was	not	caused	by	an	attenuation	of	the	Δhgc1	yeast-locked	C.	albicans	strain,	we	 employed	 NADPH	 oxidase-deficient	 mice.	 Since	 ROS	 production	 by	NADPH	oxidase	is	crucial	for	NETosis	and	killing	by	phagocytosis,	these	mice	are	highly	susceptible	to	infection	(Ermert,	2009).	
We	 infected	 C57BL/6	WT	 and	NADPH	oxidase-deficient	mice	with	WT	 and	
hgc1Δ	yeast-locked	C.	albicans.	As	seen	previously,	WT	mice	cleared	infection	with	 both	 fungal	 strains,	 indicated	 by	 rapid	 weight	 regain.	 Interestingly,	NADPH	oxidase-deficient	mice	succumbed	to	the	infection	with	both	WT	and	
hgc1Δ	yeast-locked	C.	albicans	 (Figure	8c),	 indicating	 that	 the	Δhgc1	yeast-locked	strain	is	not	attenuated.	
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Figure	8	|	ROS-deficient	mice	succumb	to	infection	with	WT	C.	albicans.	(a)	Weight	of	C57BL/6	
wild-type	mice	(WT;	n	=	6)	and	MPO-deficient	mice	(∆MPO;	n	=	5)	infected	with	1	×	104	colony-
forming	units	(CFU)	of	wild-type	or	hgc1∆	C.	albicans,	presented	relative	to	starting	weight	(day	
0),	set	as	100%.	(b)	C.	albicans	load	in	the	lungs	and	spleen	of	mice	6	days	after	infection	as	in	(a).	
Each	symbol	represents	an	 individual	mouse	(n	=	3	mice	per	group).	 (c)	Weight	of	C57BL/6	WT	
and	NADPH	 oxidase	 KO	mice	 after	 infection	with	 1x104	 colony-forming	 units	 (CFU)	 of	WT	 and	
hgc1∆	yeast-locked	C.	albicans	(n=5).	Weight	normalized	to	starting	weight	at	day	0.	(d)	Overview	
of	antimicrobial	strategies	of	WT,	ΔMPO	and	ΔNADPH	oxidase	mice	after	stimulation	with	WT	or	
Δhgc1	 yeast-locked	 C.	 albicans.	 |	 Statistics	 (a	 and	 c)	 by	 two-way	 ANOVA,	 followed	 by	 Sidak’s	
multiple	comparison	post	test;	(b)	by	two-way	ANOVA,	followed	by	Tukey’s	multiple-comparison	
post-test.	Small	horizontal	lines	indicate	the	mean.	NS	=	not	significant	p	>	0.05,	**	p	≤	0.01.	****	
p	≤	0.0001.	Data	are	representative	of	two	independent	experiments.	Error	bars	=	SD,	standard	
deviation.	
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Taken	 together,	 these	 findings	 indicate	 that	 NET	 release	 is	 an	 important	antimicrobial	 strategy,	 specifically	 targeted	 at	 large	 pathogens.	 Lack	 of	 this	extracellular	 defence	 mechanism	 renders	 mice	 susceptible	 to	 prolonged	infection	with	microbes	 that	 cannot	 be	 cleared	 intracellularly	 (Figure	 8d).	MPO	deficiency	 is	 a	 good	way	 to	model	NET	deficiency	 as	 indicated	by	 the	phenotype	of	MPO-deficient	patients	(Metzler,	2011).	However,	since	MPO	is	also	 expressed	 in	 subsets	 of	 macrophages	 (Klebanoff,	 2005),	 it	 cannot	 be	completely	 excluded	 that	MPO	deficiency	also	 impairs	other	NET-unrelated	functions	 in	 vivo.	 NADPH-deficient	 mice	 model	 chronic	 granulomatous	disease	 (CGD).	 NADPH	 oxidase	 deficiency	 and	 subsequent	 lack	 of	 ROS	production	 inhibits	 NETosis	 as	 well	 as	 killing	 by	 phagocytosis.	 Both	strategies	 are	 required	 for	 an	 effective	 immune	 response,	 each	 targeting	microbes	of	different	size.	
2.5.5 Dectin-1	is	a	negative	regulator	of	NETosis	
Blocking	phagocytic	receptors	upregulates	NET	release	in	vitro	
Since	phagocytosis	and	NETosis	seemed	to	be	two	complementing	strategies	in	antimicrobial	defence,	we	further	 investigated	their	 interplay.	Dectin-1	 is	the	 main	 fungal-specific	 phagocytic	 receptor.	 It	 recognises	 β-glucan	 in	 the	fungal	 cell	wall	 and	 triggers	uptake	of	 small	 fungal	particles.	Therefore,	we	tested	the	influence	of	dectin-1-mediated	phagocytosis	on	NET	release.	
Inhibiting	dectin-1	 in	neutrophils	with	 a	blocking	antibody	 in	 vitro	 led	 to	 a	great	reduction	of	phagocytosis	as	compared	to	unblocked	control	cells.	This	was	indicated	by	a	reduced	uptake	rate	of	yeast	particles	as	well	as	a	reduced	total	 number	 of	 phagocytosed	 particles	 (Figure	 9a).	 Interestingly,	 at	 the	same	 rate	 as	 phagocytosis	 decreased,	 the	 release	 of	 NETs	 increased.	Neutrophils	with	blocked	dectin-1	released	NETs	in	response	to	stimulation	with	hgc1Δ	C.	albicans	yeast	particles,	which	were	otherwise	unable	to	induce	NETosis	in	the	absence	of	dectin-1	blocking.	Stimulation	of	dectin-1-blocked	neutrophils	 with	 WT	 C.	 albicans	 hyphae	 led	 to	 even	 further	 increased	
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NETosis	 as	 compared	 to	untreated	dectin-1-competent	neutrophils	 (Figure	
9b).	This	is	potentially	due	to	the	blocked	uptake	of	smaller	hyphal	fragments	present	 in	 the	 fungal	 preparation.	 Interestingly,	 over	 time	 fully	phagocytosing	 neutrophils	 died	 of	 necrosis	 with	 condensed	 nuclei.	 In	contrast,	 dectin-1-blocked	 neutrophils	 showed	 reduced	 signs	 of	phagocytosis.	Their	nuclei	decondensed	and	NETs	were	formed	(Figure	9c),	indicating	a	repressive	effect	of	dectin-1	on	NETosis.	
Next	we	investigated	whether	NETosis	was	specifically	regulated	by	dectin-1	or	whether	phagocytosis	was	a	general	repressor	of	NET	release.	Therefore,	we	 tested	 the	 capacity	 of	 phagocytic	 receptors	 to	 modulate	 NET	 release.	Blocking	 the	 Fcγ	 receptor	 (FcγR)	 increased	 the	 amount	 of	 NETs	 released	upon	stimulation	with	WT	C.	albicans	hyphae	by	two	fold.	These	results	were	later	 confirmed	 by	 another	 group	 (Aleman,	 2016).	 Similarly,	 blocking	 the	mannose	 receptor	 (MR)	or	 the	 complement-dependent	phagocytic	 receptor	CR3	 increased	 NET	 release	 upon	 stimulation	 with	 C.	 albicans	 hyphae	 as	compared	to	unblocked	neutrophils	(Figure	9d).	
These	 data	 indicate	 that	 phagocytosis	 inhibits	 NET	 release	 independent	 of	the	 initiating	 receptor.	 Therefore,	 naturally	 occurring	 phagocytosis	 is	 a	master	 regulator	 of	 NETosis.	 This	 regulation	 mechanism	 attributes	 to	 the	selectivity	of	 the	 two	antimicrobial	 strategies	phagocytosis	and	NETosis	 for	small	 and	 large	 microbes,	 respectively.	 These	 results	 also	 indicate	 that	recognition	of	C.	albicans	by	dectin-1,	FcγR,	MR	or	CR3	is	not	required	for	the	initiation	of	the	NETosis	pathway.	Blocking	these	receptors	did	not	abrogate,	but	increase	NET	release	upon	stimulation	with	C.	albicans.	
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Figure	9	|	Blocking	phagocytic	 receptors	upregulates	NET	 release	 in	 vitro.	 (a)	 Phagocytosis	of	
hgc1∆	C.	albicans	yeast	(MOI	=	40)	by	neutrophils	(n	=	10	per	condition)	 left	untreated	(left)	or	
treated	with	10	µg/ml	anti-dectin-1	blocking	antibody	 (right);	 phagocytosed	yeast	particles	per	
cell	were	quantified	over	2	hour	by	 live	microscopy	(diagonal	 line:	trend	line	 fitted	to	data).	 (b)	
NET	release	by	peripheral	human	neutrophils	left	untreated	(left)	or	treated	with	10	µg/ml	anti-
dectin-1	blocking	antibody	(right),	 left	unstimulated	or	stimulated	with	C.	albicans	hyphae	(WT)	
or	 hgc1∆	 yeast	 (hgc1Δ)	 (MOI	 =	 10),	 assessed	 4	 hours	 after	 stimulation,	 presented	 as	 SYTOX+	
events	 relative	 to	 total	 neutrophils.	 (c)	 Time-lapse	 microscopy	 of	 live	 human	 peripheral	
neutrophils	 left	 untreated	 (top)	 or	 treated	 with	 10	 µg/ml	 anti-dectin-1	 blocking	 antibody	
(bottom)	and	stimulated	with	heat-inactivated	hgc1∆	C.	albicans	 yeast	 (MOI	=	40);	arrowheads	
indicate	 incomplete	 decondensation;	 arrows	 indicate	 NET	 release.	 Confocal	 images	 were	
obtained	 every	 30	 s.	 Scale	 bars	 =	 20	μm	 (d)	NET	 release	 by	 peripheral	 human	neutrophils	 left	
untreated	(Untr)	or	treated	with	blocking	antibodies	against	Mannose	receptor	(10	µg/ml,	 left),	
FcγR	(0.5	µg/ml,	middle)	or	CR3	(10	µg/ml,	right),	stimulated	with	WT	C.	albicans	hyphae	(MOI	=	
10),	assessed	4	hours	after	stimulation,	presented	as	SYTOX+	events	relative	to	total	neutrophils.	
|	(b	and	d)	Statistics	by	one-way	ANOVA	followed	by	Sidak’s	multiple-comparison	post-test	*	p	≤	
0.05,	 **	 p	 ≤	 0.01,	 ***	 p	 ≤	 0.001,	 ****	 p	 ≤	 0.0001.	 Data	 are	 representative	 of	 at	 least	 three	
independent	experiments.	
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Dectin-1	KO	mice	have	increased	NET	release	in	vivo	
Blocking	phagocytosis	in	vitro	led	to	NET	release	upon	stimulation	with	small	yeast	 and	 to	 increased	 NETosis	 upon	 stimulation	 with	 large	 hyphae.	Therefore,	we	tested	whether	phagocytosis	was	also	relevant	 for	regulating	NETosis	in	vivo,	using	dectin-1-deficient	mice.	
We	 infected	 WT	 and	 dectin-1-deficient	 mice	 with	 WT	 C.	 albicans	intratracheally	 and	 observed	 NET	 release	 in	 the	 lung	 as	 indicated	 by	 the	presence	 of	 citrullinated	 histone	 3	 (citH3).	 Interestingly,	 dectin-1	 deficient	mice	 showed	 a	 marked	 increase	 in	 NET	 release	 upon	 infection	 with	 C.	
albicans	 as	 compared	 to	WT	mice	 (Figure	 10a).	 Furthermore,	 infection	 of	dectin-1-deficient	 mice	 with	 the	 fungus	 A.	 fumigatus	 led	 to	 increased	 NET	release	in	the	lungs	as	compared	to	WT	mice	(Figure	10b).	
These	data	 further	corroborate	 the	selective	release	of	NETs	 in	response	to	particles	that	cannot	be	phagocytosed.	Mice	 lacking	the	phagocytic	receptor	dectin-1	 show	 a	 greatly	 increased	 NET	 response	 upon	 encounter	 with	 C.	
albicans.	Similarly,	A.	fumigatus	triggered	increased	NET	release	in	dectin-1-deficient	 mice,	 indicating	 that	 regulation	 of	 NETosis	 by	 phagocytosis	 is	 a	general	mechanism	and	not	restricted	to	C.	albicans.	
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Figure	10	|	Dectin-1	KO	mice	have	increased	NET	release	in	vivo.	(a)	NET	release	in	lungs	of	WT	
(C57BL/6)	 and	 dectin-1	 deficient	 mice	 infected	 with	 1x105	 CFU	WT	 C.	 albicans	 24	 hours	 post	
infection.	(b)	NET	release	in	the	lungs	of	C57BL/6	WT	mice	and	dectin-1-deficient	mice	(Dectin-1-
KO)	infected	intratracheally	with	1	×	106	colony	forming	units	(CFU)	of	A.	fumigatus,	assessed	48	
hours	 later.	|	 Immunofluorescence	staining	for	DNA	(DAPI,	blue),	MPO	(green)	and	citrullinated	
histone	H3	 (citH3,	 red),	 analysed	by	 immunofluorescence	 confocal	microscopy.	 Scale	bars	=	20	
μm.	 Images	 are	 representative	 of	 two	 independent	 experiments.	 |	 (b)	 Staining	 courtesy	 of	 Dr	
Qian	Wang.		
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2.5.6 Selectivity	of	NETosis	is	not	regulated	through	signalling	or	ROS	
Our	 data	 indicated	 that	 dectin-1	 acted	 as	 negative	 regulator	 of	 NETosis,	driving	 size-dependent	 NET	 release.	 However,	 it	 was	 unclear	 how	 this	regulation	was	achieved	mechanistically.	Therefore,	we	investigated	whether	dectin-1-mediated	 signalling	was	 activated	differentially	by	 large	 and	 small	particles.	
We	tested	the	activation	of	Syk	kinase,	which	is	phosphorylated	downstream	of	dectin-1	(Drummond,	2011).	Since	fungi	signal	through	different	TLRs,	we	investigated	whether	C.	albicans	yeast	and	hyphae	 initiated	differential	TLR	signalling.	 Therefore,	 we	 tested	 the	 phosphorylation	 of	 the	 TLR-activated	ERK	kinase	pathway	(Bourgeois	and	Kuchler,	2012;	Romani,	2011).	
	
	
 
Figure	11	 |	 Selectivity	of	NETosis	 is	 not	 regulated	 through	 signalling	or	ROS.	 (a)	 Syk	 and	ERK	
kinase	 activation	 in	 human	 peripheral	 neutrophils	 stimulated	 with	 C.	 albicans	 WT	 hyphae	 or	
hgc1∆	yeast-locked	mutant	for	the	indicated	times	and	assessed	by	immunoblotting.	Syk/pSyk	=	
72	 KDa,	 ERK/pERK	 =	 42	 +	 44	 kDa	 bands.	 (b)	 Production	 of	 reactive	 oxygen	 species	 (ROS)	 by	
human	 peripheral	 neutrophils	 after	 stimulation	 with	 C.	 albicans	 WT	 hyphae	 or	 hgc1∆	 yeast-
locked	mutant.	Unst,	unstimulated;	 LU,	 luminescence	units.	Data	are	 representative	of	at	 least	
three	independent	experiments.		
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We	stimulated	human	peripheral	neutrophils	with	C.	albicans	WT	hyphae	and	
hgc1Δ	 yeast	 and	 probed	 for	 phosphorylation	 of	 Syk	 and	 ERK	 kinase	 by	immunoblotting.	 Interestingly,	 the	 expression	 or	 phosphorylation	 of	 Syk	 or	ERK	 did	 not	 differ	 between	 neutrophils	 stimulated	 with	 either	 C.	 albicans	strain	 (Figure	11a).	 These	 results	 indicate	 that	 both	 growth	 forms	 equally	activate	CLR	and	TLR	signalling	in	neutrophils.	
Since	ROS	is	crucial	for	NETosis,	we	investigated	the	production	of	ROS	upon	stimulation	with	WT	C.	albicans	hyphae	and	hgc1Δ	yeast.	We	observed	strong	donor	variability	with	varying	ROS	profiles	upon	stimulation	with	hyphae	or	yeast	 respectively	 (Figure	11b)	 (Two	representative	examples	are	 shown).	The	amount	of	ROS	produced	after	stimulation	with	either	growth	form	did	not	correlate	with	the	release	of	NETs.	
These	results	 indicate	that	neither	activation	of	known	antifungal	signalling	pathways	 such	 as	 Syk	 or	 ERK	 signalling,	 nor	 ROS	 levels	 correlate	with	 the	selective	release	of	NETs.	Therefore,	the	regulating	mechanism	of	dectin-1	is	not	driven	by	its	function	as	signalling	receptor.	
2.5.7 Phagocytosis	inhibits	NETosis	by	sequestering	NE	
Phagosome	maturation	regulates	NETosis	
Phagocytic	 receptors	 negatively	 regulated	 NETosis	 and	 inhibition	 of	phagocytosis	 increased	 NET	 release.	 This	 regulation	 was	 independent	 of	receptor	 signalling,	 indicating	 that	 downstream	 processes	 during	phagocytosis	 might	 be	 involved.	 Phagosome	 maturation	 in	 neutrophils	 is	dependent	on	the	 fusion	of	 the	phagosome	with	neutrophil	granules,	a	step	that	 requires	 actin	 polymerisation.	 This	 fusion	 allows	 the	 delivery	 of	antimicrobial	 granule	 content	 to	 the	 phagosome	 for	 intracellular	 killing	(Mollinedo,	 2006;	 Nordenfelt	 and	 Tapper,	 2011).	 We	 tested	 whether	inhibition	 of	 phagosome	 maturation	 was	 important	 for	 the	 regulation	 of	NETosis.	
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Figure	 12	 |	 Blocking	 phagosome	 maturation	 increases	 NETosis.	 (a)	 NET	 release	 by	 human	
peripheral	neutrophils	left	untreated	(Untr)	or	treated	with	1	μM	Bafilomycin	A1	(Baf)	or	2.5	μM	
Nocodazole	(Noc),	left	unstimulated	(−)	or	stimulated	with	hgc1∆	C.	albicans	yeast	(+),	MOI	=	10,	
presented	 as	 SYTOX+	 events	 relative	 to	 total	 neutrophils.	 (b)	 Production	 of	 reactive	 oxygen	
species	(ROS)	by	human	peripheral	neutrophils	 left	untreated	or	treated	with	Bafilomycin	A1	or	
Nocodazole	and	stimulated	with	hgc1∆	C.	albicans	yeast,	MOI	=	10.	LU	=	luminescence	units.	(c)	
NET	release	by	neutrophils	pre-incubated	for	1	h	with	hgc1∆	C.	albicans	yeast	at	an	MOI	of	0,	20,	
40	 or	 80	 and	 then	 left	 unstimulated	 (−)	 or	 stimulated	 with	 C.	 albicans	 hyphae	 (+),	 MOI	 =10,	
presented	 as	 SYTOX+	 events	 relative	 to	 total	 neutrophils.	 (d)	 NET	 release	 by	 neutrophils	 pre-
incubated	for	1	hour	with	0.1	μm	polystyrene	beads	and	then	stimulated	with	C.	albicans	hyphae,	
MOI	=10.	|	Statistics	by	two-way	ANOVA,	followed	by	Sidak’s	multiple	comparison	posttest:	**	p	
≤	0.01,	****	p	≤	0.0001.	Data	are	representative	of	at	least	three	independent	experiments.		
Therefore,	 we	 pre-treated	 neutrophils	 with	 Nocodazole,	 an	 inhibitor	 of	microtubule	 formation,	 or	 with	 Bafilomycin,	 an	 inhibitor	 of	 phagosome	acidification.	 Surprisingly,	 both	 treatments	 led	 to	 induction	 of	 NET	 release	upon	 stimulation	 with	 C.	 albicans	 yeast	 particles,	 which	 did	 not	 trigger	NETosis	 in	 the	 absence	 of	 those	 inhibitors	 (Figure	 12a).	 Importantly,	treatments	 with	 neither	 Bafilomycin	 nor	 Nocodazole	 led	 to	 markedly	
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increased	ROS	production.	Instead,	ROS	were	slightly	reduced	(Figure	12b).	Therefore,	 NETosis	 was	 not	 induced	 by	 increased	 ROS	 production	 due	 to	prolonged	microbe	presence	in	the	phagosome.	
These	 data	 indicated	 that	 phagosome	 maturation	 through	 fusion	 of	neutrophil	 granules	 regulated	 NETosis.	 Since	 inhibition	 of	 phagosome	maturation	 increased	 NETosis,	 we	 tested	 whether	 forcing	 phagocytosis	would	abrogate	NET	release.	
Therefore,	we	pre-treated	neutrophils	with	increasing	amounts	of	C.	albicans	yeast	 particles	 or	 polystyrene	 beads	 and	 subsequently	 re-stimulated	 the	neutrophils	 with	 C.	 albicans	 WT	 hyphae.	 The	 small	 particles	 were	 readily	phagocytosed	by	the	neutrophils	(data	not	shown).	Interestingly,	neutrophils	that	had	phagocytosed	beads	or	yeast	particles	showed	reduced	capacity	 to	respond	 with	 NETosis	 upon	 stimulation	 with	 C.	 albicans	 hyphae.	 The	reduction	 of	 NET	 release	 correlated	 directly	 with	 the	 amount	 of	 yeast	particles	that	were	phagocytosed	before	(Figure	12c	and	d).	
These	 results	 indicate	 that	 NET	 release	 is	 dose-dependently	 linked	 to	 the	number	 of	 particles	 that	 are	 phagocytosed	 and	 the	 phagosomes	 that	 are	formed	in	the	process.	A	high	number	of	phagocytosed	particles	completely	abrogate	 NET	 release	 in	 response	 to	 an	 otherwise	 potent	 NET	 stimulus,	whereas	blocking	of	phagosome	maturation	releases	the	negative	regulation	and	increases	NETosis.	We	present	a	novel	mechanism	in	which	phagocytosis	is	a	direct	negative	regulator	of	NETosis.	
Phagocytosis	sequesters	NE	and	prevents	translocation	to	the	nucleus	
Fusion	of	preferentially	 azurophilic	 granules	during	phagosome	maturation	delivers	 granule	 content,	 such	 as	 NE,	 into	 the	 phagosome.	 During	 NET	release,	 NE	 is	 required	 to	 translocate	 into	 the	 nucleus	 where	 it	 cleaves	histones	 and	 initiates	 the	 decondensation	 of	 chromatin.	 Therefore,	 we	
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investigated	 whether	 NE	 localisation	 in	 stimulated	 neutrophils	 regulated	size-specific	NETosis.	
Upon	 stimulation	 of	 human	 neutrophils	 with	WT	 C.	 albicans	 hyphae	 up	 to	80%	 of	 the	 total	 NE	 translocated	 into	 the	 nucleus	 by	 about	 4	 hours	 post	stimulation	 (Figure	 13a	 and	 b).	 This	 finding	 was	 in	 line	 with	 previous	reports	 (Papayannopoulos,	 2010).	 In	 contrast,	 neutrophils	 that	 were	stimulated	with	hgc1Δ	yeast-locked	C.	albicans	phagocytosed	yeast	particles	and	their	nucleus	was	almost	completely	devoid	of	NE	(Figure	13a	and	b).	
In	 order	 to	 establish	 where	 NE	 was	 localised	 after	 phagocytosis,	 we	stimulated	 human	 neutrophils	 with	 C.	 albicans	 hgc1Δ	 yeast	 particles	 and	subsequently	 stained	 for	 the	markers	 of	 phagosome	maturation	 CD63	 and	p40.	Interestingly,	 in	phagocytosing	neutrophils	NE	was	associated	with	the	phagosome	 rather	 than	 the	 nucleus	 (Figure	13c).	 Furthermore,	 staining	 of	the	C.	albicans	yeast	particles	co-localised	directly	with	phagosomal	stainings	CD63	 and	 p47,	 confirming	 that	 the	 yeast	 particles	 were	 located	 inside	 the	phagosome	(Figure	13d	and	e).	
To	 test	 the	 role	 of	 dectin-1	 in	 NE	 translocation,	we	 stimulated	 neutrophils	with	small	yeast	particles.	 Importantly,	 these	neutrophils	did	not	 form	fully	functional	 phagosomes	 and	 NE	 translocation	 to	 the	 nucleus	 was	 restored	(Figure	13f).	
In	 summary,	 in	phagocytosing	neutrophils	NE	does	not	 translocate	 into	 the	nucleus,	 but	 is	 found	 in	 the	phagosome.	Blocking	phagocytosis	 restores	NE	translocation.	Therefore,	phagocytosis-driven	competition	for	NE	is	the	main	regulator	of	selective	NET	release.	
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Figure	 13	 |	 Phagocytosis	 sequesters	 NE	 and	 prevents	 translocation	 to	 the	 nucleus.	 (a)	
Localization	 of	 NE	 (red)	 and	 MPO	 (green)	 in	 human	 peripheral	 neutrophils	 1	 hour	 after	
stimulation	 with	 C.	 albicans	 hgc1∆	 yeast	 (left)	 or	 WT	 hyphae	 (right),	 assessed	 by	
immunofluorescence	 via	 confocal	microscopy	 of	 an	 optical	 section	 spanning	 the	 centre	 of	 the	
cell.	Arrows	indicate	the	nucleus.	*	=	colocalisation	of	NE	with	MPO.	Bottom	right	(Phase),	phase-
contrast	 microscopy.	 (b)	 Localization	 of	 NE	 to	 the	 nucleus	 in	 naive	 neutrophils	 (N)	 and	 in	
neutrophils	 treated	 as	 in	 (a),	 presented	 as	 nuclear	 NE	 relative	 to	 total	 NE	 per	 cell	 (multiple	
confocal	sections	of	15–20	cells	per	condition).	Statistics	by	two-way	ANOVA,	followed	by	Sidak’s	
multiple	 comparison	 posttest:	 ****	 p	 ≤	 0.0001.	 Error	 bars	 =	 SD,	 standard	 deviation.	 Data	 are	
representative	 of	 three	 independent	 experiments.	 (c)	 Localization	 of	 NE	 (yellow),	 CD63	
(magenta),	 p40	 (cyan)	 to	 the	 phagosome	 (arrows)	 and	 DAPI-stained	 DNA	 (blue)	 in	 human	
peripheral	 neutrophils	 1	 hour	 after	 stimulation	 with	 hgc1∆	 C.	 albicans	 yeast.	 |	 Images	 are	
representative	of	three	independent	experiments.	
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2.5.8 Deregulated	NET	release	promotes	pathology	
Dectin-1	KO	mice	succumb	to	NET-mediated	tissue	damage	
NETosis	is	important	for	antimicrobial	defence	but	has	also	been	implicated	in	host	 tissue	pathology	 (Narasaraju,	2011;	Papayannopoulos,	2011).	 Since,	dectin-1	 deficiency	 and	 reduction	 in	 phagocytosis	 led	 to	 increased	 NET	release,	 we	 investigated	 whether	 this	 de-regulated	 NETosis	 influenced	antifungal	 defence	 or	 immune	 pathology.	 We	 employed	 a	 pulmonary	infection	 model	 with	 a	 high	 dose	 of	 C.	 albicans	 yeast	 particles,	 where	intracellular	defence	mechanisms	would	be	sufficient	to	combat	this	infection	in	WT	mice.	
We	 infected	WT	and	dectin-1-deficient	mice	with	a	high	dose	of	C.	albicans	
hgc1Δ	 yeast-locked	 particles	 and	 observed	 the	 animals	 over	 a	 course	 of	 5	days.	 In	parallel,	we	treated	the	mice	with	an	NE	 inhibitor	(NEi)	 to	prevent	NET	formation	or	the	tissue	repair	factor	amphiregulin	(AREG)	(Figure	14a).	Untreated	 WT	 and	 dectin-1-deficient	 mice	 succumbed	 rapidly	 to	 the	 high	infectious	 load	 and	 died	 by	 day	 2	 post	 infection.	 Surprisingly,	 dectin-1-deficient	mice	treated	with	NEi	were	nearly	completely	rescued.	In	contrast,	WT	mice	 remained	mainly	 unaffected	 by	NEi	 treatment	 and	 succumbed	by	day	3	post	infection.	Treatment	of	the	dectin-1-deficient	mice	with	the	tissue	repair	 factor	AREG	 led	 to	 alleviation	 of	 the	 phenotype	 and	 rescued	 around	50%	of	 the	 infected	animals,	 indicating	that	NETosis	mediated	pathology	 in	these	 animals.	 WT	 mice	 remained	 mainly	 unaffected	 by	 AREG	 treatment	(Figure	14b).	Furthermore,	WT	mice	produced	large	amounts	of	TNFα	in	the		
Figure	13	 (continued)	|	 (d	and	e)	Localization	of	CD63	(green)	 (d)	or	p47	 (green)	 (e)	and	DAPI-
stained	 DNA	 (blue)	 in	 human	 peripheral	 neutrophils	 1	 hour	 after	 stimulation	 with	 hgc1∆	 C.	
albicans	 yeast	 (red).	 Scale	 bars	 (a,c,d	 and	 e)	 =	 5	 μm.	 (f)	 Localization	 of	 NE	 to	 the	 phagosome	
(arrows)	 or	 nucleus	 (*)	 in	 human	 peripheral	 neutrophils	 stimulated	 for	 1	 hour	 with	 hgc1∆	 C.	
albicans	 yeast	 in	 the	 presence	 of	 anti-dectin-1	 blocking	 antibody.	 Stained	 for	 NE	 (red),	 CD63	
(green)	 and	 DNA	 (DAPI;	 blue).	 Scale	 bars	 =	 5	 μm.	 |	 (a	 and	 c	 -	 f)	 Stainings	 courtesy	 of	 Ms	
Aleksandra	Lubojemska.	
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Figure	14	|	Dectin-1	KO	mice	succumb	to	NET-mediated	pathology.	(a)	NET	release	in	 lungs	of	
wild-type	and	dectin-1-deficient	mice	left	untreated	(Untr)	(left	and	middle)	or	treated	with	2.5	
µg/	g	mouse	of	the	NE	inhibitor	(+	NEi,	right),	infected	intratracheally	with	3	×	106	colony	forming	
units	 (CFU)	 hgc1∆	 C.	 albicans	 yeast,	 assessed	 24	 h	 later	 by	 immunofluorescence	 confocal	
microscopy	of	lung	sections	stained	for	DNA	(DAPI;	blue),	citrullinated	histone	H3	(citH3,	red)	and	
MPO	(green).	Scale	bars	=	50	μm.	(b)	Survival	of	C57BL/6	WT	mice	and	dectin-1-deficient	mice	(n	
=	4	per	group)	left	untreated	or	treated	with	2.5	µg/	g	mouse	of	the	NE	inhibitor	(NEi)	or	0.4	µg/	g	
mouse	 of	 amphiregulin	 (AREG),	 infected	 intratracheally	with	 1	 ×	 107	 CFU	 of	hgc1∆	 C.	 albicans	
yeast.	Statistics	by	log-rank	(Mantel-Cox)	test,	followed	by	Tukey’s	multiple	comparison	post	test:	
NS	=	not	significant	p	>	0.05,	*	p	≤	0.01,	**	p	≤	0.001.	
RESULTS	
	
	
121	
lungs.	 This	 pro-inflammatory	 cytokine	 storm	 was	 most	 likely	 caused	 by	septic	shock	in	these	mice	due	to	the	high	dose	of	infectious	material.	Dectin-1	KO	mice	did	not	show	any	signs	of	TNFα	production	 in	the	 lungs	(Figure	
14c).	These	results	are	in	agreement	with	the	previous	findings	that	dectin-1-deficient	mice	are	unable	to	mount	a	sufficient	pro-inflammatory	response	(Taylor,	2007).	Therefore,	dectin-1-deficient	mice	did	not	succumb	to	septic	shock.	Furthermore,	fungal	load	in	the	lung	and	recruitment	of	neutrophils	to	the	infected	lungs	was	comparable	in	WT	and	dectin-1	mice	(Figure	14d	and	
e).	
To	 further	 investigate	 whether	 increased	 NETosis	 caused	 pathology	 in	dectin-1-deficient	 mice,	 we	 analysed	 lung	 histology	 after	 the	 infection.	Interestingly,	 dectin-1-deficient	 mice	 showed	 increased	 tissue	 damage	 as	compared	to	WT	animals.	This	was	indicated	by	haemorrhagic	bleeding	and	fibrin	deposition	 in	 the	 lung.	 Importantly,	 these	pathologic	symptoms	could	be	alleviated	by	inhibiting	NETosis	with	NEi	treatment	(Figure	15a	and	b).	
In	 summary,	 these	 data	 indicate	 that	 NET-regulation	 in	 situations	 where	microbes	 can	 be	 eliminated	 intracellularly	 limits	 NET-mediated	 immune	pathology.	In	mice	lacking	dectin-1,	reduced	phagocytosis	leads	to	increased	NET	 release.	 The	 disruption	 of	 the	 mechanism,	 regulating	 size-dependent	NETosis	 inflicts	damage	to	 the	surrounding	 tissues	and	can	potentially	 lead	to	the	death	of	the	affected	host	(Figure	15c).	
	
Figure	 14	 (continued)	 |	 (c)	 TNFα	 levels	 in	 lung	 sections	 of	 C57BL/6	WT	 and	 dectin-1	 deficient	
mice	 infected	with	 3	 x	 106	 CFU	 of	hgc1∆	C.	 albicans	 yeast	 36	 hours	 post	 infection,	 stained	 by	
immunohistochemistry	with	anti-TNFα	(brown)	and	hematoxylin	(DNA,	blue).	Scale	bars	=	50	μm.	
(d)	C.	albicans	 load	 in	 the	 lung	of	WT	 (C57BL/6)	and	dectin-1	deficient	mice	 infected	with	of	3	
x106	CFU	of	hgc1∆	C.	albicans	yeast	12	hours	post	infection	(n=3).	Statistics	by	unpaired	t	test:	NS	
=	 not	 significant	 p	 >	 0.05.	 (e)	Overview	of	 neutrophil	 infiltration	 in	 lungs	 of	WT	 (C57BL/6)	 and	
dectin-1	 deficient	 mice	 infected	 with	 of	 3	 x	 106	 CFU	 of	 hgc1∆	 C.	 albicans	 yeast.	 Fixation	 and	
staining	of	lung	sections	with	hematoxylin	and	eosin	(HE)	36	hours	post	infection.	Scale	bars	=	1	
mm.	|	Data	are	representative	of	two	independent	experiments.	(a	and	c)	Stainings	courtesy	of	
Dr	Qian	Wang.	
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Figure	15	|	Dectin-1	KO	mice	show	increased	NET-mediated	tissue	damage.	(a)	Quantification	of	
fibrin	deposition	(left)	and	bleeding	(right)	 in	 lungs	of	wild-type	and	dectin-1-deficient	mice	 left	
untreated	(-)	or	treated	with	2.5	µg/	g	mouse	of	the	NE	inhibitor	(NEi)	(+),	infected	with	3	×	106	
colony	 forming	 units	 (CFU)	 of	 hgc1∆	 C.	 albicans	 yeast,	 assessed	 36	 hours	 later.	 Presented	 as	
average	 score	 for	 each	 mouse	 (top)	 or	 percentage	 of	 images	 from	 all	 mice	 with	 each	 score	
(bottom).	 Each	 symbol	 (top)	 represents	 an	 individual	 mouse.	 Statistics	 by	 two-way	 ANOVA	
followed	by	Tukey’s	multiple-comparison	post-test	*	p	<	0.01,	**	p	<	0.001,	***	p	<	0.0001.	Small	
horizontal	lines	indicate	the	mean.	Error	bars	=	SD,	standard	deviation.	(b)	Lungs	of	WT	(C57BL/6)	
and	dectin-1	 deficient	mice	 infected	with	 3	 x	 106	 CFU	of	hgc1∆	C.	 albicans	 yeast.	 Fixation	 and	
staining	of	lung	sections	with	hematoxylin	and	eosin	(HE)	36	hours	post	infection.	Arrows	indicate	
tissue	 damage	 manifested	 in	 fibrin	 deposition	 and	 bleeding.	 Right	 panels	 depict	 higher	
magnification	of	areas	indicated	by	black	dotted	squares.	Scale	bars	=	50	µm	(c)	Graphic	overview	
of	 the	 causes	 of	 pathology	 in	 WT	 (C57BL/6)	 and	 dectin-1-deficient	 mice	 after	 infection	 with	
hgc1∆	C.	albicans	yeast.	|	(a	and	b)	Data	are	representative	of	three	independent	experiments.	
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Taken	 together,	 we	 show	 for	 the	 first	 time	 that	 neutrophil	 antimicrobial	strategies	 are	 regulated.	 While	 large	 microbes	 induce	 NET	 release,	 small	microbes	are	phagocytosed.	Furthermore,	phagocytosis	is	a	master	regulator	of	 NET	 release	 by	 sequestering	 NE	 in	 the	 phagosome	 and	 preventing	translocation	 to	 the	 nucleus,	 a	 crucial	 step	 for	 NETosis.	 We	 show	 that	NETosis	 is	 a	 crucial	 antimicrobial	 strategy,	 selectively	 targeted	 at	 large	microbes.	However,	tight	regulation	of	NETosis	is	crucial	to	prevent	damage	to	the	surrounding	tissues.	
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2.6 Investigation	of	upstream	NET-triggering	mechanisms	
The	 following	 chapter	 contains	 preliminary	 data	 and	 represents	 work	 in	progress.	 The	 state	 of	 the	 experiments	 and	 outlook	 onto	 future	 work	 is	indicated	in	the	respective	sections.	
2.6.1 Background	and	aims	
The	molecular	mechanisms	underlying	NET	release	are	partially	understood	(Metzler,	2014;	Papayannopoulos,	2010).	However,	little	is	known	about	the	initial	activators	of	NET	release.	ROS	triggers	NETosis	(Fuchs,	2007;	Palmer,	2012).	 Furthermore,	 PMA	 directly	 activates	 protein	 kinase	 C	 (PKC)	 and	induces	ROS	and	NETosis	 (Fuchs,	2007).	However,	 these	stimuli	bypass	 the	initial	 activation	 steps	 triggered	 by	 complex	 microbial	 particles.	 It	 is	unknown	which	 steps	 lie	upstream	of	 these	pathways	 and	which	 receptors	activate	them.	It	 is	 likely	that	different	microbes	engage	different	receptors,	leading	 to	 different	 pathways	 that	 finally	 converge	 into	 one	 NETosis	activation	 program.	 This	 concept	 is	 also	 underlined	 by	 the	 fact	 that	 direct	activation	of	PKC	by	PMA	triggers	NETosis	in	60-80%	of	human	neutrophils	
in	vitro,	whereas	only	10-20%	of	neutrophils	release	NETs	upon	stimulation	with	 C.	 albicans	 hyphae.	 These	 findings	 indicate	 that	 microbe-specific	activation	steps	exist.	
That	only	a	specific	percentage	of	neutrophils	undergo	NETosis	suggests	that	there	may	be	subsets	of	neutrophils	 that	respond	differentially	to	microbial	activation.	 These	 neutrophil	 subsets	 could	 differ	 in	 their	 activation	 states.	Since	priming	 leads	 to	 increased	activation	and	a	potentiated	antimicrobial	response	 in	 neutrophils	 (Condliffe,	 1998),	 pre-activation	 could	 be	 required	for	 the	 induction	 of	 the	 NET	 pathway.	 Accordingly,	 provision	 of	 priming	signals	 could	 increase	 the	 percentage	 of	 NET-releasing	 neutrophils.	Interestingly,	a	recent	study	suggests	differences	in	neutrophil	activation	and	response	depending	on	ageing.	Aged	CD62Llo	neutrophils	are	more	activated	and	are	 characterised	by	 increased	NET	 release	 compared	 to	 their	CD62Lhi	
RESULTS	
	
	
125	
counterparts	 (Zhang,	 2015).	 Furthermore,	 neutrophil	 populations	 could	differ	in	their	surface	receptor	expression.	Many	PRRs	involved	in	C.	albicans	recognition	are	known	but	it	is	unclear	whether	these	receptors	are	relevant	for	 NET	 activation.	 Receptor	 expression	 could	 in	 turn	 be	 dependent	 on	priming	and	a	defined	activation	state	of	these	neutrophils.	Priming	with	GM-CSF	has	been	described	to	upregulate	expression	of	TLR2,	TLR4	and	TLR9	in	neutrophils	(Hayashi,	2003;	O'Mahony,	2008).	However,	different	neutrophil	populations	based	on	the	expression	of	PRRs	have	not	been	described	so	far.	
Therefore,	we	asked:	
Does	 priming	 enhance	 the	 capacity	 of	 neutrophils	 to	 respond	 by	 NETosis	upon	stimulation	with	C.	albicans?	
Which	PRRs	 are	 required	 for	C.	 albicans-mediated	 initiation	of	 the	NETosis	pathway?	Which	C.	albicans	ligands	are	necessary	for	NET	induction?	
2.6.2 Priming	of	neutrophils	does	not	influence	NET	release	
Priming	 of	 neutrophils	 with	 GM-CSF	 has	 been	 shown	 to	 increase	 the	neutrophil	fungicidal	activity.	A	study	indicated	that	GM-CSF	produced	by	NK	cells	is	required	for	the	activation	of	neutrophils	and	their	capacity	to	raise	a	sufficient	antifungal	immune	response	(Bar,	2014;	Whitney,	2014).	However,	it	 is	unknown	which	neutrophil	antimicrobial	 strategy	 is	 influenced	by	GM-CSF	priming.	Therefore,	we	 investigated	whether	GM-CSF	had	an	activating	effect,	leading	to	an	increased	percentage	of	NETing	neutrophils.	
We	treated	neutrophils	with	GM-CSF	prior	to	stimulation	with	C.	albicans.	In	our	hands	no	positive	effect	of	GM-CSF	priming	on	the	population	of	NETing	neutrophils	was	observed.	On	the	contrary,	in	some	experiments	NET	release	was	slightly	decreased	(Figure	16a),	whereas	in	others	no	difference	to	the	un-primed	 controls	 was	 seen	 (data	 not	 shown).	 Interestingly,	 it	 has	 been	shown	 that	 GM-CSF	 upregulates	 expression	 of	 dectin-1	 in	 macrophages	
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(Willment,	 2003),	 suggesting	 that	 decreased	 NET	 release	 could	 be	 a	consequence	of	increased	phagocytosis.	
During	 infection,	 IL-8	 mediates	 the	 release	 of	 neutrophils	 from	 the	 bone	marrow	 into	 the	 tissues.	 Through	 priming	 with	 IL-8	 neutrophils	 adopt	 an	activated	 phenotype	 that	 equips	 them	 for	 antimicrobial	 action	 (Roberts,	1993;	Zeilhofer	and	Schorr,	2000).	Therefore,	we	 investigated	whether	 IL-8	would	increase	NETosis	upon	stimulation	with	C.	albicans.	However,	no	effect	of	 IL-8	priming	was	 seen	upon	stimulation	with	C.	albicans	 as	 compared	 to	untreated	controls	(Figure	16b).	
	
	
 
Figure	16	|	Priming	of	neutrophils	does	not	influence	NET	release.	(a	-	c)	NET	release	by	human	
peripheral	neutrophils	pre-treated	with	(a)	indicated	amounts	of	GM-CSF,	(b)	5	ng/ml	IL-8	or	(c)	
500	U/ml	IFN-α	(left)	or	INF-β	(right)	prior	to	stimulation	with	C.	albicans	wild-type	hyphae.	NET	
release	presented	as	SYTOX+	events	relative	to	total	neutrophils.	|	Statistics	by	one-way	ANOVA	
followed	by	Dunnett’s	multiple	comparison	post-test.	NS	=	not	significant	p	>	0.05,	*p	≤	0.05,	**	
p	≤	0.01	and	***	p	≤	0.001.	Data	are	representative	of	at	least	three	independent	experiments.		
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It	has	been	reported	that	priming	neutrophils	with	INF-α	 leads	to	increased	NET	release	upon	subsequent	complement	component	5a	(C5a)	stimulation	(Martinelli,	2004).	In	SLE,	NETs	activate	pDCs	to	secrete	IFN-α,	which	in	turn	triggers	 further	 NETosis	 (Garcia-Romo,	 2011).	 Interestingly,	 in	 our	 hands	type	 I	 interferon	did	not	yield	 increased	numbers	of	NETing	neutrophils	as	compared	to	untreated	controls	(Figure	16c). 
Overall,	priming	of	neutrophils	did	not	have	a	 specific	effect	on	C.	albicans-induced	NET	release.		
2.6.3 Neutrophil	receptors	in	NET	release	
TLR	signalling	in	C.	albicans-induced	NETosis	
A	 variety	 of	 PRRs	 recognise	 C.	 albicans,	 including	 CLRs	 and	 TLRs	 (Netea,	2015a;	Romani,	2011).	(See	introduction	Innate	anti-fungal	immunity	on	page	77.)	However,	 it	 is	unknown	whether	 these	receptors	are	required	 to	 for	C.	
albicans	 to	 trigger	 NETosis.	 We	 found	 that	 phagocytic	 receptors	 such	 as	dectin-1,	CR3	and	FcγR	downregulate	NETosis,	rather	than	being	involved	in	the	 initiating	 signalling	 events	 (Branzk,	 2014)	 (See	 results	 Figure	 9.)	Therefore,	 we	 screened	 most	 TLRs	 known	 to	 be	 involved	 in	 C.	 albicans	signalling,	using	blocking	antibodies.	
Blocking	TLR1,	TLR2,	TLR4	or	TLR6	 individually	or	 in	 combination	yielded	no	 significant	 decrease	 in	 NET	 release	 upon	 stimulation	 with	 C.	 albicans.	Similarly,	blocking	the	TLR4	co-receptor	CD14	alone	or	in	combination	with	TLR4	had	no	effect	on	NET	release	(Figure	17a).	TLR4	blockade	alone	was	more	variable	depending	on	the	donor	(data	not	shown),	but	overall	did	not	exhibit	a	significant	effect	on	NET	release.	
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Figure	17	|	TLR	signalling	 in	C.	albicans-induced	NETosis.	 (a)	NET	release	by	human	peripheral	
neutrophils	 pre-treated	 with	 10	 µg/ml	 of	 the	 indicated	 anti-TLR	 blocking	 antibodies	 prior	 to	
stimulation	 with	 C.	 albicans	 pre-formed	 wild-type	 hyphae.	 NET	 release	 presented	 as	 SYTOX+	
events	relative	to	total	neutrophils.	Statistics	by	one-way	ANOVA	followed	by	Dunnett’s	multiple	
comparison	 post-test.	 NS	 =	 not	 significant	 p	 >	 0.05.	 Data	 are	 representative	 of	 at	 least	 three	
independent	experiments.	(b)	NET	release	in	the	lungs	of	wild-type	(C57BL/6)	or	MyD88	KO	mice	
24	hours	after	intratracheal	infection	with	1	×	105	colony-forming	units	(CFU)	of	C.	albicans	pre-
formed	wild-type	hyphae,	assessed	by	 immunofluorescence	microscopy	of	 citrullinated	histone	
H3	(citH3;	red),	MPO	(green)	and	DNA	(DAPI,	blue).	Representative	images	of	two	animals	(I.	and	
II.).	Scale	bars	=	20	μm.			
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In	 these	 experiments,	 results	were	 variable	 between	different	 repeats	with	differences	 in	 observed	NETosis	 depending	 on	 the	neutrophil	 donors	 (data	not	shown).	Donor	variability	is	a	problem	in	this	type	of	experiments	since	heterogeneity	 in	 receptor	 expression	 between	 individuals	 is	 likely.	Interestingly,	 we	 also	 observed	 differences	 between	 the	 same	 donors	 on	different	dates	of	blood	donation	(data	not	shown).	This	could	potentially	be	explained	by	different	immune	states	within	individual	donors	due	to	illness	or	 life	 style-related	 factors.	 Furthermore,	 although	 the	 blocking	 specificity	and	 efficiency	 of	 the	 antibodies	 had	 been	 determined	 in	 previous	 studies,	they	remain	to	be	validated	in	this	experimental	set-up.	
MyD88	is	the	main	signalling	adaptor	for	TLRs	in	neutrophils.	Therefore,	we	tested	 whether	 MyD88	 deficiency	 influenced	 NET	 release.	 We	 infected	MyD88-deficient	 mice	 with	 C.	 albicans	 pre-formed	 hyphae	 intra-tracheally.	MyD88	 KO	 mice	 exhibited	 a	 NET	 response	 similar	 to	 the	 WT	 controls,	 as	indicated	by	comparable	levels	of	citrullinated	histone	3	(citH3)	in	the	lungs	of	 both	 groups	 of	 animals	 (Figure	 17b).	 Therefore,	 MyD88-mediated	signalling	is	not	involved	in	triggering	NET	release	upon	stimulation	with	C.	
albicans	in	mice.	
Kinase	signalling	involved	in	C.	albicans-induced	NETosis	
Different	 signalling	 pathways	 are	 involved	 in	 C.	 albicans	 recognition,	including	CLR	signalling	via	Syk	(Netea,	2015a).	Furthermore,	signalling	via	the	Raf-MEK-ERK	pathway	was	described	in	PMA-stimulated	NET	formation	(Hakkim,	2011).	Therefore,	we	used	inhibitors	of	different	candidate	kinases	to	block	pathways	that	were	involved	in	fungal	recognition	or	NET	formation.	
We	 obtained	 varying	 results	 depending	 on	 the	 neutrophil	 donor	 similar	 to	the	 receptor	blocking	approach	 (data	not	 shown).	However,	 taken	 together	neither	 inhibition	 of	 Syk,	 PI3K,	 PKC,	 MEK	 nor	 Jak	 influenced	 NET	 release	significantly.	 Using	 this	 system,	 we	 could	 not	 identify	 any	 kinase	 directly	involved	in	triggering	NETosis	upon	stimulation	with	C.	albicans	(Figure	18).		
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Figure	 18	 |	 Kinase	 signalling	 in	 C.	 albicans-induced	 NET	 release.	 NET	 release	 by	 human	
peripheral	neutrophils	pre-treated	with	 inhibitors	of	 the	kinases	Syk	(BAY	61-3606;	1	µM),	PI3K	
(LY294002;	 2	 µM),	 PKC	 (Gö	 7874;	 1	 µM),	MEK	 (PD184352;	 2	 µM)	 or	 Jak	 (Ruxolitinib;	 0.5	 µM).	
prior	 to	 stimulation	 with	 C.	 albicans	 pre-formed	 wild-type	 hyphae.	 NET	 release	 presented	 as	
SYTOX+	events	relative	to	total	neutrophils.	Statistics	by	one-way	ANOVA	followed	by	Dunnett’s	
multiple	comparison	post-test.	NS	=	not	significant	p	>	0.05.	Data	are	representative	of	at	 least	
three	independent	experiments.	
The	capacity	of	C.	albicans	cell	wall	mutants	to	trigger	NETosis	in	vitro	
The	C.	 albicans	 cell	wall	 is	 a	 complex	 structure	 build	 up	 of	 different	 layers	(Netea,	2008).	The	architecture	of	the	cell	wall	is	established	by	a	variety	of	fungal	enzymes,	including	mannosylases	that	attach	mannose	residues	to	cell	wall	proteins	 in	a	glycosylation	reaction.	Modified	cell	wall	proteins	are	the	main	 PAMPs	 recognised	 by	 the	 innate	 PRRs.	 Therefore,	 we	 investigated	whether	 distinct	 cell	 wall	 components	 were	 specifically	 required	 for	neutrophil	recognition	and	triggering	of	NET	release.	
We	 employed	C.	 albicans	 strains	with	mutations	 in	 different	mannosylases	(Netea,	 2006).	 The	 mutants	 NGY	 357	 and	 NGY	 600	 were	 deficient	 in	 the	enzymes	 och1	 and	 [mnn2]6	 respectively.	 These	 enzymes	were	 responsible	for	 attaching	 mannose	 residues	 to	 the	 cell	 wall	 proteins	 in	 an	 N-	 linked	manner.	The	mutant	NGY	337	was	deficient	in	the	enzymes	mnt1	and	mnt2,	which	 were	 responsible	 for	 O-linked	 mannosylation.	 NGY	 355	 and	 CDH15	carried	mutations	in	enzymes	responsible	for	production	of	phosphomannan.	We	tested	these	mutants	for	their	capacity	to	induce	NET	release	in	vitro.	
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Figure	19	|	Capacity	of	C.	albicans	cell	wall	mutants	 to	 trigger	NETosis	 in	vitro.	 (a)	Release	of	
NETs	by	human	peripheral	neutrophils	stimulated	with	wild-type	(WT)	or	mutant	C.	albicans	pre-
formed	hyphae,	MOI	=	10.	Extracellular	DNA	was	stained	with	SYTOX	4	hours	after	 stimulation	
(right).	 Brightfield	microscopy	of	 the	neutrophils	 and	C.	 albicans	 (left).	 Scale	 bars	 =	 50	µm.	 (b)	
Quantification	of	NET	 release	 in	 (a)	 represented	as	%NETs	of	 total	 SYTOX+	events.	 Statistics	by	
one-way	 ANOVA	 followed	 by	 Dunnett’s	 multiple	 comparison	 post-test.	 Where	 not	 otherwise	
indicated:	 not	 significant	 (NS)	 p	 >	 0.05;	 otherwise	 *p	 ≤	 0.05	 and	**	p	 ≤	 0.01	 compared	 to	WT	
(SC5314).	Error	bars	=	SD,	standard	deviation.	(c)	Production	of	reactive	oxygen	species	(ROS)	by	
human	peripheral	neutrophils	stimulated	with	WT	or	mutant	C.	albicans	pre-formed	hyphae,	MOI	
=	 10.	 LU,	 luminescence	 units.	 |	 Data	 are	 representative	 of	 at	 least	 three	 independent	
experiments.		
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We	stimulated	human	neutrophils	with	the	hyphae	of	all	C.	albicans	cell	wall	mutant	strains.	Interestingly,	hyphae	of	the	NGY	357,	NGY	600	and	NGY	337	mutant	 strains	 showed	 greatly	 decreased	 NET	 release	 compared	 to	 WT	(SC5314)	C.	 albicans	 hyphae	 and	 the	 control	 strains	 NGY	 152	 and	 CAF2-1.	NGY	 335	 and	 CDH15	mutants	 did	 not	 show	 impaired	NET	 release	 (Figure	
19a	and	b).	
Since	reactive	oxygen	species	are	a	hallmark	of	NET	release,	we	investigated	the	 capacity	 of	 the	 “NET-deficient”	 mutants	 to	 induce	 ROS	 production	 in	neutrophils.	Interestingly,	neutrophils	stimulated	with	these	mutants	showed	significantly	decreased	levels	of	ROS	production	(Figure	19c).	
Taken	together,	these	results	indicate	that	N-	and	O-linked	mannosylation	on	
C.	albicans	is	required	for	sufficient	activation	of	NETosis	in	vitro.	
The	capacity	of	C.	albicans	cell	wall	mutants	to	trigger	NETosis	in	vivo	
We	identified	three	C.	albicans	cell	wall	mutants	that	had	lost	their	capacity	to	trigger	NET	release	in	human	neutrophils	in	vitro.	Next,	we	investigated	their	capacity	to	induce	NETosis	in	a	lung	infection	model	in	mouse.	
Surprisingly,	 the	mutants	NGY	 357	 and	NGY	 337	 that	 lacked	NET-inducing	capacity	 in	 vitro	 induced	 NET	 release	 in	 the	 lungs	 of	 infected	 mice.	 NET	induction	of	NGY	357	was	comparable	 to	WT	C.	albicans,	whereas	NGY	337	NET	induction	was	only	slightly	reduced.	Interestingly,	the	phosphomannan-deficient	 strain	 CDH15	 that	 had	 induced	 NETosis	 in	 human	 neutrophils	 in	
vitro,	did	not	trigger	NET	release	in	the	 in	vivo	 infection.	This	was	indicated	by	greatly	reduced	levels	of	citrullinated	histone	3	in	the	lung	(Figure	20).	
Differences	in	cell	surface	receptors	between	mouse	and	human	neutrophils	may	 account	 for	 the	 difference	 in	 the	 response	 towards	 these	 C.	 albicans	strains.	 Otherwise,	 neutrophils	 derived	 from	 peripheral	 blood	may	 behave	differently	 to	 alveolar	 neutrophils.	 Furthermore,	 effects	 of	 other	 cell	 types			
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Figure	20	|	Capacity	of	C.	albicans	cell	wall	mutants	to	trigger	NETosis	in	vivo.	NET	release	in	the	
lungs	 of	 wild-type	 (C57BL/6)	 mice	 24	 hours	 after	 intratracheal	 infection	 with	 1	 ×	 105	 colony-
forming	 units	 (CFU)	 of	 WT	 and	 mutant	 C.	 albicans	 pre-formed	 hyphae,	 assessed	 by	
immunofluorescence	microscopy	of	citrullinated	histone	H3	(citH3;	red),	MPO	(green)	and	DAPI-
stained	DNA	(blue).	Representative	images	of	three	animals	(01-03).	Scale	bars	=	50	μm.		
that	are	provided	in	the	tissue	environment	during	in	vivo	infection	might	be	lacking	 in	 vitro.	 However,	 we	 were	 primarily	 interested	 in	 neutrophil	intrinsic	 effects	 and	will	 not	 further	 investigate	 the	 interactions	with	 other	cell	types.	
Role	of	TLR4	and	MR	in	C.	albicans-mediated	NET	induction	
Our	 results	 indicated	 that	 O-	 as	 well	 as	 N-linked	 glycosylation	 of	 the	 C.	
albicans	 cell	 wall	 was	 required	 for	 sufficient	 induction	 of	 NET	 release.	 C.	
albicans	 mutants	 lacking	 these	 modifications	 failed	 to	 induce	 NETosis.	Interestingly,	 a	 recent	 study	 indicated	 that	 both	 N-	 and	 O-linked	
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glycosylation	on	the	C.	albicans	cell	wall	were	necessary	to	trigger	a	sufficient	pro-inflammatory	 immune	 response	 in	 macrophages.	 Furthermore,	 in	macrophages	 TLR4	 and	 the	 mannose	 receptor	 (MR)	 were	 identified	 to	 be	responsible	 for	 the	 recognition	 of	 O-	 and	 N-linked	 mannans	 respectively	(Netea,	2006).	Therefore,	we	investigated	the	importance	of	TLR4	and	MR	for	NET	release,	using	blocking	antibodies.	
Blocking	TLR4	or	MR	individually	led	to	a	marked	decrease	in	NET	induction	upon	 stimulation	 with	 C.	 albicans	 WT	 in	 some	 experiments.	 NETosis	 was	further	decreased	when	TLR4	and	MR	were	blocked	in	combination	(Figure	
21a).	 Blocking	 TLR4	 and	MR	did	 not	 have	 any	 effect	 on	NET	 release	 upon	stimulation	with	the	C.	albicans	mutants	NGY	337	and	NGY	357,	deficient	in	O-	and	N-linked	glycosylation	respectively	 (Figure	21a).	 Importantly,	 these	results	were	difficult	to	reproduce	using	neutrophils	obtained	from	donors	at	different	 times	 (Figure	 17a	 and	 data	 not	 shown)	 and	 these	 preliminary	experiments	need	further	verification.	
Next,	 we	 tested	 whether	 signalling	 via	 MR	 or	 TLR4	 was	 required	 for	 NET	induction.	Therefore,	we	used	saturating	amounts	of	soluble	mannan	and	LPS	in	 competitive	 blocking	 experiments.	 Indeed,	 pre-incubation	 of	 neutrophils	with	 high	 concentrations	 of	 LPS	 and	 Mannan	 decreased	 NETosis	 upon	stimulation	 with	 WT	 C.	 albicans	 hyphae	 in	 a	 dose-dependent	 manner	compared	 to	 unblocked	 neutrophils	 (Figure	 21b).	 Again,	 due	 to	 donor	variability	that	was	observed	between	experiments	(data	not	shown),	 these	experiments	need	further	verification.	
Next,	 we	 investigated	 whether	 MR	 and	 TLR4	 were	 required	 to	 trigger	production	 of	 ROS.	 Interestingly,	 C.	 albicans-induced	 ROS	 production	 was	decreased	 in	 the	 presence	 of	 anti-MR	 and	 anti-TLR4	 blocking	 antibodies	(Figure	21c).	Furthermore,	competition	with	high	doses	of	Mannan	and	LPS	decreased	ROS	production	upon	stimulation	with	C.	albicans	hyphae	(Figure	
21d).	
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Figure	 21	 |	 Role	 of	 TLR4	 and	MR	 in	C.	 albicans-mediated	NETosis.	 (a)	NET	 release	 by	 human	
peripheral	neutrophils	pre-treated	with	10	µg/ml	anti-TLR4	and	anti-MR	blocking	antibodies	prior	
to	stimulation	with	wild	type	or	mutant	C.	albicans	pre-formed	hyphae.	NET	release	presented	as	
%NETs	 of	 total	 SYTOX+	 events	 (left)	 and	 SYTOX+	 events	 relative	 to	 total	 neutrophils	 (right).	 (b)	
NET	 release	by	human	peripheral	 neutrophils	 pre-treated	with	 indicated	 concentrations	of	 LPS	
and	 mannan,	 left	 unstimulated	 (Unst)	 or	 stimulated	 with	 C.	 albicans	 pre-formed	 wild-type	
hyphae.	(c)	and	(d)	Production	of	reactive	oxygen	species	(ROS)	by	human	peripheral	neutrophils	
pre-treated	with	10	µg/ml	anti-TLR4	and	anti-MR	blocking	antibodies	(c)	or	pre-treated	with	100	
µg/ml	LPS	and	1000	µg/ml	mannan	prior	to	stimulation	with	WT	C.	albicans	pre-formed	hyphae.	
LU,	luminescence	units.	|	MOI	=	10.	Statistics	by	one-way	ANOVA	followed	by	Dunnett’s	multiple	
comparison	post-test.	Where	not	otherwise	indicated:	not	significant	(NS)	p	>	0.05;	otherwise	*p	
≤	0.05,	****	p	≤	0.0001.	Data	are	representative	of	at	least	three	independent	experiments.	Error	
bars	=	SD,	standard	deviation.		
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These	preliminary	data	suggest	that	MR	and	TLR4	might	play	a	role	in	the	C.	
albicans-mediated	 onset	 of	 NETosis.	 Notably,	 these	 results	 need	 further	careful	validation.	Furthermore,	 it	 is	not	known	which	 ligand	on	C.	albicans	would	be	recognised	by	TLR4.	Even	though	there	are	descriptions	of	 fungal	lipopolysaccharide	 (Cheng,	 2005),	 most	 fungi,	 including	 C.	 albicans	 do	 not	contain	LPS.	Furthermore,	previous	studies	claiming	that	fungi	activate	TLR4	(Meier,	2003;	Netea,	2003;	Tada,	2002)	need	to	be	interpreted	with	caution.	Possible	 contamination	 with	 the	 ubiquitous	 bacterial	 LPS	 in	 these	 studies	cannot	be	completely	excluded.	
Taken	 together	 these	 data	 show	 that	N-	 and	O-	 linked	mannosylation	 of	C.	
albicans	 cell	 wall	 proteins	 is	 required	 for	 the	 activation	 of	 the	 NETosis	pathway.	 Since	 previous	 studies	 have	 linked	 MR	 and	 TLR4	 to	 C.	 albicans	recognition,	our	findings	may	indicate	that	MR	and	TLR4	are	responsible	for	the	recognition	of	 these	glycosylated	structures	on	C.	albicans	and	required	for	NET	induction.	However,	the	results	need	to	be	validated	carefully	since	great	donor	variation	between	the	experiment	occurred.	
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Neutrophils	 control	 efficiently	 a	 large	 variety	 of	 microbes.	 However,	 until	now	 they	 were	 thought	 to	 carry	 out	 a	 single	 defence	 program	 with	 little	capacity	to	adapt.	It	was	unknown	whether	neutrophils	were	able	to	regulate	their	 antimicrobial	 strategies	 and	 selectively	 target	 individual	 pathogens.	Strikingly,	 in	this	study	we	found	that	neutrophils	are	able	to	regulate	their	antimicrobial	strategies	and	fine-tune	their	response	according	to	the	type	of	microbe	they	encounter.	We	uncovered	a	novel	mechanism	that	regulates	the	release	of	NETs	by	allowing	neutrophils	to	sense	the	size	of	a	microbe	based	on	 their	 capacity	 to	 phagocytose	 the	 particle.	 We	 show	 that	 phagocytic	receptors	 such	 as	 dectin-1	 are	 important	 for	 sensing	 and	 regulating	 the	immune	response.	
Our	data	demonstrate	 the	 importance	of	microbe	size	 in	modulating	 innate	immune	 effector	 strategies.	 Previous	 findings	 show	 that	 immune	 receptors	can	 discriminate	 between	 soluble	 and	 particulate	 ligands	 and	 are	 able	 to	trigger	 varied	 responses	 accordingly.	 Innate	 immune	 cells	 such	 as	macrophages	 and	 neutrophils	 sense	 β-glucan	 through	 dectin-1	 and	 can	discriminate	 whether	 receptor	 activation	 occurred	 in	 the	 context	 of	 a	particulate	 microbe	 or	 by	 soluble	 β-glucan	 shed	 from	 distant	 microbes	(Goodridge,	 2011).	 This	 discrimination	 is	 important	 for	 the	 initiation	 of	 an	adequate	 immune	 response,	 which	 eliminates	 microbes	 locally	 while	preventing	unnecessary	 inflammatory	 responses.	 In	 this	 context	particulate	
β-glucan	 cross-links	 dectin-1	 in	 synapse-like	 structures	 and	 drives	 the	exclusion	 of	 regulatory	 tyrosine	 phosphatases,	which	 initiates	 downstream	Syk	signalling.	Soluble	β-glucan	fails	to	exclude	the	inhibitory	phosphatases,	leading	to	suppression	of	dectin-1	signalling.	Furthermore,	in	dendritic	cells	frustrated	 phagocytosis	 prolongs	 dectin-1-signalling	 and	 increases	 kinase	activation,	 leading	 to	 elevated	 levels	 of	 pro-inflammatory	 cytokines	 in	 vitro	(Hernanz-Falcón,	 2009).	 Another	 study	 suggests	 that	 C.	 albicans	 yeast-mediated	dectin-1	ligation	on	DCs	and	subsequent	release	of	IL-6	leads	to	the	induction	 of	 a	 protective	 Th17	 response	 in	 the	 skin	 (Kashem,	 2015a).	 In	contrast,	invasive	C.	albicans	hyphae	induce	a	Th1	response,	due	to	their	lack	
DISCUSSION	
	
	 	
140	
of	β-glucan	exposure	and	failure	to	activate	dectin-1.	These	findings	indicate	a	regulatory	function	of	dectin-1	signalling	in	DCs.		
In	our	results	we	did	not	observe	significant	differences	in	kinase	activation	in	 response	 to	 particles	 of	 different	 size.	 Phosphorylation	 of	 Syk	 and	 ERK	kinases	was	prominent	 in	 response	 to	 small	 yeast	 and	 large	hyphae.	These	results	 show	 that	 that	 exclusion	 of	 regulatory	 phosphatases	 or	 prolonged	dectin-1	 signalling	 does	 not	 play	 a	 role	 in	 regulating	 the	 antimicrobial	response	towards	microbes	of	varying	size,	including	the	different	C.	albicans	growth	forms,	in	neutrophils.	
	
	
 
Figure	 22	 |	 Phagocytosis	 negatively	 regulates	NETosis.	Phagocytosed	 yeast	 particles	 drive	 the	
translocation	of	NE	to	the	phagosome	via	fusion	with	azurophilic	granules,	sequestering	NE	away	
from	the	nucleus.	In	contrast,	during	the	response	to	hyphae	in	the	absence	of	a	phagosome,	NE	
translocates	 from	 azurophilic	 granules	 to	 the	 nucleus,	 processing	 histones	 to	 drive	 chromatin	
decondensation.	 By	 inhibiting	 NETosis,	 phagocytosis	 prevents	 tissue	 damage	 caused	 by	
uncontrolled	NET	release.		
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In	contrast,	we	show	that	selective	NET	release	is	based	on	the	competition	between	 phagocytosis	 and	 NETosis	 for	 the	 availability	 of	 NE	 (Figure	 22).	Phagocytosis	 is	 a	 rapid	 event	 in	 neutrophils,	 leading	 to	 uptake	 of	 particles	and	 formation	 of	 phagosomes	 within	 minutes.	 Phagosome	 maturation	 in	neutrophils	 requires	 the	 fusion	 of	 the	 phagocytic	 vacuole	 with	 granules,	depositing	granule	content	in	the	phagosome.	The	fusion	step	sequesters	NE	in	 the	 phagosome	 and	 depletes	 the	 general	 cellular	 pool	 of	 this	 molecule.	However,	translocation	of	NE	into	the	nucleus	is	an	absolute	requirement	for	NETosis.	 NE	 processes	 histones	 to	 decondense	 chromatin,	 leading	 to	 NET	release.	Here	we	show	 that	phagocytosis	 is	a	negative	 regulator	of	NETosis	by	 depleting	 the	 cellular	NE	 pool	 and	 preventing	NE	 translocation	 into	 the	nucleus.	Inhibition	of	phagocytosis	by	physical	prevention	of	particle	uptake	via	a	modified	transwell	or	by	blocking	of	the	phagocytic	activity	of	dectin-1	leads	 to	 the	 release	 of	 the	 negative	 regulation	 and	 increase	 in	 NETosis.	Increasing	numbers	of	phagocytosed	beads,	leading	to	increasing	numbers	of	regulatory	 phagosomes	 caused	 a	 dose-dependent	 decrease	 of	 NET	 release	upon	 stimulation	 with	 C.	 albicans	 hyphae.	 These	 findings	 indicate	 that	prolonged	 dectin-1	 signalling	 through	 frustrated	 phagocytosis	 alone	 is	 not	sufficient	to	trigger	NETosis.	Instead,	NET	release	is	regulated	by	the	fate	of	NE.	 In	 the	 case	 of	 undisturbed	NE	 translocation,	 the	 nucleus	 is	 driven	 into	chromatin	 decondensation,	 entirely	 independent	 of	 upstream	 dectin-1	signalling.	
Our	findings	suggest	that	if	a	microbe	is	small	enough	to	be	taken	up,	it	can	be	controlled	intracellularly	in	the	phagosome.	However,	if	phagocytosis	fails,	an	 extracellular	 strategy	 needs	 to	 be	 in	 place	 to	 prevent	 outgrowth	 and	dissemination	of	the	microbe	and	NETosis	is	triggered.	Our	study	reveals	that	failure	to	trigger	NET	release	upon	encounter	with	large	microbes	increases	susceptibility	 and	 impairs	 clearance	 of	 infection.	 Patients	 with	 CGD	 suffer	from	 recurrent	 bacterial	 and	 fungal	 infections.	 Previous	 studies	 show	 that	reconstitution	of	NADPH	oxidase	activity	and	ROS	production	through	gene	therapy	 results	 in	 resolution	 of	 fungal	 infections	 in	 these	 patients	 and	
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restoration	of	NETosis	in	vitro.	However,	since	CGD	patients	are	also	deficient	in	 phagocytosis	 it	 is	 unclear	 which	 contribution	 NET	 release	 had	 in	 the	clearance	 of	 these	 infections	 (Bianchi,	 2009).	 In	 contrast,	 patients	with	 full	MPO	 deficiency	 are	 mainly	 susceptible	 to	 fungal	 infections	 and	 in	 vitro	experiments	show	that	neutrophils	from	MPO-deficient	patients	fail	to	form	NETs	(Metzler,	2011).	Studies	indicate	that	the	group	A	Streptococcus	(GAS)	DNase	Sda1	degrades	NETs,	representing	an	immune	evasion	strategy.	Sda1-deficient	 GAS	 mutants	 fail	 to	 degrade	 NETs	 and	 are	 less	 virulent	 in	 vivo	(Buchanan,	2006).	However,	since	Sda1	also	degrades	biofilm	formation,	the	importance	of	NETs	in	clearing	infection	cannot	be	determined	entirely	with	these	susceptible	microbes.	In	contrast,	our	experiments,	using	MPO-KO	mice	allowed	 us	 to	 directly	 compare	 infections	 in	 NET-deficient	 with	 NET-competent	mice	 in	vivo.	 In	combination	with	NET-inducing	or	non-inducing	microbes	 such	 as	 C.	 albicans	 hyphae	 and	 yeast,	 respectively,	 this	experimental	set-up	provided	us	with	a	strong	tool	to	dissect	the	importance	of	NET	release	for	antifungal	defence	in	vivo.	Here	we	show	for	the	first	time	directly	that	NETosis	is	crucial	for	protection	against	large	microbes,	as	NET-deficient	mice	succumb	to	 fungal	 infection	with	 large	hyphae.	These	results	demonstrate	 that	 selective	 NETosis	 is	 required	 for	 effective	 antifungal	immunity.	
We	 demonstrate	 that	 NETosis	 is	 an	 extracellular	 antimicrobial	 strategy	selectively	 targeted	 at	 large	 microbes.	 However,	 there	 is	 a	 vast	 literature	describing	 NET	 release	 upon	 stimulation	 with	 small	 bacterial	 stimuli.	 In	many	 instances	 different	 approaches	 in	 NET	 detection	 might	 account	 for	seemingly	conflicting	data.	For	 instance,	we	did	not	observe	NET	release	 in	response	 to	 various	 bacteria	 in	 vitro	 or	 in	 vivo.	 However,	 bacteria	 have	developed	 various	 immune	 evasion	 strategies	 that	 include	 prevention	 of	phagocytosis,	 phagosomal	 escape	 and	 degradation	 of	 NETs.	 The	 regulatory	mechanism	 we	 uncovered	 here	 might	 ensure	 that	 NETs	 are	 released	 in	response	to	virulent	small	microbes	that	disrupt	phagocytosis.	For	example,	phagosome	lysis	would	liberate	NE	to	translocate	to	the	nucleus	and	promote	
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NET	 formation.	 Alternatively,	 we	 demonstrate	 that	 Mycobacterium	 bovis	bacillus	 Calmette-Guérin	 (BCG)	 forms	 large	 aggregates,	 which	 cannot	 be	taken	up	via	phagocytosis	 induce	NETosis,	whereas	single	BCG	bacteria	are	phagocytosed	 and	 do	 not	 trigger	 NET	 release.	 Hence,	 sensing	 bacterial	aggregation	to	release	NETs	might	be	important	in	controlling	large	bacterial	aggregates	 and	 critical	 in	 defence	 against	 biofilms	 and	 abscess	 formation.	Interestingly,	 BCG	 is	 able	 to	 disrupt	 phagosome	 maturation,	 but	 this	mechanism	 was	 not	 relevant	 in	 driving	 NETosis	 since	 the	 small,	phagocytosed	 bacteria	 failed	 to	 induce	 NETs	 in	 our	 experiments.	 Yet,	 NET	release	 in	 response	 to	 microbial	 interference	 with	 phagosome	 maturation	might	 be	 relevant	 in	 response	 to	 other	 bacteria.	 Previous	 studies	 describe	that	Neisseria	 gonorrhoea	 evades	 intracellular	 killing	 by	 delaying	 fusion	 of	the	 phagosome	with	 primary	 and	 azurophilic	 granules	 (Johnson	 and	 Criss,	2013).	 This	 delayed	 fusion	 opens	 up	 a	 time	 window	 in	 which	 sufficient	amounts	 of	 NE	 could	 translocate	 to	 the	 nucleus	 to	 induce	 NETosis.	Accordingly,	N.	gonorrhoea	has	been	shown	to	induce	NETs	(Juneau,	2015b).	Indirect	evidence	of	phagocytic	regulation	of	NET	release	is	also	provided	by	different	 strains	 of	 the	 gingival	 bacterium	 Porphyromonas	 gingivalis	 that	trigger	 exclusively	 either	 phagocytosis	 or	 NETosis	 dependent	 on	 the	presence	 or	 absence	 of	 the	 virulence	 factor	 gingipain	 respectively	(Jayaprakash,	 2015).	 Whether	 NETosis	 has	 evolved	 as	 a	 back-up	 immune	strategy	 to	 capture	 small	 microbes	 that	 evade	 the	 first	 line	 of	 phagocytic	killing	 or	whether	 it	 is	 a	microbial	 immune	 evasion	 strategy,	 employed	 by	bacteria	 to	 deplete	 neutrophils	 and	 other	 immune	 cells	 (Thammavongsa,	2013)	 is	not	 clear.	 In	order	 to	 answer	 this	question	 it	 needs	 to	be	 clarified	whether	NETs	 are	 effective	 in	 controlling	 bacteria.	 Importantly,	 a	 non-lytic	form	 of	 NETosis	 that	 leads	 to	 live	 cytoplasts	 that	 are	 able	 to	 migrate	 and	phagocytose	 (Pilsczek,	 2010;	 Yipp,	 2012)	 adds	 an	 additional	 layer	 of	complexity	to	this	question.	
Selective	 employment	 of	 the	neutrophil	 antimicrobial	 strategies	 is	 not	 only	required	for	sufficient	antimicrobial	defence	but	may	also	have	a	detrimental	
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effect	on	the	host.	NETs	contain	a	range	of	antimicrobial	agents	and	cytotoxic	mediators,	 including	 potent	 proteases	 as	 well	 as	 histones	 that	 have	 been	shown	to	cause	tissue	pathology	(Xu,	2009).	Studies	in	humans	indicate	that	failure	 to	 clear	 NETs	 from	 the	 tissue	 environment	 causes	 damage	 to	 the	organism	 (Hakkim,	 2010).	 Our	 findings	 highlight	 the	 need	 for	 a	 tight	regulation	 of	NETosis	 that	 serves	 as	 a	 protective	mechanism	 that	 prevents	unnecessary	 tissue	 damage	 driven	 by	 excessive	 NET	 release.	 Importantly,	mutation	 or	 blocking	 of	 dectin-1	 decreases	 phagocytosis,	 releasing	 the	regulatory	block	of	NE	sequestration	and	allowing	NE	translocation	and	NET	release	also	upon	stimulation	with	small	 fungal	particles.	NETosis	 triggered	by	 small	 microbes	 represents	 a	 de-regulation,	 since	 these	 particles	 can	 be	eliminated	 intracellularly.	 We	 demonstrate	 for	 the	 first	 time	 a	 direct	 link	between	the	disregulation	of	NET	release	and	tissue	pathology	caused	by	the	increased	 NETosis.	 Furthermore,	 in	 agreement	 with	 our	 findings,	 recent	studies	 show	 the	 release	 of	 NETs	 upon	 stimulation	with	 larger	 particulate	crystal	structures	such	as	monosodium	urate	or	cholesterol	crystals	(Schorn,	2012;	Warnatsch,	 2015).	 NETs	 triggered	 by	 cholesterol	 crystals	 have	 been	shown	 to	 contribute	 to	 the	 inflammatory	 phenotype	 of	 atherosclerosis	 by	amplifying	 inflammasome	 activation	 (Warnatsch,	 2015).	 Therefore,	 while	NET	 release	 upon	 stimulation	 by	 large	 microbes	 mediates	 clearance	 of	infection	 and	 containment	 of	 inflammation,	 NET	 activation	 by	 sterile	particles	 leads	 to	 prolonged	 persistence	 of	 NETs	 and	 amplification	 of	inflammation.	 These	 data	 confirm	 our	 findings	 that	 NETosis	 needs	 to	 be	tightly	regulated	to	ensure	efficient	immune	defence	while	preventing	tissue	pathology.	 In	 contrast,	 a	 study	 suggested	 that	 aggregated	 NETs	 release	proteases	 that	 degrade	 cytokines,	 reducing	 inflammation	 and	 pathology	 in	gout	 disease	 (Schauer,	 2014).	 However,	 the	 authors	 did	 not	 genetically	interrogate	the	role	of	NETosis	by	using	a	mouse	model	with	enhanced	NET	release,	 but	 injected	 NET	 aggregates	 into	 the	 inflamed	 tissue	 instead.	 The	physiological	 relevance	 of	 these	 findings	 remains	 to	 be	 investigated.	According	 to	 this	 study	NETs	might	be	beneficial	or	detrimental	depending	on	their	local	concentration.	
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The	 importance	 of	 regulated	 NET	 release	 also	 opens	 new	 pathways	 for	clinical	 understanding	 of	 NET-related	 conditions.	 Several	 autoimmune	diseases	 are	 characterised	 by	 the	 presence	 of	 anti-nuclear	 autoantibodies.	Not	 much	 is	 known	 about	 the	 triggers	 of	 autoimmune	 disorders	 such	 as	systemic	 lupus	 erythematosus	 (SLE)	 or	 rheumatoid	 arthritis	 (RA)	 and	 the	original	source	of	the	auto-antigens	that	cause	the	initial	break	of	tolerance.	The	release	of	NETs	into	the	extracellular	space	provides	a	source	of	nuclear	auto-antigens,	 including	 double-stranded	 DNA	 and	 citrullinated	 histones.	Understanding	the	regulation	of	NETosis	could	help	to	understand	the	onset	of	autoimmune	diseases.	According	to	our	findings	it	 is	possible	that	people	with	mutations	 in	 phagocytic	 receptors	 are	 prone	 to	 increased	NETosis.	 In	situations	of	severe	infection,	elevated	NET	release	could	excessively	expose	nuclear	 autoantigens,	 causing	 tolerance	 to	 break.	 Interestingly,	 studies	describe	an	increased	incidence	of	mutations	in	complement	receptor	CR3	in	patients	 with	 SLE	 (Zhou,	 2013).	 These	 mutations	 cause	 the	 complement-mediated	phagocytic	pathway	to	be	partially	reduced.	While	the	incidence	of	these	mutations	is	around	30%	in	the	healthy,	undiagnosed	population,	it	 is	increased	 to	 up	 to	 70%	 incidence	 in	 SLE	 patients.	 This	 indicates	 that	mutations	 in	 phagocytic	 receptors	 could	 be	 a	 potential	 risk	 factor	 for	 the	onset	of	autoimmune	disease	caused	by	the	loss	of	NET	regulation.	
To	 completely	 comprehend	 the	 circumstances	 under	 which	 NETs	 are	released,	 it	 is	 important	 to	 understand	 the	 initiating	 signals	 that	 activate	NETosis.	 Our	 results	 suggest	 that	 N-	 and	 O-linked	 glycosylation	 of	 the	 C.	
albicans	cell	wall	are	required	for	triggering	NETosis	and	that	TLR4	and	MR	might	be	involved	in	transducing	the	signals.	More	work	needs	to	be	done	to	verify	 these	 results	 and	 to	 uncover	 other	 receptors	 that	 are	 required	 to	initiate	 NET	 release.	 Understanding	 the	 activators	 of	 the	 NETosis	 pathway	would	 offer	 further	 therapeutic	 avenues	 for	 regulating	 this	 important	antimicrobial	strategy.	
Overall,	 our	 findings	 establish	 that	 neutrophils	 have	 the	 ability	 to	 respond	selectively	to	different	microbial	triggers.	The	tight	regulation	of	NET	release	
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is	 crucial	 for	 a	 sufficient	 antimicrobial	 defence	 against	 large	 pathogens	 as	well	 as	 for	 the	 prevention	 of	 host	 pathology.	 The	 implications	 of	 this	 tight	regulation	 for	 the	 onset	 of	 for	 example	 autoimmune	 diseases	 provides	potential	for	further	investigation.	
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Neutrophils	
Human	neutrophil	isolation	
Peripheral	blood	was	collected	with	consent	from	de-identified,	healthy	adult	volunteers	 according	 to	 the	 protocol	 approved	 by	 the	 Francis	 Crick	 ethics	board	according	to	the	Human	Tissue	Act.		
Neutrophils	 were	 freshly	 isolated	 as	 described	 elsewhere	 (Aga,	 2002).	 In	brief:	6	ml	of	heparinised	whole	blood	was	overlaid	over	6	ml	of	pre-warmed	Histopaque	1119	(Sigma,	11191)	in	15	ml	falcon	tubes	and	centrifuged	for	20	min	 at	 800	 x	 g.	 The	 plasma	 and	 PBMC	 layer	 were	 removed	 with	 pasteur	pipettes.	The	neutrophil	 layer	was	washed	with	10	ml	Hank’s	Balanced	Salt	Solution	 (HBSS)	 without	 magnesium,	 calcium	 or	 phenol	 red	 (Thermo	Scientific,	SH3058801)	with	0.1%	donor	plasma	(HBSS--)	and	centrifuged	for	10	 min	 at	 300	 x	 g.	 A	 percoll	 (GE	 healthcare,	 17-5445-02)	 gradient	 was	prepared	 from	 layers	of	2	ml	each.	The	 layers	were	 from	the	bottom:	85%,	80%,	75%,	70%	and	65%.	2	ml	of	neutrophils	re-suspended	in	HBSS--	were	overlaid	 over	 the	 gradient	 and	 centrifuged	 for	 20	 min	 at	 800	 x	 g.	 The	neutrophil	 layer	was	removed	and	washed	 in	10	ml	HBSS--.	The	neutrophil	pellet	 was	 re-suspended	 in	 2	 ml	 HBSS--.	 Neutrophils	 were	 counted	 in	 a	Thoma	hemocytometer.	 For	plating	 in	 cell	 culture	dishes,	 neutrophils	were	re-suspended	 in	 HBSS	 with	 magnesium	 and	 calcium,	 without	 phenol	 red	(HBSS++)	 (Thermo	 Scientific,	 SH3026801).	 3%	 donor	 plasma	 was	 added	were	indicated.	
Mouse	neutrophil	isolation	
Mouse	femur	and	tibia	of	the	hind	legs	were	removed	and	bone	marrow	was	flushed	 out	 with	 sterile	 PBS.	 Neutrophils	 were	 isolated	 using	 the	 Easysep	mouse	 neutrophil	 enrichment	 kit	 (Stemcell	 Technologies,	 19762)	 following	the	instructions.	In	brief:	bone	marrow	cells	were	incubated	with	a	negative	selection	 cocktail	 of	 antibodies	 targeting	 all	 cells	 but	 neutrophils.	Magnetic	
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beads	were	attached	to	the	antibodies	in	a	second	step.	Finally	all	antibody-bound	 cells	 were	 captured	 in	 the	 reaction	 tube	 using	 a	 strong	 magnet.	Neutrophils	were	poured	into	a	new	tube	and	washed	with	HBSS++.	
Mouse	 plasma	 was	 obtained	 by	 exsanguination	 of	 anesthetised	 mice.	 The	collected	blood	was	incubated	for	10	min	at	37°C.	Plasma	was	separated	by	centrifugation.	3%	plasma	was	used	in	all	in	vitro	experiments.	
NET	release	and	quantitation	
5x104	neutrophils	per	well	were	plated	on	 the	bottom	of	a	24-well	plate	 in	HBSS++	 in	 the	 presence	 or	 absence	 of	 3	 %	 human	 plasma	 as	 indicated.	Neutrophils	 were	 stimulated	 with	 the	 indicated	 stimuli.	 4	 h	 later	 Sytox	(Invitrogen,	 S7020)	was	 added	 and	 cells	were	 analysed	 for	NET	 release	by	fluorescent	microscopy.	Images	were	taken	using	Micro-Manager	(Edelstein,	2014).	
NET	release	was	scored	using	Fiji	(Schindelin,	2012)	as	previously	described	(Papayannopoulos,	2010).	In	brief:	Fluorescence	images	of	Sytox	signal	were	transformed	 into	 binary	 images.	 The	 area	 of	 the	 Sytox	 positive	 events	was	determined.	Area	values	were	distributed	 into	bins	of	 increasing	area	 sizes	and	 the	 results	were	 plotted	 as	 the	 area	 of	 each	 Sytox	 positive	 event	 over	total	number	of	 cells	 in	 the	 respective	bins.	Events	with	an	area	over	1000	µm2	were	considered	NETs.	
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Microbes	
Fungal	strains	
Strain	name	 Genotype	 Reference	
C.	albicans:	 	 	SC5314		 WT	 (Gillum,	1984)	yeast-locked	 hgc1Δ	 (Zheng,	2004)	NGY	337	 mnt1/mnt2Δ	 (Mora-Montes,	2010)	NGY	355	 pmr1Δ	 (Bates,	2005)	NGY	357	 och1Δ	 (Bates,	2006)	NGY	600	 [mnn2]6Δ	 (Hall,	2013)	CDH15	 mnn4Δ	 (Hobson,	2004)	NGY	152	 WT	(CAI4,	URA3Δ,	isogenic	to	SC5314)	 (Brand,	2004)	CAF2-1	 WT	(URA3	het,	isogenic	to	SC5314)	 (Fonzi	and	Irwin,	1993)	
A.	fumigatus:	 	 	NIH	5233	(ATCC	13073)	 WT	 (ATCC,	1307)	
Fungal	culture	and	hyphal	preparation	
All	fungal	strains	were	cultured	overnight	shaking	in	yeast	extract-peptone-dextrose	(YEPD)	medium	at	37°C	and	subcultured	in	YEPD	medium	the	next	morning.	To	induce	hyphal	growth	overnight	cultures	were	subcultured	for	4	h	in	Roswell	Park	Memorial	Institute	(RPMI)	medium.		
Heat-inactivation	was	 achieved	by	 incubating	C.	 albicans	 shaking	 for	 1	h	 at	90°C.	 Hyphae	 were	 fragmented	 using	 the	 EmulsiFlex-C5	 high-pressure	homogenizer	(Avestin).		
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Bacterial	strains	
Strain	 Reference	
E.	coli	DH5α	 (Laboratories,	1986)	
K.	pneumoniae	KP52145	 (Benghezal,	2007)	
M.	bovis	BCG-dsRed	 (Kasmapour,	2012).	
S.	pneumoniae	D39	 Dr	M.	Coles,	University	of	York	
Bacterial	culture	and	BCG	preparation	
E.	 coli	 and	K.	 pneumoniae	were	 cultured	 overnight	 in	 Lysogeny	 broth	 (LB)	shaking	at	37°C	and	subcultured	the	next	morning	to	an	OD600	of	1.	
S.	 pneumoniae	 D39	 was	 grown	 in	 brain–heart	 infusion	 broth	 under	microaerophilic	 conditions	 at	 37°C	 for	 16	 hours	 to	 autolytic	 phase,	 then	subcultured	 and	 grown	 to	 an	OD600	 of	 0.4,	 centrifuged	 and	 resuspended	 in	PBS	immediately	prior	to	infection.	
BCG-dsRed	(Kasmapour,	2012)	was	grown	to	an	OD600	of	0.8	in	Middlebrook	7H9	medium	supplemented	with	10%	Oleic	acid,	Albumin,	Dextrose,	Catalase	(OADC),	 0.05%	Tween-80,	 0.4%	glycerol	 and	50ug/ml	Hygromycin	 at	 37°C	with	 shaking	 at	 100	 rpm.	 Bacterial	 cultures	 were	 centrifuged	 and	 the	supernatant	 was	 repeatedly	 passed	 through	 a	 syringe	 to	 remove	 large	aggregates.	 The	 obtained	 single	 cells	 and	 small	 aggregates	 were	 used	 for	experiments.	
In	vitro	assays	
Immunoblotting	
1x106	human	peripheral	neutrophils	were	plated	HBSS++	 in	12-well	plates.	Neutrophils	were	stimulated	with	C.	albicans	yeast	or	pre-formed	hyphae.	At	indicated	 times	 cells	 were	 lysed	 in	 Sodium	 dodecyl	 sulphate	 (SDS)	 sample	buffer	and	stored	at	-80°C.	A	standard	immunoblotting	protocol	was	carried	
MATERIAL	AND	METHODS	
	
	
153	
out	 as	 described	 elsewhere.	 In	 brief:	 samples	were	 loaded	onto	 a	 Criterion	TGX	10-20	%	Tris-glycine	gel	(Biorad,	5671113)	and	run	for	20	min	at	300	V.	Proteins	were	transferred	onto	a	PVDF	membrane	(Biorad,	1704157),	using	the	Trans-Blot	Turbo	Transfer	System	(Biorad,	1704155).	Membranes	were	blocked	with	5%	skim	milk	(Sigma,	70166)	for	1	h.	Primary	antibodies	in	5%	skim	milk	 were	 incubated	 for	 1h	 and	 the	 membrane	 was	 washed	 in	 Tris-Buffered	 Saline	 and	 Tween	 20	 (TBST).	 Secondary	 antibodies	 coupled	 to	horseradish	 peroxidase	 (HRP)	 in	 5%	 skim	milk	were	 incubated	 for	 1h	 and	the	 membrane	 was	 washed	 again	 in	 TBST.	 The	 membrane	 was	 incubated	with	 enhanced	 chemiluminescent	 (ECL)	 substrate	 (Thermo	 Fisher,	 32106)	and	developed	onto	a	photo	film	in	the	dark	room.	
Primary	antibodies:	H3:	anti-histone	H3	(pan)	(Millipore,	07-690),	Syk:	anti-Syk	 (N-19)	 (Santa	Cruz,	 sc-1077),	pSyk:	anti-phospho-Zap-70	 (Tyr319)/Syk	(Tyr352)	 (Cell	 Signalling,	 2701s),	 ERK:	 p44/42	 MAPK	 (Erk1/2)	 (Cell	Signalling,	 9102S),	 pERK:	 ERK1/2	 (pTpY185/187)	 (Life	 Technologies,	44680G).	 Secondary	 antibody:	 goat	 anti-rabbit	 HRP	 (Thermo	 Scientific,	31463).	
Transwell	assay	
The	rims	of	conventional	24-well	transwell	inserts	(0.4	µm	pore	size,	10	µm	membrane	 thickness)	 (Corning	 Incorporated,	 3470)	were	 cut	 off	 to	 enable	the	 transwell	 strainer	 to	 sit	 directly	 on	 the	 bottom	 of	 the	 culture	 dish,	allowing	 for	 direct	 contact	 with	 the	 neutrophils	 plated	 in	 the	 well.	 For	stimulation,	C.	 albicans	yeast	was	 seeded	 in	 the	 transwell	 strainer.	 4h	 later	neutrophils	were	analysed	for	NET	release	as	described	above.	
Nuclei	of	neutrophils	attached	 to	 the	bottom	of	 the	 transwell	 strainer	were	stained	with	4',6-Diamidino-2-Phenylindole,	Dihydrochloride	(DAPI)	4	h	post	stimulation.	 The	 strainer	was	placed	on	 a	 coverslide	 and	 the	 attached	 cells	were	imaged	by	inverted	fluorescent	microscopy.	
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Reactive	oxygen	measurement	
1x106	 neutrophils	 were	 plated	 in	 white	 opaque	 96-well	 plates	 in	 100	 µl	HBSS++.	 After	 settlement	 of	 cells	 to	 bottom	 of	 the	 well,	 plates	 were	 pre-incubated	 on	 ice	 to	 delay	 ROS	 reaction	 to	 facilitate	 measurement.	 50	 µl	reaction	mix	 (	 1.2	 U/ml	 horseradish	 peroxidase	 (HRP),	 100	 µM	 luminol	 in	PBS)	was	added.	Neutrophils	were	immediately	stimulated	with	a	MOI	of	2.5	(2.5x106)	WT	C.	albicans	(yeast	or	pre-formed	hyphae)	or	C.	albicans	cell	wall	mutants	 as	 indicated.	 C.	 albicans	was	 spun	 onto	 the	 neutrophils	 and	 ROS	production	 was	 measured	 immediately	 as	 luminescence	 units	 at	 425	 nm,	using	a	FLUOstar	Omega	plate	reader	(BMG	Labtech).	
Phagocytosis	rate	and	blocking	phagocytosis	
3x105	 human	 peripheral	 neutrophils	 were	 plated	 on	 glass	 bottom	 petri	dishes	 (MatTEK,	 CCS-8)	 and	 incubated	 for	1	h	 in	 the	presence	of	 10	µg/ml	anti-dectin-1	 blocking	 antibody	 (BD6;	 AbD	 Serotec,	 MCA4662)	 prior	 to	stimulation.	Sytox	was	added	for	detection	of	NET	release.	Neutrophils	were	stimulated	with	C.	albicans	yeast	or	pre-formed	hyphae	and	NET	release	was	examined	over	 a	 time	of	4	h	using	 confocal	microscopy.	Time-lapse	 images	were	 analysed	 for	 number	 of	 phagocytosed	 particles	 by	 recording	 the	number	of	phagocytosed	particles	per	cell	for	each	frame.	
5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	for	1	h	at	37°C	in	the	presence	of	blocking	antibodies	against	mannose	 receptor	 (MR)	 (15-2;	 Invivogen,	 mab-hmr;	 10	 µg/ml),	 FcγR	(CD16/CD32	 Fc	 block,	 2.4G2;	 BD	 Bioscience,	 553142;	 0.5	 µg/ml)	 or	complement	 receptor	 3	 (CR3,	 CD11b)	 (ICRF44;	 Biolegend,	 301330;	 10	µg/ml).	 Subsequently	 neutrophils	 were	 stimulated	 with	 C.	 albicans	 pre-formed	hyphae	(MOI	=	10).	NET	release	was	assessed	4	h	later	as	described	above.	
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Inhibition	of	vesicle	fusion	
5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	 for	 1	 h	 at	 37°C	 in	 the	 presence	 of	 1	 µM	bafilomycin	 (Sigma,	B1793)	 or	 2.5	 µM	 nocodazole	 (Sigma,	 M1404).	 Subsequently	 neutrophils	were	stimulated	with	hgc1Δ	yeast-locked	C.	albicans	(MOI	=	10).	NET	release	was	assessed	4	h	later	as	described	above.	
Phagocytosis	of	yeast	or	beads	to	inhibit	NETosis	
Small	 polystyrene	 beads	 (3	 µm	 diameter,	 Krisker	 biotech)	were	 opsonized	for	30	min	at	37°C	with	100%	plasma	prior	to	stimulation.	5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	for	30	min	at	37°C	with	hgc1Δ	yeast-locked	C.	albicans	or	polystyrene	beads	to	induce	 phagocytosis.	 Afterwards	 neutrophils	 were	 stimulated	 with	 pre-formed	C.	albicans	hyphae	(MOI	=	10).	NET	release	was	assessed	4	h	later	as	described	above.	
Neutrophil	priming	
5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	 for	 1	 h	 at	 37°C	 in	 the	 presence	 of	 0.5,	 5	 or	 50	 ng/ml	recombinant	GM-CSF	(Peprotech,	300-03),	5	ng/ml	 IL-8	 (R&D,	208-IL-010),	500	U/ml	 IFN-αA	(Gibco,	PHC4014),	500	U/ml	 IFN-αA/B	(Miltenyi)	or	500	U/ml	IFN-β1a	(Gibco,	PHC4244).		
Receptor	blocking	
5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	for	1	h	at	37°C	in	the	presence	of	10	µg/ml	blocking	antibodies	against	TLR1	(H2G2;	Invivogen,	mabg-htlr1),	TLR2	(TL2.1;	e-Bioscience,	16-9922),	TLR4	(HTA125;	Santa	Cruz,	sc-13593),	TLR6	(C5C8;	Invivogen,	mabg-htlr6)	 and	 CD14	 (HCD14;	 Biolegend,	 325605)	 alone	 or	 in	 the	 indicated	combinations.	 Subsequently	 neutrophils	 were	 stimulated	 with	 C.	 albicans	
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pre-formed	 hyphae	 (MOI	 =	 10).	 NET	 release	 was	 assessed	 4	 h	 later	 as	described	above.	
Kinase	inhibition	
5x104	neutrophils	per	well	were	plated	on	the	bottom	of	a	24-well	plate	and	pre-incubated	for	1	h	at	37°C	in	the	presence	of	inhibitors	of	the	kinases	Syk	(BAY	61-3606;	Merck,	574717;	1	µM),	PI3K	(LY294002;	Cell	Signalling,	9901;	2	 µM),	 PKC	 (Gö	 7874;	 Merck,	 365252;	 1	 µM),	 MEK	 (PD184352;	 Sigma,	PZ0181;	2	µM)	or	Jak	(Ruxolitinib;	Invivogen,	tlrl-rux;	0.5	µM).	Subsequently	neutrophils	were	stimulated	with	C.	albicans	pre-formed	hyphae	(MOI	=	10).	NET	release	was	assessed	4	h	later	as	described	above.	
XTT	viability	assay	
Increasing	 amounts	 of	 neutrophils	 (5x103	 –	 5x105)	 were	 seeded	 in	 200	 µl	HBSS	++	in	a	96-well	plate.	Subsequently	neutrophils	were	stimulated	with50	µl	5x104	C.	albicans	pre-formed	WT	hyphae	(MOI	=	10	–	0.1	respectively).	At	indicated	 time	 points	 50	 µl	 of	 6	 mg/ml	 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide	 (XTT)	 was	 added.	 The	 plate	was	 incubated	 for	 30	min	 at	 37°C	 to	 allow	 for	 the	 colour	 reaction	 to	 take	place.	 100	 µl	 of	 the	 reaction	were	 transferred	 in	 duplicates	 into	 a	 new	96-	well	 plate	 and	 absorbance	was	 read	 at	 450	 nm.	 Viability	was	 expressed	 as	fold	change	compared	to	C.	albicans	hyphae	alone.	
In	vivo	mouse	infection	
All	mouse	 experiments	 conformed	 to	 the	 guidelines	 of	 the	 UK	 home	 office	under	an	approved	project	license.	
Mice	
The	mice	used	 in	 the	experiments	were	all	between	6	and	8	weeks	old	and	sex	 matched.	 C57BL/6	 mice	 were	 used	 as	 WT	 controls.	 All	 genetically	
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modified	 mice	 were	 bread	 on	 this	 background.	 Dectin-1	 KO	 mice	 were	obtained	 from	 Prof	 Gordon	 Brown	 (Aberdeen,	 UK).	 NADPH	 oxidase	 KO	(Cybb/J)	mice	were	obtained	from	Prof	Arturo	Zychlinsky	(Berlin,	Germany).	AhR	 KO	 mice	 were	 obtained	 from	 Prof	 Gitta	 Stockinger	 (Mill	 Hill	 London,	UK).	MyD88	KO	mice	were	obtained	from	Prof	Victor	Tybulewicz.	
	Mouse	infection	
Anesthetised	mice	were	 infected	 intratracheally	with	 the	 indicated	doses	of	
A.	fumigatus,	C.	albicans	hgc1Δ	yeast-locked	or	WT	(pre-formed	hyphae	only	where	 indicated).	 Infection	with	S.	pneumoniae	was	done	intranasally	by	Dr	Gregory	T	Ellis.	Weight	and	survival	of	mice	were	monitored	daily.	
Where	 indicated	2.5	µg/g	mouse	neutrophil	elastase	 inhibitor	(NEi)	(Sigma,	GW611313A)	 and	 0.4	 µg/g	 mouse	 AREG	 (R&D	 Systems,	 989-AR)	 were	administered	intraperitoneally	4	h	prior	to	infection	and	subsequently	every	24	h.	
Enumerating	fungal	load	
To	 assess	 fungal	 load,	 mouse	 organs	 (lungs	 and	 spleens)	 were	 dissected,	homogenized	 in	 sterile	 PBS	 and	 serial	 dilutions	 of	 the	 homogenates	 were	spread	onto	sabourad	dextrose	agar	plates.	Colonies	were	counted	after	plate	incubation	at	37°C.	
Microscopy	
Confocal	microscopy	of	fixed	cells	
5x104	 human	 peripheral	 neutrophils	 were	 plated	 on	 glass	 coverslips	 1	 h	prior	 to	 stimulation.	 After	 stimulation,	 cells	 were	 fixed	 with	 2%	paraformaldehyde	 for	 20	 min	 at	 37°C.	 Immunofluorescence	 staining	 was	performed	as	described	elsewhere.	 In	brief:	 cells	were	permeabilised	using	phosphate	 buffered	 saline	 (PBS),	 0.5%	Triton-X-100	 for	 2	min.	 Slides	were	
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washed	with	PBS	and	blocked	with	blocking	buffer	(PBS,	2%	BSA,	2%	donkey	serum)	 for	 1	 h.	 Slides	were	 incubated	with	 primary	 antibodies	 in	 blocking	buffer	 for	 1h,	 washed	 with	 PBS,	 incubated	 with	 secondary	 antibodies	 in	blocking	 and	 DAPI	 in	 blocking	 buffer	 for	 1h	 and	 washed	 with	 PBS	 again.	Coverslips	 were	 mounted	 on	 glass	 microscopy	 slides	 with	 ProLong	 Gold	antifade	mountant	(Thermo	Scientific,	P36934).		
Primary	 antibodies:	 Anti-neutrophil	 elastase	 (NE)	 (Abcam,	 ab21595),	 anti-human/mouse	 myeloperoxidase	 (MPO)	 (R&D	 Systems,	 AF3667),	 anti-C.	albicans	(Acris,	BP1006),	anti-p40	(1.22;	Millipore,	05-794),	anti-p47	(Santa	Cruz,	 sc-17845),	 anti-CD63	 (RFAC4;	 Millipore,	 CBL553),	 DAPI	 (Life	technologies,	D1306).	Secondary	antibodies:	donkey	anti-rabbit,	donkey	anti-mouse	 coupled	 to	 AlexaFluor	 488,	 AlexaFluor	 468	 or	 AlexaFluor	 647	 (all	Invitrogen).	
Stained	cells	were	imaged	using	confocal	microscopy.	Images	were	analysed	using	Fiji	(Schindelin,	2012).	
Confocal	microscopy	of	tissue	
For	 lung	histology	dissected	 lungs	of	 infected	mice	were	 fixed	over	night	 in	2%	 paraformaldehyde	 and	 embedded	 in	wax	 for	 sectioning.	 Sections	were	treated	with	a	standard	antigen	retrieval	protocol	and	 immunofluorescence	staining	 as	 described	 elsewhere.	 In	 brief:	Wax	 sections	were	 baked	 for	 60	min	at	60°C.	Wax	was	removed	for	10	min	in	NeoClear	(VWR,	1.09843.5000).	Slides	were	 rehydrated	 in	 an	 ethanol	 series	 (100%,	96%,	80%,	70%,	50%)	for	5	min	each	and	rinsed	in	aqua	dist.	and	PBS	afterwards.	Antigen	retrieval	was	 done	 for	 20	 min	 at	 95°C	 in	 10	 mM	 sodium	 carbonate	 buffer	 (0.1	 M	Na2CO3,	 0.1	 M	 NaHCO3,	 0.5	 M	 ethylene-diamine-tetraacetic	 acid	 (EDTA),	0.05%	Tween	20;	pH9).	Slides	were	cooled	to	room	temperature	and	tissues	were	 permeabilised	 using	 PBS,	 0.5%	 Triton-X-100	 for	 2	 min.	 Slides	 were	washed	with	PBS	and	blocked	with	blocking	buffer	(PBS,	2%	BSA,	2%	donkey	serum)	 for	 1	 h.	 Slides	were	 incubated	with	 primary	 antibodies	 in	 blocking	
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buffer	 for	 1h,	 washed	 with	 PBS,	 incubated	 with	 secondary	 antibodies	 in	blocking	 and	 DAPI	 in	 blocking	 buffer	 for	 1h	 and	 washed	 with	 PBS	 again.	Coverslips	 were	 mounted	 onto	 the	 slides	 using	 ProLong	 Gold	 antifade	mountant	(Thermo	Scientific,	P36934).	
Cit-H3:	 anti-Histone	 H3	 (citrulline	 R2	 +	 R8	 +	 R17)	 (Abcam,	 ab5103),	 anti-human/mouse	myeloperoxidase	 (MPO)	 (R&D	Systems,	AF3667),	DAPI	 (Life	technologies,	D1306).	Secondary	antibodies:	donkey	anti-rabbit,	donkey	anti-mouse	 coupled	 to	 AlexaFluor	 488,	 AlexaFluor	 468	 or	 AlexaFluor	 647	 (all	Invitrogen).	
Slides	 were	 imaged	 using	 confocal	 microscopy.	 Image	 analysis	 was	performed	using	Fiji	(Schindelin,	2012).	
Confocal	microscopy	of	live	cells	and	M.	bovis	
6x105	human	peripheral	neutrophils	were	plated	with	Sytox	on	glass	bottom	cell	culture	slides	(MatTEK,	CCS-8)	and	stimulated	with	a	mixture	of	M.	bovis	BCG-dsRed	 single	 cells	 and	 aggregates.	 NET	 release	 was	 examined	 over	 a	period	of	4h	using	confocal	microscopy.	Time-lapse	images	were	analysed	for	NET	release	using	Fiji	(Schindelin,	2012).	
Histological	scores	for	tissue	damage.	
Dissected	 lungs	 of	 infected	 mice	 were	 fixed	 overnight	 in	 2%	paraformaldehyde	 and	were	 embedded	 in	wax	 for	 sectioning.	 The	 sections	were	 rehydrated	 as	 described	 above,	 were	 stained	 with	 hematoxilin	 and	eosin	and	imaged	with	a	VS120	virtual	slide-scanning	system	(Olympus).	15	images	 of	 each	 section	 were	 randomly	 assigned	 for	 analysis	 of	 fibrin	deposition	and	bleeding	in	the	tissue	according	to	the	following	scores:	fibrin	score,	0	 (no	 fibrin	deposition	 in	airspace),	1	 (few	 fibrin	 fibres),	2	 (<50%	of	airspace	filled	with	fibrin	deposition)	or	3	(>50%	of	airspace	filled	with	fibrin	deposition);	and	bleeding,	0	(none),	1	(mild:	fewer	than	five	red	blood	cells	in	
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at	 least	 5–10%	 of	 alveoli	 ),	 2	 (moderate:	 five	 to	 ten	 red	 blood	 cells)	 or	 3	(severe:	over	ten	red	blood	cells	in	>10%	of	alveoli).	
Immunohistochemistry	
Lung	 sections	 treated	 as	 described	 above	 were	 stained	 with	 antibody	 to	tumour-necrosis	 factor	 (Abcam,	 ab6671)	 followed	 by	 a	 biotinylated	secondary	 antibody	 (Vector	 Laboratories,	 BA-1000)	 amplified	 with	Streptavidin	 ABC	 (Vector	 Laboratories,	 PK-6100),	 then	 were	 treated	 with	DAB	 (3,3-diaminobenzidine	 tetrahydrochloride;	 Vector	 Laboratories,	 SK-4100)	 and	 imaged	 by	 light	 microscopy.	 DAB	 reactions	 were	 performed	 in	parallel	and	at	the	same	time	for	all	samples.	
Quantification	of	NE	localization	
Confocal	z-series	(every	0.8	μm)	covering	the	entire	neutrophil	were	used	to	quantify	total	NE	and	NE	co-localizing	with	the	nucleus	using	Fiji	(Schindelin,	2012).	 For	 nuclear	 localization	 the	 NE	 signal	 was	 measured	 using	 a	 mask	created	 with	 the	 corresponding	 DAPI	 (DNA)	 channel	 for	 each	 section.	 NE	signals	 in	 individual	sections	were	added	to	yield	 the	total	NE	 for	each	cell.	15-20	neutrophils	per	condition	were	processed.		
Live	microscopy	of	C.	albicans	growth	inhibition	
2.5x105	neutrophils	per	well	were	plated	 in	HBSS++	 in	8-well	 glass	bottom	dishes	in	the	presence	of	DAPI	and	Sytox.	Where	indicated	50	U/ml	DNase	I	was	 added.	 Subsequently	 neutrophils	 were	 stimulated	 with	 2x104	 (MOI	 x	0.04)	 C.	 albicans	 pre-formed	 hyphae.	 Wells	 were	 imaged	 by	 inverted	fluorescence	microscopy	over	the	course	of	10	hours	at	37°C	and	5%	CO2.	
Images	were	analysed	using	Fiji	(Schindelin,	2012).	Increase	in	hyphal	length	was	determined	using	the	NeuronJ	plugin	(Meijering,	2004).	
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Statistics	
P	values	were	calculated	by	the	statistic	tests	indicated	in	the	figure	legends	of	 the	 respective	 experiments.	 P	 values	 of	 0.05	 or	 less	 were	 considered	significant.	
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Abbreviations	
ABAH	 4-aminobenzoic	acid	hydrazide	ACPA	 anti-citrullinated	peptide	antibodies	adsA	 adenosine	synthase	AhR	 aryl	hydrocarbon	receptor	AIM2	 absent	in	melanoma	2	ANA	 anti-nuclear	antibodies	ANCA	 anti-neutrophil	cytoplasmic	antibodies	AOX	 alternative	oxidase	AP-1	 activator	protein	1	APRIL	 a	proliferation-inducing	ligand	AREG	 amphiregulin	AZU	 azurocidin	BAFF	 B	cell	activating	factor	BCG	 Bacillus	Calmette–Guérin	(Mycobacterim	bovis	strain)	BCR	 B	cell	receptor	BM	 bone	marrow	BUVEC	 bovine	umbilical	vein	endothelial	cell	
C.	albicans	 Candida	albicans	C/EBPα	 CCAAT/enhancer	binding	protein	α	C5a	 complement	component	5a	CARD9	 caspase	recruitment	domain-containing	protein	9	CD	 cluster	of	differentiation	CF	 cystic	fibrosis	CFU	 colony-forming	units	CG	 cathepsin	G	CGD	 chronic	granulomatous	disease	citH3	 citrullinated	Histone	3	CLR	 C-type	lectin	receptor	CPS-I	 capsular	polysaccharide	I	CR3	 complement	receptor	3	
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CRAMP	 cathelicidin-related	antimicrobial	peptide	CTLD	 C-type	lectin-like	domain	CTSC	 cysteine	protease	cathepsin	C	dAdo	 deoxyadenosine	DAP12	 DNAX	activation	protein	of	12kDa	DAPI	 4',6-diamidino-2-phenylindole	DC	 dendritic	cell	DC-SIGN	 dendritic	cell-specific	intercellular	adhesion	molecule-3-grabbing	non-integrin	DPI	 diphenyleneiodonium	DPPI	 dipeptidyl	peptidase	1	EC	 epithelial	cell	Egr2	 early	growth	response-2	EM	 erythromyeloid	progenitor	endA	 endonuclease	A	ERK	 extracellular	signal-regulated	kinase	FPR	 formyl	peptide	receptor	G-CSF	 granulocyte	stimulating	factor	GAS	 group	A	streptococcus	Gfi-1	 growth	factor	independent-1	GFTP	 guanosine	diphosphate-fucose	transporter	GM-CSF	 granulocyte-macrophage	colony-stimulating	factor	GMP	 granulocyte/monocyte	precursor	GO	 glucose	oxidase	GPCR	 G-protein-coupled	receptor	GPI	 glycosylphosphatidylinositol	GPR43	 G-protein-coupled	receptor	43	HE	 hematoxylin	and	eosin	HSC	 hematopoietic	stem	cell	HSPC	 hematopoietic	stem	and	progenitor	cell	ICAM-1	 intercellular	adhesion	molecule	1	IDO	 indoleamine-2,3-dioxygenase	
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IFN	 interferon	IL-		 interleukin	ILC	 innate	lymphoid	cell	IRAK4	 interleukin-1	receptor-associated	kinase	4	IRF	 interferon	regulatory	factor	ITAM	 immunoreceptor	tyrosine-based	activation	motif	Jak	 janus	kinase	kDa	 kilo	dalton	KO	 knock-out	LAD	 leukocyte	adhesion	deficiencies	LER	 low	expression	region	LFA-1	 lymphocyte	function-associated	antigen	1	LMP	 lymphomyeloid	progenitor	LOS	 lipooligosaccharides	LPS	 lipopolysaccharide	LTB4	 leukotriene	B4	lukGH	 leukotoxin	GH	Mac-1	 macrophage-1	antigen	MAPK	 mitogen-activated	protein	kinase	MDA5	 melanoma	differentiation	antigen	5	MDP	 muramyl	dipeptide	MDSC	 myeloid-derived	suppressor	cell	MEK	 mitogen-activated	protein	kinase	kinase	MHC	 major	histocompatibility	complex	MMP-8	 metalloprotease-8	MNase	 micrococcal	nuclease	MOI	 multiplicity	of	infection	MPO	 myeloperoxidase	MPP	 multipotent	precursor	MR	 mannose	receptor	MRP	 myeloid	related	protein	MSU	 monosodium	urate	
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MyD88	 myeloid	differentiation	primary	response	gene	88	MZ	 marginal	zone	NADPH	 nicotinamide	adenine	dinucleotide	phosphate	NE	 neutrophil	elastase	NEi	 neutrophil	elastase	inhibitor	NET	 neutrophil	extracellular	trap	NF-κB	 nuclear	factor-κB	NFAT	 nuclear	factor	of	activated	T-cells	NK	cell	 natural	killer	cell	NLR	 nucleotide-binding	oligomerisation	domain	(NOD)-like	receptor	NLRP3	 NOD-,	LRR-	and	pyrin	domain-containing	3	NS	 not	significant	NTHI	 nontypeable	Haemophilus	influenzae	OPC	 oropharyngal	candidiasis	PAD4	 peptidylarginine	deiminase	4	PAF	 platelet	activating	factor	PAMP	 pathogen	associated	molecular	pattern	PD-L1	 programmed	death-ligand	1	pDCs	 plasmacytoid	dendritic	cells	PI3K	 phosphoinositide	3-kinase	PKA	 protein	kinase	A	PKC	 protein	kinase	C	PLC	 phospholipase	C	PLS	 Papillon-Lefèvre	syndrome	PMA	 phorbol	myristate	acetate	PMN	 polymorphnuclear	cell	PPARγ	 peroxisome	proliferator	activated	receptor-γ	PR3	 proteinase	3	PRR	 pattern	recognition	receptor	PSGL-1	 P-selectin	glycoprotein	ligand-1	PSMγ	 phenol-soluble	modulin	δ-toxin	
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RA	 rheumatoid	arthritis	RIG-I	 retinoic	acid-inducible	gene	1	RIP2	 receptor-interacting	serine/threonine	protein	kinase	2	ROS	 reactive	oxygen	species	RSV	 respiratory	syncytial	virus	SC	 stem	cell	SCAMP	 secretory	carrier	membrane	protein	SCN	 severe	congenital	neutropenia	SDF1	 stromal	derived	factor	1	SLE	 systemic	lupus	erythematosus	SNARE	 soluble	N-methylmaleimide-sensitive	factor	attachment	protein	(SNAP)–receptor	SOD	 superoxide	dismutase	SsnA	 secreted	nuclease	A	STAT1	 signal	transducer	and	activator	of	transcription-1	Syk	 spleen	tyrosine	kinase	TCR	 T	cell	receptor	TEM	 transendothelial	migration	TLR	 Toll-like	receptor	TNFα	 tumour	necrosis	factor	α	TRIF	 TIR-domain-containing	adapter-inducing	interferon-β	Unst	 unstimulated	Untr	 untreated	UPR	 unfolded	protein	response	VAMP-2	 vesicle-associated	membrane	protein	2	VLA-4	 very	late	antigen-4	VVO	 vesiculovacuolar	organelle	vWF	 van	Willebrand	factor	WHIM	 warts,	hypogammaglobulinemia,	infections,	myelokathexis	WT	 wild-type	XTT	 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide	
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